Development and Application of Comparative Genomic Hybridisation (CGH) by Ghaffari, Saeed R
Development and Application of 
Comparative Genomic Hybridisation (CGH)
Saeed R. Ghaffari M.Sc. M.D.
Thesis submitted to the Faculty of Medicine, University of Glasgow, for 
the degree of Doctor of Philosophy (Ph.D.)
Institute of Medical Genetics, Yorkhill Hospitals Campus, 
University of Glasgow
©  October 1998
ProQuest Number: 11007712
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007712
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
GLASGOW 
universht 
h b r a k t
"GLftSGOW UWWHSirf 
UBRASW
/3G^
To: Jila
“With them the Seed of Wisdom did I sow, 
And with my own hand labour'd it to grow: 
And this was all the Harvest that I reap'd— 
I came like Water, and like Wind I go." 
(Rubayyat of Omar Khayyam)
TABLE OF CONTENTS
D E C L A R A T IO N .............................................................................................................................................. ix
L IS T  OF P U B L IC A T IO N S ............................................................................................................................. X
LIST OF A B S TR A C TS................................................................................................................................... X
Posters:............................................................................................................................................................x
Spoken presentations:...................................................................................................................................x
OTHER PR ESEN TA TIO N S..........................................................................................................................XI
TAB LE OF F IG U R E S ....................................................................................................................................XII
L IS T  OF A B B R E V IA TIO N S ..................................................................................................................... xvn
A C K N O W LED G EM EN TS..........................................................................................................................x ix
S U M M A R Y ...................................................................................................................................................... x x
1 : IN T R O D U C T IO N ......................................................................................................................................1
1.1 B a c k g r o u n d ............................................................................................................................................ 2
1.2 T he ce ll , th e  ch ro m o so m e , a n d  th e  D N A .................................................................................... 4
1.2.1 The c e ll ............................................................................................................................................. 4
1.2.2 Structure o f  D N A ............................................................................................................................4
1.2.3 Sequence architecture o f the human genome............................................................................ 5
1.2.4 Human chromosomes.....................................................................................................................5
Chromosome structure................................................................................................................................6
1.3 Chromosomes in  c l in ic a l  m e d ic in e ................................................................................................. 6
1.3.1 Chromosome aberrations..............................................................................................................6
Numerical aberrations.................................................................................................................................7
Structural aberrations..................................................................................................................................7
1.3.2 Cryptic chromosomal ab errations...............................................................................................9
1.3.3 Chromosomes in malignan t diseases..........................................................................................9
1.4 M ethods of ch ro m o so m e  a n a l y s is ............................................................................................... 10
1.4.1 Cell Culture....................................................................................................................................10
1.4.2 Harvesting and Slide Preparation ............................................................................................ 10
1.4.3 Banding techniques...................................................................................................................... 10
Solid Staining............................................................................................................................................ 11
G (Giemsa) banding.................................................................................................................................. 11
High resolution banding............................................................................................................................11
Other banding techniques......................................................................................................................... 12
1.4.4 Fluorescence in situ hybridisation (FISH)..............................................................................12
Denaturation and hybridisation principles................................................................................................12
Probe labelling........................................................................................................................................... 14
Direct and indirect detection..................................................................................................................... 14
Denaturation of probe and target DNA.....................................................................................................14
In situ suppression hybridisation...............................................................................................................15
iv
Post-hybridisation and detection washings.............................................................................................. 15
Principles of fluorescence microscopy..................................................................................................... 16
Image analysis in FISH............................................................................................................................. 16
FISH probes and their applications..........................................................................................................17
Multicolour FISH......................................................................................................................................18
Fibre-FISH................................................................................................................................................ 19
Reverse chromosome painting................................................................................................................. 19
1.4.5 Comparative Genomic Hybridisation (CGH)........................................................................ 20
Metaphase chromosomes for CGH.......................................................................................................... 21
Isolation of DNA for C G H ...................................................................................................................... 21
Differential labelling of D N A ..................................................................................................................22
Hybridisation and post-hybridisation....................................................................................................... 22
Fluorescence microscopy and visual analysis of C G H ........................................................................... 23
Acquisition and display of digital images................................................................................................24
Sensitivity and Mapping resolution......................................................................................................... 26
Applications of CGH................................................................................................................................27
Limitations and difficulties...................................................................................................................... 30
1.5 A im s  of this  s t u d y .............................................................................................................................. 31
2 : MATERIALS AND METHODS................................................................................................ 32
2.1 Sa f e t y .....................................................................................................................................................33
2.2 Patients  a n d  samples ........................................................................................................................ 33
2.3 Culture  techniques  and  chrom osom e  pr ep a r a tio n ............................................................. 34
2.3.1 Peripheral blood culture............................................................................................................ 34
2.3.2 Harvesting.....................................................................................................................................34
2.3.3 Slide preparations........................................................................................................................35
2.3.4 G-banding.....................................................................................................................................35
2.4 F luorescence in situ hybrid isation  (F IS H )...............................................................................37
2.4.1 Labelling o f  probes by nick translation...................................................................................37
Direct labelling of D N A ...........................................................................................................................38
Indirect labelling of D N A .........................................................................................................................38
2.4.2 Labelling o f  probes by PC R ...................................................................................................... 38
2.4.3 Pre-hybridisation and hybridisation........................................................................................40
Slide preparation...................................................................................................................................... 40
Denaturing of target DNA and the probe.................................................................................................40
Hybridisation............................................................................................................................................41
2.4.4 Post-hybridisation........................................................................................................................41
Washing steps...........................................................................................................................................41
Detection.................................................................................................................................................. 42
Visualisation.............................................................................................................................................42
2.5 Extrac tio n  of g eno m ic  D N A ..........................................................................................................43
2.5.1 Blood and bone marrow............................................................................................................. 43
2.5.2 Fixed cells.....................................................................................................................................44
V
2.5.3 Solid tumours.................................................................................................................................44
2.6 Co m p a r a tive  Ge n o m ic  H yb r id is a t io n  (C G H )............................................................................ 44
2.6.1 Metaphase Spreads......................................................................................................................44
2.6.2 Genomic DNA Probes and Labelling Procedures................................................................45
2.6.3 Pre-hybridisation and hybridisation....................................................................................... 45
2.6.4 Washing steps................................................................................................................................ 46
2.6.5 Digital image analysis...............................................................................................................47
2.6.6 SmartCapture™ V 2.1................................................................................................................ 47
Image capture........................................................................................................................................... 47
Flat fielding...............................................................................................................................................50
Background removal.................................................................................................................................51
DAPI enhancement...................................................................................................................................51
Thresholding..............................................................................................................................................52
Fluorescence ratio (FR) equalisation........................................................................................................53
Global analysis.......................................................................................................................................... 53
Axial analysis........................................................................................................................................... 54
2.6.7 Quips CGH analysis....................................................................................................................54
2.7 T he polymerase  c h a in  rea c tio n  (PCR)........................................................................................57
2.7.1 Standard PCR ................................................................................................................................57
2.7.2 DOP-PCR.......................................................................................................................................59
2.7.3 Quantitative PCR..........................................................................................................................60
2.7.4 Purification o f PCR products.................................................................................................... 61
Isopropanol precipitation of PCR products..............................................................................................61
Millipore Ultrafree ® filter units..............................................................................................................61
2.7.5 Identification of PCR products................................................................................................. 62
2.8 Pla s m id /C o sm id  Probe Cultu r e  and  is o l a t io n .......................................................................63
2.9 Preparation  of single  stran ded  D N A  by  m a g n etic  se pa r a tio n .......................................64
2.10 D N A  MOLECULES AS HYBRIDISATION TARGETS.............................................................................. 66
2.10.1 Slide preparation......................................................................................................................... 66
Silanisation of glass supports....................................................................................................................66
Poly-l-lysine treatment............................................................................................................................. 67
2.10.2 Comparative hybridisation to DNA fibres ...............................................................................67
Preparation of probe and target D N A ...................................................................................................... 68
Alignment of DNA by a moving interface (Molecular combing)........................................................... 68
Dual-colour FISH to aligned DNA fibres................................................................................................ 69
CGH to dotted DNA fibres.......................................................................................................................71
2.10.3 CGH to DNA microarrays.......................................................................................................... 72
Hybridisation targets.................................................................................................................................72
Pre-hybridisation and hybridisation..........................................................................................................73
Image analysis.......................................................................................................................................... 73
3 : R E S U LT S ...................................................................................................................................................74
vi
3.1 Optim isa tio n  of th e  C G H  techn iq ue  for c l in ic a l  cyto genetics  la b o r a to r y ............. 75
3.1.1 CGH using published protocols............................................................................................... 75
3.1.2 Modification o f  the CGH technique........................................................................................ 76
Target metaphase...................................................................................................................................... 77
Genomic DNA labelling............................................................................................................................80
DNA hybridisation.................................................................................................................................... S3
Post-hybridisation washings.....................................................................................................................84
Image processing and analysis..................................................................................................................84
3.2 T est of m o d if ie d  protocol u sin g  kno w n  cyto g enetic  a b n o r m a lities .............................87
3.3 I m pr o vin g  l im its  of C G H .................................................................................................................91
3.3.1 CGH on a case with low percentage supernumerary marker chromosome.................... 91
Earlier results.............................................................................................................................................91
CGH Analysis............................................................................................................................................94
FISH confirmation of the CGH results.....................................................................................................94
3.3.2 CGH on samples with suspected cryptic abnormalities......................................................94
Detection of cryptic chromosomal translocations.................................................................................... 95
Family 1 .................................................................................................................................................... 95
Family 2 .................................................................................................................................................. 101
Family 3 .................................................................................................................................................. 101
Further CGH on suspected cases of cryptic abnormalities.....................................................................102
3.3.3 CGH on a sample with hypotriploidy....................................................................................102
3.3.4 Overnight CG H .........................................................................................................................108
3.4 Reinterpretatio n  of a  pu ta tiv e  isochrom osome  X p ............................................................110
3.5 A CASE of fo llicular  ly m p h o m a  w it h  co m plex  chrom osom e  a b n o r m a l it ie s ........... 114
Conventional chromosome analysis......................................................................................................114
CGH analysis.............................................................................................................................................114
FISH confirmation o f  CGH results........................................................................................................117
3.6 CGH in  h a em a to lo g ic a l  m a l ig n a n c ie s .................................  119
Volume o f  samples.....................................................................................................................................119
Comparison o f  CGH results with G-banding results.........................................................................119
A case of ALL with 9p;9q translocation.................................................................................................119
A case of AML with chromosome Y monosomy...................................................................................120
A case of CML with 9q-..........................................................................................................................120
3.7 CGH USING UNIVERSALLY AMPLIFIED D N A  SAMPLES................................................................  124
3.8 D N A  MOLECULES AS HYBRIDISATION TARGETS............................................................................  126
3.8.1 DNA fibres.................................................................................................................................. 126
Single DNA fibres................................................................................................................................... 126
CGH to dotted high density DNA fibres.................................................................................................141
3.8.2 DNA microarrays..................................................................................................................... 147
Optimisation............................................................................................................................................147
CGH to Single stranded DNA arrays...................................................................................................... 149
:D IS C U S S IO N ......................................................................................................................................... 157
4.1 O p t im is a t io n  o f  t h e  CGH t e c h n iq u e  f o r  c l in ic a l  c y t o g e n e t ic s  l a b o r a t o r y ..............158
4.1.1 Target metaphase..............................................................................................................158
4.1.2 Denaturation conditions....................................................................................................159
4.1.3 Genomic DNA concentration............................................................................................159
4.1.4 Genomic DNA labelling....................................................................................................159
4.1.5 Probe size...........................................................................................................................160
4.1.6 Post-hybridisation steps....................................................................................................160
4.1.7 Image analysis...................................................................................................................160
4.1.8 The modified protocol.......................................................................................................161
4.2 T e s t  o f  m o d if ie d  p r o t o c o l  u s in g  k n o w n  c y t o g e n e t ic  a b n o r m a l it ie s ............................. 161
4.3 I m p r o v in g  l i m it s ..................................................................................................................................................... 162
4.3.1 Mosaic supernumerary ring Chromosome 19 identified by CGH.................................162
4.3.2 CGH for cryptic translocation screening in patients with idiopathic mental retardation 
164
4.3.3 CGH for hyperploid tumours............................................................................................168
4.3.4 Ch’ernigh t CGH ............................................................................................................... 169
4.4 R e in t e r p r e t a t io n  o f  a  p u t a t iv e  is o c h r o m o s o m e  X p ......................................................................170
4.5 A c a s e  o f  f o l l ic u l a r  l y m p h o m a  w it h  d o u b l e  m in u t e s  AND c o m p l e x  c y t o g e n e t ic
a b n o r m a l it ie s .....................................................................................................................................................................171
4.6 CGH FOR THE INVESTIGATION OF HAEMATOLOGICAL MALIGNANCIES...........................................  172
4.6.1 A case o f  ALL with 9p;9q translocation.......................................................................... 172
4.6.2 A case ofAML with loss o f  the Y chromosome............................................................. 174
4.7 CGH USING UNIVERSALLY AMPLIFIED DNA SAMPLES.......................................................................... 175
4.8 DNA MOLECULES AS HYBRIDISATION TARGETS.......................................................................................  176
4.8.1 Comparative hybridisation to DNA fibre targets............................................................176
4.8.2 CGH to dotted high-density DNA fibres........................................................................ 178
4.8.3 CGH to DNA microarrays................................................................................................ 178
4.9 C o n c l u s io n  a n d  f u t u r e  p r o s p e c t s ..............................................................................................................179
: REFERENCES.............................................................................................................................. 181
DECLARATION
I certify that this thesis does not contain material previously published or written by any other 
person except where referred to in the text and that the results of this study have not been 
submitted for any other degree or diploma. Parts of the results of this study are published in 
journals, or presented in conferences or meetings as indicated in the next page.
S.R. Ghaffari
ix
LIST OF PUBLICATIONS
Ghaffari SR, Boyd E, Tolmie JL, Crow YJ, Trainer AH, Connor JM. A new strategy for cryptic 
telomeric translocation screening in patients with idiopathic mental retardation. J Med Genet 
1998,35:225-233
Ghaffari SR, Boyd E, Connor JM. Jones AM Tolmie JL. Mosaic supernumerary ring 
chromosome 19 Identified by comparative genomic hybridisation J M ed Genet 1998;35:836- 
840
Ghaffari SR, Boyd E, Reid R, Paterson L, Connor JM. A case of follicular lymphoma with 
double minutes and amplification of 3p26. Cancer Genet Cytogenet.{In press).
LIST OF ABSTRACTS
Posters:
Ghaffari SR, Boyd E, Stewart J, Connor JM. Comparative genomic hybridisation in the 
investigation of haematological malignancies. J Med Genet 1997:34:(2.32)
Ghaffari SR, Boyd E, Tolmie JL, Connor JM.Comparative genomic hybridisation reveals the 
origin of a mosaic, supernumerary ring chromosome 19 in a 70 year old lady with mental 
retardation. J Med Genet 1997:34 (12.07).
Ghaffari SR, Boyd E, Reid R, Paterson L, Connor JM. A case of follicular lymphoma with 
double minutes and 3p26 amplification. J M ed Genet 1998:34 (2.21).
Spoken presentations:
Ghaffari SR, Boyd E, Tolmie JL, Crow YJ, Trainer AH, Conner JM. A novel strategy for 
cryptic telomeric translocation screening in patients with idiopathic mental retardation. J Med  
Ge/ieM  997:34 (SP65)(British Human Genetics Conference September 1997)
x
Ghaffari SR. CGH for constitutional chromosome abnormalities and prospects for CGH to 
DNA microarray targets. J Med Ge/ieM  998:35 (SP03) (British Human Genetics Conference 
September 1998)
OTHER PRESENTATIONS
Cytogenetics, past, present and future. Cytogenetic Symposium, Glasgow 23rd May 1997
Comparative genomic hybridisation in clinical genetics. University of Glasgow seminar in 
Medical Genetics, 11th February 1998
xi
TABLE OF FIGURES
CHAPTER 1
Figure 1.1: Specific pairing of the two strands of the DNA.....................................................................5
Figure 1. 2: Structural abnormalities.(l)..................................................................................................... 8
Figure 1. 3: Structural abnormalities (2)..................................................................................................... 8
Figure 1. 4:Denaturation and hybridisation of DNA:............................................................................... 13
Figure 1. 5: A flow diagram of the main steps of fluorescence in situ hybridisation (FISH)............... 13
Figure 1. 6: Schematic illustration of CGH...............................................................................................21
Figure 1. 7: A schematic diagram of CGH analysis illustrating the quantitation of green and red
fluorescence intensity ratios along chromosomes............................................................................ 28
Figure 1. 8. Detection of chromosomal imbalance by CGH and digital image analysis.....................29
CHAPTER 2
Figure 2.1: Normalisation window...........................................................................................................48
Figure 2. 2: CGH image capture settings...................................................................................................49
Figure 2. 3: Settings for flat fielding in the capture window...................................................................50
Figure 2. 4: BackgroundRemove window: Settings for CGH images................................................... 51
Figure 2. 5: Segmentation of the chromosomes in a CGH image........................................................... 52
Figure 2. 6: ColourRatio window settings for CGH................................................................................ 53
Figure 2. 7: Outline of CGH study using Quips CGH analysis software....................................... 56
Figure 2. 8: Schematic diagram for magnetic separation of DNA strands.............................................65
CHAPTER 3
Figure 3.1: Effects of denaturation time and temperature on target chromosome morphology and
hybridisation quality........................................................................................................................... 77
Figure 3. 2: Correlation between CGH fluorochrome quality, CGH DAPI image and rapid DAPI test
image....................................................................................................................................................79
Figure 3. 3: Effects of the methods of slide ageing on the CGH image quality. Better results were
usually obtained when slides had been stored at room temperature for 24 hours.........................81
Figure 3. 4: Correlation between the CGH image quality and the probe................................................ 83
Figure 3. 5: Effects of alteration of the DNA concentration in hybridisation solution on the
fluorescent intensity............................................................................................................................84
Figure 3. 6: CGH global analysis of a case with trisomy 13.................................................................... 89
Figure 3. 7: Profile CGH analysis in the same case as Figure 3. 6 .........................................................90
Figure 3. 8: G-banded metaphase spread showing a supernumerary ring.............................................92
Figure 3. 9: FISH results of the case with marker chromosome.............................................................93
xii
Figure 3. 10: Telomeric CGH (1)...............................................................................................................97
Figure 3.11: Telomeric CGH (2).............................................................................................................. 98
Figure 3.12: Telomeric CGH (3).............................................................................................................. 98
Figure 3.13: Two-colour FISH using chromosomes 2q and 17q telomeric probes..............................100
Figure 3.14: Standard CGH ratio profile from the case with hypotriploidy...................................... 104
Figure 3.15: CGH analysis by modified approach.................................................................................105
Figure 3.16: CGH ratio profile from the case with hypotriploidy using the modified analysis 106
Figure 3. 17: CGH ratio profile from the case with hypotriploidy using the modified analysis 107
Figure 3. 18: Global CGH result of a case with trisomy 21 studied by overnight CGH ....................109
Figure 3.19: Schematic representation of the chromosome abnormality in the case presented in 3.4.
 110
Figure 3. 20: CGH image using a DNA sample from the case with suspected iXp............................ I l l
Figure 3. 21: Profile CGH analysis showing a deletion of 4/5 of Xq and gain of whole Xp 112
Figure 3. 22: Quantitative PCR results from the case described above targeting the X IST ............... 113
Figure 3. 23: G-banded metaphase chromosomes with multiple abnormalities from the case with
follicular lymphoma.........................................................................................................................115
Figure 3. 24: Mean green-to-red ratio for profiles for chromosomes reflecting DNA sequence copy
number changes in the case presented in 3.5..................................................................................116
Figure 3. 25: FISH using chromosome 8 painting probes......................................................................118
Figure 3. 26: FISH using chromosome 3 painting probes...................................................................... 118
Figure 3. 27: G-banded metaphase chromosomes from the case described above.............................. 122
Figure 3. 28: FISH to directly prepared metaphase spreads from the the case described above 123
Figure 3. 29: Global CGH results of universally DOP-PCR amplified DNAs from a normal male
(Green) and normal female (Red) individual.................................................................................125
Figure 3. 30: Mean of normalised green/red ratios plotted against the fluorochrome ratios...............140
Figure 3. 31: 400x magnification of YOYO-1 stained high-density cosmid fibres containing exon-48
of human DMD gene.........................................................................................................................142
Figure 3. 32: Spotting of DNA targets on pre-treated glass slides for CGH........................................143
Figure 3. 33: A close up view of the immobilised spotted DNA fragments.........................................144
Figure 3. 34: Graphic depiction of results shown in Table 3. 17.......................................................... 146
Figure 3. 35: Agarose gel showing amplification products from SR Y , DMD and hMSH2 genes.... 147
Figure 3. 36: Agarose gel showing single stranded PCR product of DMD ..........................................148
Figure 3. 37: CGH to single stranded DNA microarrays.......................................................................151
Figure 3. 38 Scatter graphic of the results shown in Table 3. 18...........................................................153
Figure 3. 39: Graphic depiction of the results shown in Table 3. 19....................................................155
Figure 3. 40: A close up view of the immobilised spotted DNA fragments.........................................156
CHAPTER 4
Figure 4.1: The derivative chromosome suggested by G banding and CGH..................................... 173
xiv
LIST OF TABLES 
CHAPTER 1
Table 1.1: Incidence on common chromosomal abnormalities................................................................ 7
Table 1. 2: List of some other banding techniques...................................................................................12
CHAPTER 2
Table 2.1: PCR program for labelling of DNA probes............................................................................39
Table 2. 2: Quips CGH Analysis Suite Programs.................................................................................... 55
Table 2.3: Standard PCR.............................................................................................................................58
Table 2.4: DOP PCR profiles....................................................................................................................60
CHAPTER 3
Table 3.1: CGH using two main published approaches, summary of results........................................ 75
Table 3. 2: Comparative genomic hybridisation, using two main published approaches..................... 76
Table 3. 3: Factors investigated in genomic DNA labelling....................................................................80
Table 3.4: Script used for processing of 20 images................................................................................. 86
Table 3.5: Test of modified protocol using known cytogenetic abnormalities, summary of results:. 87 
Table 3. 6:CGH results in JK using standard CGH approach with different fluorescence ratio (FR)
thresholds............................................................................................................................................ 96
Table 3. 7: Overnight CGH parameters compared with those of standard CGH protocol.................. 108
Table 3. 8 CGH and banding results in 14 Patients with haematological malignancies..................... 121
Table 3. 9: CGH using universally amplified DNA samples: summary of results:............................. 124
Table 3.10: Values corresponding to comparative cosmid hybridisation to 22 DNA fibre targets
[FITC (Green)ZTexasRed (Red): 2/1...............................................................................................127
Table 3.11: Values corresponding to comparative cosmid hybridisation to 17 DNA fibre targets
[FITC (Green)/TR (Red): 3/1... ]..................................................................................................... 129
Table 3.12: Values corresponding to comparative cosmid hybridisation to 17 DNA fibre targets
[FITC (Green)/TR (Red): 3/2.]..................................................................................................... 131
Table 3.13: Values corresponding to comparative cosmid hybridisation to 14 DNA fibre targets
[FITC (Green)/TR (Red): 1/1.]..................................................................................................... 133
Table 3.14: Values corresponding to comparative cosmid hybridisation to 18 DNA fibre targets
[FITC (Green)/TR (Red): 2/3... ]..................................................................................................... 135
Table 3.15: Values corresponding to comparative cosmid hybridisation to 19 DNA fibre targets
[FITC (Green)/TR (Red): 1/2.]..................................................................................................... 137
Table 3.16: Comparative cosmid hybridisation to 106 DNA fibres: summary of results.................. 139
Table 3.17: CGH to high density DNA fibres dotted on glass slides................................................. 145
Table 3.18: Data extracted from the image shown in Figure 3. 37......................................................152
Table 3.19: Data from CGH to 2 groups of 9 spots of single stranded DNA microarrays................ 154
XV
CHAPTER 4
Table 4.1 Main parameters in absolute fluorescence intensity.................................     168
xvi
LIST OF ABBREVIATIONS
A Adenine
ASO Allele specific oligonucleotide hybrids
bp Base pair
BAC Bacterial artificial chromosome
C Cytosine
°C Degree Celsius
CCD Charge coupled device
CGH Comparative genomic hybridisation
CISS Chromosomal in situ suppression
cm Centimetre
DAPI 4'-6-diamidino-2-phenylindole
del Deletion
ddATP Dideoxyadenisine triphosphate
ddCTP Dideoxycytosine triphosphate
ddGTP Dideoxyguanosine triphosphate
ddTTP Dideoxythymidine triphosphate
ddNTPs Dideoxyribonucleotide triphosphate
DMS Double minutes
DMD Duchenne muscular dystrophy
DNA Deoxyribonucleic acid
dNTP 2'-deoxyribonucleoside triphosphate
DOP-PCR Degenerate oligonucletide primers PCR
E. coli Escherichia coli
EDTA Ethylenediamine tetraacetic acid
FISH Fluorescence in situ hybridisation
FITC Fluorescein isothiocyanate
G Guanine
g gram
hMSH2 Human mut S homologous 2
ISH in situ hybridisation
kb Kilobase
kd Kilo dalton
M Molar
Mb Megabase
MES 2-(N-morpholino) ethanesulfonic acid
F 9 Microgram
Fl Microlitre
mg Miligram
ml Mililitre
p.M Micro molar
mM Milimolar
mm Milimetre
ng Nanogram
OD Optical density
P Short arm of chromosome
PAC P1-derived artificial chromosome
PHA Phytohaemagglutinin
PCR Polymerase chain reaction
pmol Picomole
q Long arm of chromosome
r Ring chromosome
RBC Red blood cells
RNA Ribonucleic acid
ROI Region of interest
rpm. Revolutions per minute
SCLC small cell lung carcinoma
SD Standard deviation
SDS Sodium dodecyl sulphate
SSC Saline sodium citrate
T Thymine
t Translocation
TBE Tris-acetate ethylenediaminetetra acetic acid
TE Tris- ethylenediaminetetra acetic acid
ter Terminal
TR TexasRed
Tris Tris (hydroxymethyl) aminomethane
UV Ultraviolet
V Volume
W Watt
WCP Whole chromosome paint
X Human X chromosome
Y Human Y chromosome
YAC Yeast artificial chromosome
ACKNOWLEDGEMENTS
I would like to thank Professor J. M. Connor and Dr Elizabeth Boyd for their invaluable 
supervision and guidance throughout the study; and all colleagues and friends in the Institute 
of Medical Genetics for their help and encouragement.
xix
SUMMARY
The aims of this study were first, to optimise the comparative genomic 
hybridisation (CGH) technique and test its reliability as a diagnostic tool in a 
clinical genetics laboratory, second, to investigate whether any of the current 
limitations could be overcome, and third, to improve the resolution of the 
technique beyond the current limits by targeting DNA molecules instead of 
metaphase chromosomes.
During the course of this study, a modified approach to CGH was developed 
and tested on samples with known and unknown abnormalities in various 
fields of clinical cytogenetics. The technique was used to detect unbalanced 
abnormalities in patients with common constitutional abnormalities, marker 
chromosomes, mosaicism, haematological malignancies and solid tumours. 
In all fields CGH detected some abnormalities which had remained 
undetected using conventional cytogenetics or molecular cytogenetic 
techniques.
During the optimisation 94 samples were used. Samples with known 
karyotypes were the subject of CGH using different conditions of slide 
preparation, slide treatment, DNA isolation (from different samples including 
fixed cells) DNA labelling, hybridisation, detection and washing approaches. 
Some modifications in the standard procedures were adopted and then the 
modified approach was applied to 56 cases with different abnormalities.
Overnight CGH was successfully developed and applied during this study. 
Nineteen experiments using 10 test DNAs all correctly detected the 
abnormalities in the cases. 10 samples were the subject of CGH using 
samples amplified by degenerate oligonucletides primers PCR (DOP-PCR). 
CGH reliably detected unbalanced abnormalities in the affected cases using 
as little as 1 ng of DNA.
CGH was applied on 14 samples from patients with haematological 
malignancies. In 2 cases CGH did not detect the abnormality found by 
conventional cytogenetics because of the balanced nature of the 
rearrangements. Both CGH and conventional cytogenetics found no 
abnormality in 5 samples. In 3 abnormal cases CGH and G-banding results
xx
were compatible. In 3 patients, CGH detected abnormalities missed by 
routine cytogenetic analysis. These abnormalities were detected in 
mosaicism of as low as 30% of abnormal cells.
CGH detected new abnormalities that were not detected by conventional 
cytogenetics in a case of follicular lymphoma. A new site of DNA 
amplification at chromosome 3p26 was also detected. A new method for 
defining the copy number differences in cases with ploidy changes was 
suggested and was successfully applied in a case with hypotriploidy.
13 mentally handicapped patients with normal karyotypes without any clinical 
clue to a specific syndrome were the subjects of CGH at the next stage of 
this study. Using a new approach CGH detected telomeric gains and losses 
in 5 patients from 3 families. Those abnormalities were then confirmed using 
targeted FISH. Balanced carriers of the translocations in three generations 
were then detected using targeted FISH.
Comparative genomic hybridisation revealed the origin of a mosaic 
supernumerary ring chromosome 19 in a 72 year-old woman with mental 
retardation. That abnormality could not be identified by conventional banding 
methods over many years and, more recently, fluorescence in situ 
hybridisation (FISH) studies which systematically employed different 
chromosome probes. In a female with mental retardation and a putative iXp, 
CGH ruled out that diagnosis by detecting the presence of Xq in the DNA 
material from the patient. CGH then reliably defined the abnormality as an 
Xp;Xq translocation.
To improve the resolution of the CGH technique combed DNA fibres instead 
of metaphase chromosomes were used as the target DNA for the 
hybridisation of specific probes. CGH was then successfully performed on 
high-density DNA fibres of 35 kb nucleotides. At the final stage of this study 
CGH was performed on spots of single stranded DNA arrays of ~300-500 bp 
corresponding to chromosomes X, Y, and chromosome 2 on glass slides. 
Preliminary results showed that this approach could differentiate the copy 
number differences using a statistical analysis.
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This study shows that CGH is a powerful adjunct to the current techniques in 
clinical cytogenetics for detection of unbalanced abnormalities in the various 
fields of clinical genetics. This study also presents several modifications in 
CGH technique and image analysis which improve the resolution and the 
reliability of the technique and make it faster and less complex. It also 
provides an opportunity for future studies for CGH on DNA microarray targets 
that would be a very important step towards the complete automation of the 
cytogenetics.
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1.1 Background
In 1866, Mendel showed that many characteristics were passed on as 
individual, separate factors, which came to be called genes. These are 
transmitted from one generation to the next in a predictable, regular manner. 
In 1903, the cytologists Boveri and Sutton independently noticed intriguing 
parallels between the way in which the hypothetical Mendelian genetic 
factors behaved, and the distribution of real, visible structures inside cells, 
the chromosomes.
Cytogenetics is the study of chromosomes by microscopy. The exact number 
of human chromosomes in somatic cells was determined as 46 by Tjio and 
Levan in 1956. This finding was quickly followed by the discovery that 
abnormal chromosome numbers were present in patients with Down's 
syndrome (Lejeune et al 1959). This, together with the introduction of the 
PHA-stimulated lymphocyte culture technique (Moorehead et al 1960) 
marked the beginning of clinical cytogenetics, although since chromosomes 
were stained with feulgen or giemsa, only gross abnormalities could be 
detected.
In 1970, Pardue and Gall developed the in situ hybridisation (ISH) technique. 
They showed that labelled DNA probes could be annealed to complementary 
DNA sequences in cytologic preparations of chromosomes made by standard 
techniques. Pardue and Gall also noted that when the denatured 
chromosomes were stained by Giemsa, the paracentric regions were 
preferentially stained (C bands). Various modifications of the denaturing and 
staining process by other scientists following Pardue and Gall yielded 
chromosomes that showed patterns of differential staining along their length, 
which appeared specific for each chromosome. These experiments led to the 
establishment of standard chromosome banding patterns (Caspersson et al 
1970; Seabright 1971), which have become the criteria for chromosome 
identification and classification in human cytogenetics.
2
Chromosome banding techniques have facilitated the identification of specific 
human chromosomes and presently provide the major basis upon which 
chromosomal aberrations are diagnosed. The interpretation of chromosome 
banding patterns requires skilled personnel and is often technically difficult, 
especially with respect to detecting minor structural changes and when 
analysing complex karyotypes, such as those of highly aneuploid tumour 
cells. An additional complexity is that readable metaphase chromosome 
spreads are sometimes very difficult or impossible to prepare from certain 
cell types or tissues.
While the initial in situ methodology was a powerful tool for gene mapping, 
the high background caused by the isotopic probes reacting with the 
sensitive photographic emulsion imposed significant limitations in terms of 
time and precise localisation of the target sequence. The search for non­
isotopic alternatives for labelling probes for ISH led first to the introduction of 
biotin (Langer et al 1981) and then other haptens including 
acetylaminofluorene (Landegent et al 1984), mercury (Bauman et al, 1983), 
digoxigenin (Heiles et al 1988; Seibl et al 1990), and sulphonate (Lichter et al 
1988). These methods require indirect detection using specific antibodies. 
However, in recently introduced direct labelling methods the fluorochromes 
such as FITC, Cy3 and TexasRed are coupled directly to the nucleotides that 
are used in the labelling of the DNA probes.
In 1980s, molecular biology coupled with cytogenetics, resulted in the 
emergence of a new discipline, molecular cytogenetics (Landegren et al 
1988). The development of FISH and the generation of numerous 
chromosome-specific DNA probes have provided new possibilities for 
complementing chromosome banding techniques. Interphase cytogenetics 
has allowed the assessment of numerical and structural chromosome 
aberrations. Multiple colour FISH has further enhanced the capacity for 
identifying chromosome aberrations with speed and accuracy (Nederlof et al 
1990; Reid et al 1992). However, in order to select DNA probes useful for the 
detailed analysis of a clinical sample, previous knowledge of the types of 
expected aberrations is required.
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Molecular genetics has provided additional powerful tools for use in the 
search for genetic imbalances in genomic DNA. This approach requires large 
numbers of polymorphic DNA markers informative for the patient in question. 
Although amplifications of specific DNA sequences can easily be detected, 
e.g., in Southern blots from genomic DNA, it might be difficult to choose the 
appropriate probes. It is even more difficult to distinguish between two and 
three copies of a DNA segment. The global analysis of genomic DNA from 
tumour samples for chromosomal gain and losses by presently available 
methods of molecular genetics therefore remain too laborious to be 
implemented in routine diagnostic schemes.
Comparative genomic hybridisation (CGH) is a new molecular cytogenetics 
technique, which was first described by Kallioniemi et al (1992). CGH is a 
genome-wide screening method in which differentially labelled test and 
control DNAs are co-hybridised to a normal target metaphase to assay the 
copy number differences and provides a new global approach for searching 
clinical and tumour specimens for genetic imbalances in a single 
hybridisation.
1.2 The cell, the chromosome, and the DNA
1.2.1 The cell
Visible with the light microscope within each cell of the body are the 
cytoplasm and a darkly staining body, the nucleus. The cytoplasm has within 
it a complex arrangement, the endoplasmic reticulum, small bodies 
concerned with cell respiration, the mitochondria, and the ribosomes, 
involved with protein synthesis. The nucleus is surrounded by a membrane 
which separates it from the cytoplasm and within the nucleus are the 
chromosomes which bear the genes.
1.2.2 Structure of DNA
The basic components of DNA are 2-deoxyribose, and four heterocyclic 
bases: two purines (adenine and guanine), and two pyrimidines (thymine and 
cytosine). The sugar residues are linked by phosphodiester bonds between
4
the 5' position of one deoxyribose and the 3' position of the next, while one of 
the four bases is attached to the 1' position of each deoxyribose. The two 
strands are linked by means of hydrogen bonds between the purine bases 
and the pyrimidines (Figure 1.1).
Figure 1.1: Specific pairing of the two strands of the DNA
1.2.3 Sequence architecture o f the human genome
The haploid human genome consists of 3000 million base pairs (3000 Mb) of 
DNA. It consists of different sequence classes: single sequence or low copy 
DNA, intermediate repeated DNA sequences consisting of families of DNA 
sequences repeated between 102 and 105 times per genome and, highly 
repetitive or satellite DNA repeated 106 times per genome.
There are two different classes of intermediate repeat sequences called 
SINEs and LINEs. SINEs and LINEs are mobile genetic elements that 
undergo selection to increase in number but do not contribute to the 
phenotype. The most common LINE is called L1. The most common SINE is 
a family of sequences called Alu.
Most satellite DNA is found in very long tandem arrays in heterochromatic 
regions around the centromere. An important example of a satellite DNA 
sequence is a-satellite DNA which has an essential function in centromeres 
of chromosomes. Minisatellites consist of tandem repeats of units 10-100 bp 
in size. The number of repeats and the sequence of the repeat units are both 
polymorphic.
1.2.4 Human chromosomes
The 6000 Mb of DNA that constitutes the human genome is divided between 
23 pairs of chromosomes; 22 of these chromosomes are present in both
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males and females and are defined as autosomes. The remaining pair is 
different in males and females and is known as the sex chromosomes.
Chromosome structure
A single DNA molecule runs the length of each chromosome. This molecule 
is about 250 Mb in size in the largest human chromosome (chromosome 1). 
Physically the DNA in chromosome is packaged at mitotic metaphase into a 
chromosome in a compaction ratio of about 10000 to one. The basic unit is 
called a nucleosome, a cylinder about 8x11 nm in size, in which 140 bp of 
DNA is wound around a histone core containing two molecules each of the 
four core histones: H2A, H2B, H3, and H4. Each nucleosome is linked to the 
next by a 60 bp long piece of naked DNA. There are about 74 nucleosomes 
per average gene of 15-kb length, up to 6.5 x105 nucleosomes per average 
chromosomes, and up to 30x106 nucleosomes per nucleus. DNA wound up 
in nucleosomes is coiled again to form a fibre 25 to 30 nm in diameter. The 
30 nm fibre is stabilised by a fifth histone called histone H1. Finally, at mitosis 
the 30 nm fibre winds around a scaffold of protein to form a fibre 700 nm in 
diameter. Various non-histone proteins are also associated with the DNA.
The whole DNA-RNA-protein complex is known as chromatin. During 
interphase, chromosomes are not so tightly condensed as in metaphase but 
the DNA must still be highly packaged.
1.3 Chromosomes in clinical medicine
1.3.1 Chromosome aberrations
Genetic mutations involve deletion, duplication, or rearrangement of DNA. 
Those changes that are large enough to be detectable under the light 
microscope are classified as chromosome aberrations. The overall rate of 
chromosome aberrations at birth is about 0.6% (0.35% numerical, 0.23% 
structural, and 0.02% both).
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Numerical aberrations
Numerical aberrations involve the gain or loss of one or more chromosomes 
(aneuploidyj, or the addition of one or more complete haploid complements 
(polyploidy).
The failure of paired chromosomes or sister chromatids to separate at 
anaphase (non-disjunction) and anaphase lag resulting in chromosome loss 
are the usual causes of aneuploidy. Gain of one or two homologous 
chromosomes is referred to as trisomy and tetrasomy respectively. Loss of a 
single chromosome results in monosomy. The most common numerical 
abnormalities are shown in Table 1.1.
Table 1.1: Incidence on common numerical chromosomal abnormalities
Trisomy 21 1/800
47,XXX 1/960
47,XXY 1/1080
47.XYY 1/1080
Trisomy 18 1/8140
45,X 1/9600
Trisomy 13 1/19000
Structural aberrations
Structural chromosome rearrangements result from chromosome breakage 
with subsequent reunion in a different configuration and can be balanced or 
unbalanced. In balanced rearrangements, the chromosome complement is 
complete with no loss or gain of genetic material and therefore they are 
generally harmless unless one of the breakpoints damages an important 
functional gene. Balanced carriers may have balanced or unbalanced 
offspring. In individuals with unbalanced chromosomal abnormalities the 
chromosomal complement contains an incorrect amount of chromosome 
material causing severe clinical effects. The main types of balanced and
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unbalanced structural abnormalities are shown diagrammatically in Figure 1. 
2 and Figure 1. 3.
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Figure 1. 2: Structural abnormalities: (a) reciprocal translocation (b) robertsonian 
translocation (c) insertional translocation (d) deletion//duplication
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Figure 1. 3: Structural abnormalities: (a) ring chromosome (b) isochrom osome of long arm 
(c) pericentric inversion (d) paracentric inversion
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1.3.2 Cryptic chromosomal aberrations
By 1995 there were several case reports of subtle or "cryptic" chromosomal 
aberrations mainly involving telomeric ends of chromosomes. These events 
were not detected by conventional cytogenetic methods but were detected by 
molecular cytogenetic methods (Lamb et al 1989; Ledbetter 1992; Wilkie 
1993). A cryptic chromosomal aberration is therefore defined as one that is 
sufficiently subtle enough that it would not be reliably detected, in the majority 
of diagnostic laboratories, by G-band analysis at the 400-500 band stage of 
resolution. These findings showed the necessity of improving resolution of 
the conventional techniques or molecular cytogenetic methods or using 
molecular techniques.
1.3.3 Chromosomes in malignant diseases
Chromosome aberrations are common in malignant cells. Certain 
chromosomes seem to be more commonly involved in particular 
malignancies. Over 70 human neoplasms are known to have one of the more 
than 40 specific recurrent chromosomal abnormalities that can be either 
translocations, deletions, duplications, inversions, or trisomies.
Translocations are seen in leukaemia and non-Hodgkin's lymphoma, 
whereas deletions are found most frequently in myelodysplasia and solid 
tumours. At present, the most important practical benefit of cytogenetic 
analysis in haematological malignancies is in helping to determine prognosis, 
although the identification of specific translocations can also aid in the 
diagnosis. More accurate determination of the prognosis for remission and 
long-term disease-free survival will, in turn, probably have a major impact on 
therapeutic recommendations.
Cytogenetics and molecular biology have each successfully identified non- 
random alterations in the genome that are associated with malignant 
disorders. Growth of solid tumours in culture for cytogenetic analysis is poor 
and is compounded by low mitotic indices. Often the specimens are 
contaminated with bacteria and other microbial agents and may contain large 
regions of necrotic tissue. The major clone that does grow may not reflect its 
true representation in the tumour in vivo. In addition, karyotyping is often
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hampered by the low number of high quality metaphase spreads, low 
percentage of the abnormal cells and/or the complex nature of chromosomal 
changes.
1.4 Methods of chromosome analysis
1.4.1 Cell Culture
Most cytogenetic studies involve the examination of a dividing cell population 
by blocking cell division at metaphase with an inhibitor of spindle formation. 
Normal circulating blood cells do not divide under routine culture conditions. 
Several mitogens such as phytohaemagglutinin (PHA), pokeweed mitogen 
and concanavalin A can stimulate the proliferation of blood cells. The peak 
mitotic activity is reached after 60-70 hours of culture and is the optimum 
harvesting point for chromosome studies. However, 48 to 90-hour cultures 
may be used.
1.4.2Harvesting and Slide Preparation
During the harvest procedure a mitotic inhibitor accumulates metaphases by 
preventing the formation of the spindle apparatus. Then, addition of the 
hypotonic solution causes water to rush into the cell and the cytoplasmic 
membrane stretches as the cell swells. Cells are preserved in this situation 
by fixative. When the fixed cell suspension is dropped onto a slide, the 
fixative immediately becomes a thin layer and does not support the cells any 
more. Evaporation of the fixative causes the cell to flatten and forces the 
chromosomes to spread out.
1.4.3 Banding techniques
Several different staining methods can be utilised to identify individual 
chromosomes.
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Solid Staining
The chromosomes are exposed to a stain that has an affinity for DNA (like 
Giemsa), yielding a uniformly dark appearance to the chromatids. Solid 
staining has applications in the investigation of fragile sites, in the study of 
chromosome breakage syndromes, and for scoring radiation damage. It is 
also applied in the determination of marker chromosomes, the extent of 
satellite polymorphism, and in the measurement of individual chromosomes.
G (Giemsa) banding
This is the method most commonly used. The chromosomes are treated with 
trypsin which denatures their protein content and then with Giemsa stain 
which gives each chromosome a characteristic and reproducible pattern of 
light and dark bands. The dark bands contain mainly AT-rich DNA, and the 
light hands are CG-rich. G banding generally provides high quality 
chromosome analysis with approximately 400 bands per haploid genome. 
Each of these bands corresponds to approximately 8 Mb of DNA.
High resolution banding
High resolution banding of the chromosomes up to 800 bands per haploid 
genome involves first inhibiting cell division with the folic acid antagonist, 
methotrexate followed by adding folic acid in the medium which releases the 
cells into mitosis. Colchicine is then added at a specific time interval, when a 
higher proportion of cells will be in prometaphase and the chromosomes will 
not be fully contracted, giving a more detailed banding pattern. This method 
can detect quite subtle changes and has led to the definition of several 
microdeletion syndromes.
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Other banding techniques
Some other banding techniques with specific applications are shown in Table 
1. 2
Table 1. 2: List of some other banding techniques
Technique Banding pattern Main applications
Q-banding Similar to Giemsa identification of the Y  
heterochromatic region, study of 
the satellite regions of the 
acrocentric chromosomes
DAPI (4'-6-diamidino-2- 
phenylindole) banding
similar to Q-banding highlights the centromeres of 
chromosomes 1, 9, and I 6
C-Banding heterochromatic regions are 
preferentially stained
Study of centromeres and other 
heterochromatic regions
R (Reverse) banding reverse of those obtained 
using conventional G 
banding.
useful for the definition of 
telomeric regions
1.4.4 Fluorescence in situ hybridisation (FISH)
Denaturation and hybridisation principles
FISH is the most commonly used molecular cytogenetic technique. FISH is 
based on the denaturation and hybridisation principles (Figure 1. 4). Since 
the two strands of DNA are only linked by non-covalent forces, they can 
easily be separated in the laboratory, for example by increased temperature 
or high pH (denaturation).
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Figure 1. 4: Denaturation and hybridisation of DNA: As a double helix is heated those
regions with less sequence homology between the strands, or those with a high proportion of 
relatively weak AT base pairs come apart; eventually, the whole helix separates. If an 
appropriately labelled DNA sequence (probe) is denatured and added to denatured nuclei or 
chromosomes during the process of re-annealing, some of that labelled DNA will hybridise to 
its complementary sequence in the chromosomal DNA. Detection of the labelled DNA will 
identify the site of hybridisation and thus the region of chromosomal DNA complementary to 
the DNA sequence in the labelled probe.
Reducing the temperature or the pH will allow hydrogen bonds between 
complementary DNA sequences to reform; this is referred to as re-annealing. 
Hybridisation between single-stranded DNA molecules forms the basis of the 
use of DNA probes to detect specific sequences in samples of DNA. The 
specificity of the reaction can be adjusted by altering the temperature and/or 
the ionic strength. Higher temperature or lower ionic strength gives greater 
stringency of hybridisation, i.e, the probe has to be more like the sequence to 
be detected. Outline of the FISH technique is depicted in Figure 1. 5.
Visualisation
Detection
Washing
Hybridisation
Denaturation of probe and target DNA
Labelling of probe Preparation of target cells
Figure 1. 5: A flow diagram of the main steps of fluorescence in situ hybridisation (FISH).
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Probe labelling
Nick-translation is the most commonly used technique for probe labelling. In 
this method, DNase randomly nicks the double-stranded DNA probe, and 
then DNA polymerase is used to fill in the nicked strand with newly 
synthesised DNA containing the hapten-nucleotide. Similarly, in the PCR 
method, the labelled nucleotide is added to the reaction mixture. Probe- 
specific primers can be used for probe sequences of about 1 kilobase (kb), 
but larger sequences, for example, cosmid clones, are best labelled using 
degenerate oligonucleotide primed-PCR (DOP-PCR, Telenius et al 1992).
Direct and indirect detection
Biotin and digoxigenin have proved to be the most useful haptens, and a 
variety of methods have been developed to detect both these labels in 
cytologic preparations using fluorescence or enzyme-linked reactions. 
Probes labelled with either biotin or digoxigenin as reporter molecules could 
be visualised by indirect detection of hybridised probe via avidin or 
antidigoxigenin. The biotin has a strong affinity for avidin and streptavidin. 
When the latter molecule is coupled to a fluorochrome, such as fluorescein 
isothiocyanate (FITC), and added to the chromosomal slide, the probe signal 
on the chromosome can be visualised by fluorescence microscopy it is 
possible to build a strong fluorescence signal using several layers of 
fluorochrome-coupled antibodies.
Directly fluorochromated probes provide an alternative procedure. In Direct 
labelling of the DNA probes, fluorochromes such as FITC, Cy3, and Cy5 
which are coupled directly to the nucleotides (e.g., FITC-12-dUTP) are used.
Denaturation of probe and target DNA
The standard procedures for FISH use air-dried chromosome preparations, 
which are denatured by heating in 70% formamide at 65°C for 2-3 minutes 
before being placed in ice-cold 70% ethanol. This is followed by dehydrating 
through an ethanol series and air drying. The rapid cooling ensures that the
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denatured single-stranded DNA in the preparations does not re-anneal. 
Meanwhile, the DNA probe is denatured for 5-10 minutes at 70°C.
In situ suppression hybridisation
Almost all types of DNA probe used in FISH applications in diagnostic 
cytogenetics contain interspersed repetitive elements (see section1.2) that 
will hybridise to complementary sequences throughout the entire genome 
leading to a high level of background signals. This background can be 
suppressed effectively by preannealing unlabelled genomic or Cot-I (enriched 
for highly repetitive sequences) DNA to the labelled probe before hybridising 
the probe to the target DNA (Landegent e al. 1987, Lichter et al 1988, Pinkel 
et al 1988). The unlabelled DNA acts as a competitor and will form duplexes 
rapidly with the repetitive DNA sequences within the probe. The remaining 
low-copy DNA in the probe will then be available to hybridise with 
complementary sequences in the target DNA. For hybridisation, the labelled 
DNA probe is prepared in a hybridisation buffer (containing formamide and 
dextran sulphate) together with Cot-I DNA. This mix is added to the slide 
containing denatured target DNA; covered with a coverslip, which is sealed 
with cow gum; and incubated at 37 to 43°C for 2-16 hours.
Post-hybridisation and detection washings
Following hybridisation, the coverslip is removed, and the slide is washed in 
50% formamide and SSC at 42-45°C. The choice of detection method 
depends on the hapten used in the labelling of the DNA probe. If a 
biotinylated probe is used, detection involves treating the slide with 
fluoresceinated avidin and fluoresceinated antiavidin and incubating in 
detection buffer at 37°C for 30 minutes followed by washing in several 
changes of detection buffer, SSC with Tween-20, dehydration through an 
ethanol series, and mounting in DAPI antifade. The slides are viewed using a 
fluorescence microscope equipped with a UV mercury lamp and appropriate 
excitation and emission filters. Multiple excitation/dichroic/bandpass filter 
blocks are available, which can be used in the microscope to observe 
simultaneously several fluorochromes excited by different wavelengths.
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Principles of fluorescence microscopy
Fluorescence microscopy is used to detect structures, molecules or proteins 
within the cell. Fluorescent molecules absorb light at one wavelength and 
emit light at another, longer wavelength. When fluorescent molecules absorb 
a specific absorption wavelength for an electron in a given orbital, the 
electron rises to a higher energy level (the excited) state. Electrons in this 
state are unstable and will return to the ground state, releasing energy in the 
form of light and heat. This emission of energy is fluorescence. Because 
some energy is lost as heat, the emitted light contains less energy and 
therefore is a longer wavelength than the absorbed (or excitation) light.
In fluorescence microscopy, a cell is stained with a dye and the dye is 
illuminated with filtered light at the absorbing wavelength; the light emitted 
from the dye is viewed through a filter that allows only the emitted 
wavelength to be seen. The dye glows brightly against a dark background 
because only the emitted wavelength is allowed to reach the oculars or 
camera port of the microscope. In epi-illumination excitation light goes 
through the objective lens and illuminates the object. Light emitted from the 
specimen is collected by the same objective lens.
Image analysis in FISH
FISH signal tends to fade on exposure to UV light in the fluorescence 
microscope. This fading can be reduced to a certain extent by the use of 
antifade agents in the mounting medium. However, the need to detect 
fluorescent signals of low intensity and their rapid analysis has led to the 
development of sensitive cameras and computer based image analysis 
systems. These systems allow the fluorescence image to be digitised and 
acquired by a computer and archived. The stored image is then available for 
image processing and analysis. For many applications in diagnostic 
cytogenetics, however, the DNA probes are large enough to produce bright 
signals, and image processing is not essential. Digital fluorescence 
microscopy has particular application in multicolour FISH and in the detection 
of weak fluorescent signals.
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FISH probes and their applications
A wide range of DNA probes are available for chromosome analysis by FISH. 
Genomic DNA probes
These include DNA extracted from blood or bone marrow samples, cell 
cultures or solid tumours labelled by fluorochromes. FISH using genomic 
DNA probes results in an evenly distributed hybridisation along all the 
chromosomes. These probes are particularly useful to identify human 
chromosomes in somatic cell hybrids.
Whole chromosome paint (WCP) probes
These are genomic probes consisting of a cocktail of probes obtained from 
the different parts of a particular chromosome. These probes are made from 
chromosome specific genomic libraries, from single chromosome- 
interspecific somatic cell hybrids, or from flow sorted chromosomes. When 
this mixture is labelled and used in a hybridisation experiment the entire 
relevant chromosome is painted. WCP probes are particularly useful for 
characterising the marker chromosomes and complex chromosomal 
aberrations. The main disadvantages are that intrachromosomal 
rearrangements (such as inversions) cannot be identified and that (due to the 
use of unlabelled Cot-I DNA) centromeric areas and telomeres, are not 
painted
Centromeric probes
These probes are cloned from repetitive sequences found in and around the 
centromeric regions of a specific chromosome. All human centromeres 
except those of chromosomes 13 and 21, and 14 and 22, which share 
indistinguishable sequences, have chromosome specific sequences of this 
type. Centromeric probes are suitable for making a rapid diagnosis of one of 
the common aneuploidy syndromes in interphase nuclei. They are used in 
aneuploidy detection in uncultured amniotic fluid cells, for preimplantation 
diagnosis of aneuploidy in cells from blastocytes, for the diagnosis and
17
detection of residual disease in the management of certain haematological 
malignancies, and for the analysis of nondisjunctional abnormalities in sperm
Chromosome-specific unique sequence probes
These are a series of overlapping DNA sequences along each chromosome. 
These probes are mostly cloned in YAC vectors, which can accept up to 
2Mb. Probes cloned in cosmid vectors (up to 40 kb), plasmid vectors (up to 
10 kb) and bacteriophage vectors (up to 25 kb) are also available. They are 
particularly useful for identifying submicroscopic chromosomal aberrations.
Multicolour FISH  
Basic principles
The simplest approach to multitarget FISH would be to develop a set of 
spectrally distinct fluorescent dyes and label each hybridisation probe with a 
different dye (Nederlof et al 1989). However, this has not yet been achieved.
Fewer fluorescent dyes can be used if more than one dye is used to identify 
each chromosomal target (Nederlof et al 1990). In combination coding, 2n-1 
targets can be identified, each corresponding to a possible combination of n 
different fluorescent dyes used in the hybridisation. Different combinations of 
the three fluorochromes in each probe can give up to seven distinguishable 
colour differences by digital fluorescence microscopy (Dauwerse et al 1992; 
Ried et al 1992).
Ratio coding also uses combinations of fluorophores, but varies the relative 
proportion of each fluorophore used in the combination (Nederlof et al 1992; 
Dauwerse et al 1992; Lengauer et al 1993). By distinguishing the relative 
amounts of fluorescence, several targets can be identified for each 
fluorophore combination used. The simultaneous visualisation of 12 different 
probes labelled with different fluorescence ratios has been reported. (Ried et 
al 1992, Lengauer et al 1993, Wiegant et al 1993). Ratio-coded 
chromosomes can become difficult to distinguish when the number of ratios 
increases beyond four and ratios of images obtained with a digital camera 
can be used to better differentiate the targets. This exploits a sensitive
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monochromatic, cooled, charged-coupled device (CCD) camera and 
computerised image processing. A grey-level image of the fluorescence of 
each fluorochrome is acquired sequentially and merged to provide a false 
colour. Because the three images must be aligned accurately in the merged 
image, a system to prevent registration errors, triple band-pass filters are 
used in the epifluorescence optical.
Fibre-FISH
Chromosome fibres at metaphase are very condensed and therefore the 
fluorescent signals from two cosmid clones hybridised to the same 
chromosome can be resolved only if they are more than 2 to 3 Mbs apart. 
Various techniques have now been developed that release the chromosome 
fibre from its associated protein within the chromosome scaffold (Fidlerova et 
al 1994; Parra and Windle, 1993; Wiegant et al 1992). This permits DNA 
sequences to be hybridised directly onto extended chromosome fibres fixed 
on a microscope slide and analysed by FISH.
The analysis of extended DNA fibres by FISH has application both in the 
mapping and ordering of contiguous DNA sequences and, more recently, in 
the diagnosis of single gene aberrations using cosmid probes. One important 
example has been in the detection of carriers of intragenic gene deletions in 
X-linked Duchenne muscular dystrophy (Florijn et al 1995). In this and similar 
situations, carrier detection by PCR techniques can be difficult, and fibre- 
FISH can be used.
Reverse chromosome painting
In this technique small numbers of aberrant chromosomes are flow-sorted or 
microdissected and amplified by DOP-PCR. The products are labelled and 
used as probes to localise the signal on normal metaphase chromosome 
spreads (Carter et al 1992). This approach has been used for detailed study 
of marker chromosomes and to analyse abnormal chromosome with 
translocations or deletions.
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1.4.5 Comparative Genomic Hybridisation (CGH)
Utilisation of FISH for the detection of chromosomal aberrations has 
depended on the applications of specific nucleic acid probes. Therefore,
FISH is generally restricted to a limited number of chromosomal regions. 
Moreover, pre-knowledge of the regions that might be subject to 
chromosomal aberration is essential.
CGH is a technique which instead of metaphase cells, utilises a DNA sample 
from a patient. If the whole human genomic DNA is fluorochrome (or hapten) 
labelled and hybridised to a normal target metaphase under suppression 
conditions, all of the chromosomes are stained. However, when certain 
chromosomes or chromosomal segments are over- or under-represented in 
the genomic DNA, stronger or weaker signals are expected in the 
corresponding hybridisation target regions. While large amplifications (>24 
copies for an amplicon more than 600 kb) are readily detected based on 
these principles when there are subtle deviations from a balanced genome, 
CGH is required.
CGH involves the different labelling of two genomic complement DNAs (test 
and control) followed by co-hybridisation on normal “target” metaphase 
chromosomes to assay copy number differences (Kallioniemi et al 1992; du 
Manoir et al 1993) (Figure 1. 6-1.8). The control DNA introduces an internal 
standard which prevents errors secondary to experimental parameters which 
include differential denaturation of chromosomal regions with different base 
composition, chromatin packaging as well as differential hybridisation of 
probe sequences due to base composition and target accessibility.
Differential fluorescent hybridisation signals represent gains and losses of the 
test DNA relative to the reference DNA. Ratios of the signals can be 
quantified along the length of each homologue and provide a copy number 
karyotype of the test DNA (Figure 1. 7).
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Figure 1. 6: Schematic illustration of CGH. Labelled genom ic DNA from test (green) and 
control (red) are co-hybridised to normal metaphase chromosomes.
Metaphase chromosomes for CGH
Normal metaphase chromosomes are used as hybridisation targets in CGH. 
The quality of CGH is mainly dependent on the quality of the metaphase 
chromosomes. It is recommended to prepare a large number of slides at 
once, so that an entire experiment can be carried out with one batch of slides 
(Kallioniemi et al 1994). The hybridisation characteristics of all batches of 
slides are tested using labelled DNAs from a control cell line. In the case that 
a high quality hybridisation cannot be achieved, the entire batch has to be 
abandoned. Moreover, slides should contain minimal number of overlapping 
chromosomes. Preparations with too short chromosomes are also 
abandoned. After hybridisation chromosomes are counterstained with DAPI 
to obtain a faint R-banding pattern which helps to identify the chromosomes. 
Metaphase chromosomes with uniform and adequate hybridisation and good 
retained morphology are qualified for the analysis (Kallioniemi et al 1994).
Isolation of DNA for CG H
DNA isolated from any tissue can be used for CGH. When CGH is applied on 
solid tumours, it is very important to ascertain that DNA is isolated from the 
malignant cells. Contamination of the malignant cells with normal or necrotic 
cells or regions with inflammations will dilute the tumour DNA and therefore
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reduces the ability to see copy number differences. Current methods for DNA 
isolation yield high-molecular weight DNA suitable for CGH. DNA extracted 
from formalin-fixed, paraffin-embedded archived tumour specimens has also 
been used for CGH.
Differential labelling of DNA
Genomic DNA probes for CGH can be labelled either with directly 
fluorochrome-conjugated deoxynucleotides (direct labelling) or with reporter 
groups such as biotin or digoxigenin detected via fluorochrome-coupled 
reporter binding molecules (indirect labelling). Directly fluorochrome- 
conjugated probes require fewer post-hybridisation manipulations, and 
improve the quality of hybridisation signal. The size of the DNA before and 
after labelling is an important consideration in the overall success of the CGH 
assay. Labelled DNAs should range in size from 500 to 2000 bp to achieve 
optimal hybridisation. In some cases, very high molecular weight DNA 
requires mechanical shearing before labelling, and in others the extracted 
DNA can be labelled without pre-shearing. Nick translation has been the 
method of choice for labelling the DNAs due to the ability to regulate the 
nicking activity of DNase I relative to the synthesising activity of DNA 
polymerase I to achieve optimally sized fragments. Other techniques, such 
as random priming and degenerate-primer (DOP) PCR have also been used 
for labelling genomic DNA for CGH (Speicher et al 1993).
Hybridisation and post-hybridisation
Hybridisation protocols essentially follow those used in FISH (section 1.4.4). 
Equal amounts (120-500 ng) of each of the differentially labelled test and 
control DNAs are mixed with human Cot-I DNA (2-10 pg), ethanol 
precipitated, and dissolved in the hybridisation buffer. Cot-I is added to block 
the binding of the labelled repetitive sequences in both genomes. Repeat 
sequences, if not adequately blocked, tend to result in large ratio changes at 
the peri-centromeric and heterochromatic regions. The hybridisation mix is 
then heat-den atured and allowed to preanneal to compete out hybridisation 
signal due to repeat sequences. Before hybridisation, the slides containing
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the target metaphases are denatured. The chromosomes require sufficient 
denaturation to permit accessibility of the labelled DNA, however, the 
chromosomal morphology must be retained for identification purposes. 
Denaturation is carried out at 70-74 °C for 2-3 minutes in 70% formamide/2 x 
SSC followed by (in some protocols) a proteinase K digestion. In situ 
hybridisation is carried out in a moist chamber at 37°C for 2-4 days. Post­
hybridisation steps are carried out as in standard FISH. In case of indirect 
labelling of the genomic probes, immunological detection with appropriate 
fluorochrome coupled reagents is carried out. After the appropriate detection 
steps, the chromosomes are DAP I counterstained for identification purposes.
Fluorescence microscopy and visual analysis of CG H
Visualisation of the fluorescent hybridisation signal is performed with a 
fluorescence microscope using appropriate double or triple band pass filters 
that allow simultaneous visualisation of two or more fluorochromes. A rough 
assessment of the quality of the hybridisation experiment can be made 
according to the background levels and the differences in the fluorescence 
intensity in the sex chromosomes (when test and control DNAs are derived 
from different sexes). For visual analysis, the intensity of two fluorescent 
dyes must be compared along the length of a chromosome where similar 
hybridisation signals should be observed for each homologue. Gains of DNA 
sequences in the test DNA relative to the control DNA are visualised as 
increased fluorescent signals of the test DNA on the chromosomal region 
from which the sequences are derived. Losses are detected as an increased 
relative fluorescent signal of control DNA. High level gene amplifications 
(>10-20 fold) as well as large gains and losses affecting chromosome 
regions are visually detectable. Small deletions and other lower level copy 
number differences and ratio changes in tumour cells contaminated with 
normal cells often cannot be reliably evaluated without digital image analysis 
(Kallioniemi et al 1992, 1994; du Manoir 1993).
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Acquisition and display of digital images
For a comprehensive assessment of all chromosomal imbalances present in 
the test DNA, quantitative measurement and analysis of fluorescence 
intensities are necessary. The acquisition of image is carried out by first 
carefully scanning the entire slide for the best metaphase cells. A sensitive 
(preferably cooled) CCD camera is required to obtain digitised metaphase 
images. Grey level images of each of the fluorochromes are obtained using a 
computer-controlled filter-wheel with a series of single-band-pass excitation 
filters which sequentially excite DAPI, FITC and rhodamine or TexasRed. 
This allows visualisation of all three fluorochromes without any registration 
shifts between images (Figure 1. 8). After an optimum optical as well as 
exposure time settings is worked out, it should be kept constant for a series 
of metaphases corresponding to a single case. In general, using a cooled 
CCD camera, exposure times are in the range of 1-10 seconds for FITC and 
0.5 to 2 seconds for rhodamine or TexasRed images.
Quantitative analysis of green and red fluorescence ratio profiles 
for CGH
The three fluorochrome-specific high-resolution images captured from each 
entire metaphase spread with CCD camera are stored in an appropriate 
format and used for the analysis. Various software in different computer 
platforms are available for the CGH analysis.
Evaluation of CGH images
The quality of hybridisation is critically important for the reliable CGH 
analysis. Image and hybridisation quality can be assessed either visually, or 
by objective criteria defined by image analysis. All images obviously should 
be well focused and show smooth high intensity hybridisation. In case of 
indirect labelling granulation is the most common problem leading to high 
noise background. Good quality hybridisations are uniform rather than 
granular. Metaphases that contain high degrees of non-specific granules and 
fluorescence spots on the chromosomes are not used for CGH analysis. 
Analysis of chromosomes with banding pattern of fluorescence signals which
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are not adequately denatured is unreliable. On the other hand, over­
denatured chromosomes with damaged morphology also are not suitable for 
CGH analysis. Distribution of the green and red fluorescence should be 
similar between the sister chromatids of a chromosome, the two 
chromosome homologues in each metaphase and the same chromosome 
between different metaphases. Distribution of the background fluorescence 
on the slide surrounding the chromosome should be minimal and uniform. 
Fluorescence intensity corresponding to the test and the control DNA should 
be minimal at the centromeric regions. Finally, chromosomes should show 
adequate length with intense DAPI banding pattern and minimal overlapping.
Initial chromosome segmentation
After selecting suitable CGH images, the chromosomes are segmented 
automatically using the “chromosome definition image” obtained by adding 
the counterstain reference images after standardising them so that they have 
the same range of pixel values.
The two images are combined, because some reports suggest that 
segmentation based on a DAPI counterstain image alone is inadequate due 
to weak staining in some regions particularly chromosome telomeres.
Background correction
Background fluorescence must be removed before the fluorescence ratios 
are calculated. Background can be removed by subtracting the 
intrachromosomal fluorescence intensity from the chromosomal 
fluorescence. If background varies across the metaphase, a local estimate is 
required for each chromosome
Normalisation of fluorescence intensities
Normalisation of fluorescence intensities is necessary for meaningful 
comparison of data from different metaphase spreads and different 
preparations. Normalisation minimises the effects of differences in the 
hybridisation and imaging conditions. Two main approaches are currently 
used for normalisation. In the first, the total intensities of the metaphase
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images resulting from the two hybridisations are made equal. In the second 
approach, the computed ratio profiles are normalised so that the modal ratio 
profile value for a metaphase is one.
Segmentation correction
After background removal and normalisation of the fluorescence intensities, 
minor errors in the segmentation of chromosomes are corrected interactively. 
This stage is dependent on the type of the software used and aims to 
separate touching chromosomes, cut out non-target areas of the image, like 
interphase nuclei, or exclude the chromosome clusters which are not 
separable from the analysis.
Green to red ratio profiles.
At this stage, for each (segmented) chromosome, the symmetry axis is 
determined and green to red ratio are integrated along lines that are 
perpendicular to the medial axis and spaced at one pixel intervals along the 
axis. The integration covers both chromatids and thereby comprises the sum 
of two independent observations. The integrated green to red ratio profiles 
that run from the terminal region of the short arm (pter) to the terminal part of 
the long arm (qter) of each chromosome are then used to calculate the green 
/red ratio profile for each chromosome.
Averaging of profiles collected from several metaphases
To reduce the effects of random noise in CGH images, data from 5-20 
metaphase images (10-40 chromosomes) are combined and profiles of the 
mean ratio and ± 1 SD are calculated and displayed. To (at least partly) 
compensate the effect of different and/or non-uniformly condensation, all 
ratio profiles are normalised to a standard length for each chromosome type.
Sensitivity and Mapping resolution
It has been shown that a linear correlation between chromosome copy 
number (1-5) and the average green to red ratio is detectable. This 
relationship is only obtained when the size of the affected region is in the
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range of 10-20 Mb (Kallioniemi et al 1992). It is predicted that this can be 
improved up to 3-5 Mb which is the smallest distance that can be adequately 
discriminated by FISH. Detection of copy number aberrations of smaller sizes 
is possible if the DNA sequences show high level of amplification. The total 
amount of the amplified DNA required to be detectable by CGH is estimated 
to be at least 2Mb (Piper et al 1994).
Applications of CGH
CGH was developed to be used in tumour cytogenetics where banded 
chromosome analysis is often difficult, or even impossible. Since its 
development, CGH has been applied mostly as a useful tool for research 
tumour cytogenetics with more than 300 publications since 1992. CGH 
studies have resulted in a large set of new data regarding recurrent 
chromosomal aberrations in solid tumours. The recurrent genomic alterations 
detected by CGH have lead to the localisation of the genes relevant for the 
development of certain tumours (Mohamed et al 1993; Kallioniemi et al 1994, 
1995; Speicher et al 1994; Reid et al 1995). CGH has become an important 
method for the detection of proto-oncogenes, which are amplified in certain 
tumours.
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F igu re  1. 7: A schematic diagram of CGH analysis i I lust rating the quantitation of green and 
red fluorescence intensity ratios along chromosomes by a digital image analysis program, (a) 
Chromosomes are f i r s t  segmented and the chromosome outl ine (1 )  is displayed. The medial 
axis (2 )  is determined based on this outl ine. Green and red fluorescence intensities are then 
integrated along transverse I ines ( 3) drawn across the medial axis at one-pixel in tervals 
from  p-te lom ere to q-telomere. Quantitation is performed from  two separately col lected 
g ray- leve l images of the metaphase spread in both green and red fluorescence. Integrated 
green and red fluorescence intensities and the ir  ratios are determined for each pixel along the 
medial axis and plotted as a histogram. The ratios are normalised so that the average ratio fo r 
the entire metaphase spread is 1.0. Chromosomal regions that show an increased green to red 
ratio are present at an elevated copy number (gained, ampl if led) in the test DNA, whereas
those w ith  a decreased ratio  are lost from  the test DNA ( red thick I ine).
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Figure l .  8: Detection of chromosomal imbalance by CGH and digital image analysis using 
DNA samples from  a male patient w ith tr isom y 1 8 (test DNA) and a normal female individual 
(control DNA) (a) Hybridisation patterns of TexasRed labelled (contro l)  and (b) FITC- 
labelled (test) DNA. (c) DAPI counterstain image of the target metaphase, (d) Digital 
conversion of the image shown in c providing a banding pattern resembl ing classic G-banding, 
thus faci I i tat ing identification of the chromosomes. ( e) M ixed colour image obtained by digital 
overlaying of the images shown in a and b. Greenish/reddish colours indicate chromosomal 
sequences that are over represented/underrepresented in the test DNA compared to those in 
the control DNA. ( f )  Global CGH analysis. This image shows a transformational of the intensity 
ratio prof i le into three colours. Gains are indicated in green, losses are indicated in red, and 
the normal chromosomal complements is indicated in white.
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CGH has detected many previously unknown abnormalities in various types 
of solid tumours. Chromosomal copy number changes in breast carcinomas, 
small cell lung carcinomas (SCLC), malignant gliomas, and uveal melanomas 
were detected very early after the development of the CGH. Most of the 
gains identified by CGH were novel and included frequently observed high 
level amplifications. These amplifications are likely to indicate the 
chromosomal regions, where genes relevant for tumour development or 
progression are localised. These developments will probably lead to inclusion 
of DNA probes and probe sets in analysis of the corresponding tumour type 
by other methods such as interphase cytogenetics. Comparison of G-banding 
with CGH results in leukaemias has revealed discrepancies in a large 
number of cases. CGH is also used in combination with DOP-PCR to analyse 
DNA gain or losses in samples containing a very few cells which are not 
sufficient for conventional techniques. Recent applications of CGH in 
haematological malignancies and clinical cytogenetics are discussed 
together with the results of this study in chapter 4.
Limitations and difficulties
CGH cannot detect balanced translocations or inversions. Point mutations 
and small intragenic abnormalities also are not detectable by CGH. Peri- 
centromeric and heterchromatic regions cannot be reliably analysed as they 
are being blocked by competitive DNA (Cot-1) in hybridisation, although in 
cases of malignancy this problem can be partly overcome by using the 
control DNA from the normal tissue of the same individual.
Contamination of the tumour DNA with surrounding normal tissues will dilute 
the test to control ratio changes. This causes serious difficulties when the 
normal tissue contribution is more than 50%. In bi- or multi-clonal tumours, 
the different genetic aberrations present in individual clones may sometimes 
compensate one another or exist at too low a frequency to be detected.
There are some reports that when the biotin labelled test DNA is compared 
with digoxigenin labelled control DNA and detected by avidin-FITC and anti- 
digoxigenin rhodamine, the green to red ratio at 1p32-pter, 16p, 19 and 22 
may occasionally be distinctly below the average ratio. This would therefore
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lead to a false positive interpretation of a deletion. This problem may be due 
to differential hybridisation properties of digoxigenin and biotin labelled 
probes. This problem is not reported using directly labelled probes (du 
Manoir et al 1993; Kallioniemi et al 1994).
Due to normalisation steps in the CGH image analysis, ploidy changes are 
not independently detectable in CGH. CGH has not been used as a 
diagnostic tool in any clinical genetics laboratory, nor has it been used for the 
detection of constitutional chromosome abnormalities. Moreover as CGH 
uses normal metaphase chromosome as target DNA, its resolution is limited 
to that of routine cytogenetics. Furthermore CGH follows 48-72 hours 
protocols, which makes it impossible to use in urgent situations. Finally, as 
the fluorescence intensity corresponding to the test and control DNA 
gradually decrease at the chromosome ends, when the absolute intensities 
approaches the background fluorescence, unreliable ratio changes may 
appear and therefore current approaches to CGH image analysis are unable 
to analyse the telomeric regions reliably.
1.5 Aims of this study
The aims of this study were first, to optimise the comparative genomic 
hybridisation technique and test its reliability as a diagnostic tool in a clinical 
genetics laboratory, second, to investigate whether any of the current 
limitations could be overcome, and third, to improve the resolution of the 
technique beyond the current limits by targeting DNA molecules instead of 
metaphase chromosomes.
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2: Materials and Methods
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2.1 Safety
Lab coat and gloves were worn at all times when handling blood and other 
biological or chemical materials, which were always handled in appropriate 
category safety cabinets. All glassware, most plastics and all tips for 
micropipetting were sterilised in an autoclave (Denly) at 121°C for 15 
minutes. When necessary, solutions were also sterilised by autoclaving.
2.2 Patients and samples
The clinical cytogenetics service in this department serves a population of 
roughly three million people. Samples used in the early stages of this study 
had been sent for diagnostic proposes, and if there was enough material left, 
then it was used for the work described here.
Blood was the most frequently used tissue specimen in this study. Blood 
samples from normal male individuals were used for preparation of normal 
target metaphases in CGH, and samples from patients were used for targets 
in FISH and for conventional cytogenetic studies. Genomic DNA extracted 
from blood specimens of patients and normal individuals was used as test 
and control DNA in CGH experiments. Bone marrow and solid tumour 
samples also were used in CGH, FISH and conventional cytogenetic 
experiments.
After optimisation, CGH was first used in patients with constitutional 
chromosome abnormalities, solid tumours or haematological malignancies to 
compare its capabilities with conventional methods. CGH investigations then 
were performed on samples from patients with haematological malignancies 
or solid tumours when conventional techniques had failed to resolve the 
abnormalities.
For detection of cryptic chromosome abnormalities, families with two affected 
members with apparently normal karyotype and a similar phenotype related 
through at least one healthy first degree relative were selected. These 
features are highly suggestive of the segregation of a cryptic chromosomal 
translocation.
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2.3 Culture techniques and chromosome preparation
2.3.1 Peripheral blood culture
Solutions:
Growth medium
Iscoves medium 100 ml
Heparin 1 ml
Glutamine 1 ml
PHA 2 ml
Penicillin/Streptomycin 1 ml
(100 units/ml and 100 jig/ml respectively)
Procedure:
Using an aseptic technique, 0.5 ml heparinised whole blood was added to 4.5
ml of growth medium and mixed by gently inverting each culture tube a few
times. The culture tubes were then incubated in a slanting position at 37°C
for 72 hours.
2.3.2 Harvesting
Solutions:
Colcemid solution: 10 pg/ml
Hypotonic solution: 0.075 M KCI
Fixative solution: 3/1 methanol/acetic acid
Procedure:
0.1 ml Colcemid solution was added to each 5 ml culture, mixed gently by 
shaking the tube and incubated at 37°C for an additional 45 minutes. The 
tubes were then spun at 1200 rpm for 8 minutes before pipetting off the 
supernatant into a container of 10% Chloros. The pellet was resuspended in 
10 ml of hypotonic solution and incubated for a further 7 minutes. The tubes 
were then spun at 1200 rpm for 8 minutes and the supernatant was pipetted 
off into a container of 10% Chloros. The pellet was carefully resuspended in 
10 ml of fresh fixative and spun at 1200 rpm for 8 minutes before pipetting off
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the supernatant. Once again, the pellet was resuspended in fresh fixative and 
spun for 8 minutes before pipetting off the supernatant. The pellet was then 
thoroughly resuspended in 5 ml of fresh fixative and placed in refrigerator for 
at least 30 minutes.
2.3.3 Slide preparations
Microscope slides were cleaned by soaking in Decon® overnight and rinsed 
with running tap water for at least 2 hours. The clean slides were then stored 
in water for at least 30 minutes at +4°C before use. The tubes containing the 
cell suspension were removed from the refrigerator and spun at 1200 rpm for 
8 minutes. After pipetting off the supernatant, the pellets were resuspended 
in 0.5 ml of fresh cold fixative solution. 3-4 drops of the cell suspension were 
then dropped onto a cold, wet slide. For G-banding, the slides were then 
placed on a hotplate to dry and evaluated under a light microscope (Phase 
contrast). Slides which passed the quality control were then baked for at least 
one hour at 80°C before use.
2.3.4 G-banding
Solutions:
Trypsin solution:
Difco trypsin 
Saline solution
2 x SSC (pH 7.4):
NaCI 
Na citrate 
Distilled water 
Staining solution:
Leishman powder 
Methanol
(For staining slides this solution was
3 parts buffer)
Saline solution:
1 vial 
10 mis
17.50 g 
8.82 g
up to 1000 mis 
3 g
up to 2000 mis 
diluted with buffer (pH 6.8) in the ratio 1 part to
0.9 g/L NaCI
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Procedure:
The giemsa bands (G-bands) were obtained by digesting the chromosomes 
with the proteolytic enzyme trypsin. The aged slides were immersed in 
trypsin solution for 7-15 seconds and then rinsed with saline solution before 
being stained in Leishmanns solution for 2 minutes. The rinsed slides were 
then placed on a hotplate to dry and analysed under a light microscope.
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2.4 Fluorescence in situ hybridisation (FISH)
Uni-colour or multi-colour targeted FISH using painting, centromeric or 
telomeric probes was carried out mostly to confirm the Comparative genomic 
hybridisation (CGH) results. In families where CGH had already detected the 
abnormality, targeted FISH was used to detect carriers or other affected 
individuals in the family. In most circumstances, commercially available 
labelled probes were used, in some cases, however, fluorochrome or hapten 
labelling of the probes was performed in the laboratory.
2.4.1 Labelling of probes by nick translation
Both direct and indirect labelling of DNA probes were performed in this study.
Solutions and reagents:
Enzymes
DNA polymerase I/DNase Gibco BRL
(0.5U/p.l)/(40 pg/(J)
10x A4 Solution (Gibco BRL)
0.5 M Tris-HCI, pH 8.0 
50 mM MgCI2
0.1 mg/ml bovine serum albumin 
0.1 M B-mercaptoethanol 
0.2 mM dATP 
0.2 mM dCTP 
0.2 m M dG TP  
Reporter Molecules:
Either: 40 (iM Fluorescein-12-dUTP (DuPont) or 
40 j.iM TexasRed-5-dUTP (DuPont) or 
40 piM Biotin-11-dUTP or 
0.125 mM digoxigenin-11-dUTP 
DNA precipitation solutions:
Sodium acetate 3 M
Ethanol 100%
TE buffer:
10 mM Tris/HCI pH 8.0 ; 1 mM EDTA 
Distilled water
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Direct labelling of DNA
For nick translation a final volume of 50 pi solution containing 1 jag of the 
DNA to be labelled, 5 jal DNA polymerase I/DNase, 5 pi of 10xA4 solution 
and either 40 pM Fluorescein-12-dUTP, or 40 pM TexasRed-5-dUTP 
dissolved in distilled water was incubated for 90 minutes at 15°C in a water 
bath. After nick translation, the reaction was stopped by incubating the 
reaction tube in a waterbath at 70°C for 10 minutes. 2.5 pi sodium acetate 
and 150 pi ethanol was then added to the reaction tube. The labelled DNA 
was precipitated by vortexing the tube for 30 minutes at 14000 rpm. After 
pouring off the supernatant the DNA pellet was resuspended in appropriate 
amount of TE buffer.
Indirect labelling of DNA
In this method, digoxigenin or biotin were used as reporters instead of 
directly fluorochrome coupled nucleotides. Biotinylation was carried out using 
Biotin-11-dUTP in exactly the same manner as the previous method. For 
digoxigenation of the DNA probes 0.125 mM digoxigenin-11-dUTP was used.
2.4.2 Labelling of probes by PCR
Solutions and reagents:
DNA polymerase (Amplitaq®)
10x reaction buffer 
dATP (10 mM) 
dCTP (10 mM) 
dCGP (10 mM) 
dTTP (1.2 mM)
Primers (forward and reverse) 20uM each 
FITC-12-dUTP (1 mM)
TexasRed (1 mM)
Biotin-11-dUTP (0.4 mM)
Distilled water
Perkin Elmer 
Perkin Elmer
DuPont
DuPont
38
Procedure:
1 pig of genomic DNA or 1-2 ng of the target DNA probe (where probe was in 
plasmid, cosmid or YAC) was used for PCR DNA labelling.
PCRs were performed in a total volume of 50 pi. (0.5 pi of AmpliTaq® DNA 
polymerase, 1 pi of 10x reaction buffer, 1 pi of each dATP, dCTP, dGTP, 2.5 
pi dTTP, 5 l^ of each primer, 5 l^ of FITC-12-dUTP or TexasRed-5-dUTP, or 
2.5 pi Biotin-11- dUTP 0.4 mM, appropriate amount of the DNA to be 
amplified, and up to 50 pi distilled water).
Fifty microlitres of mineral oil was added on top of the reaction mixture to 
prevent evaporation. PCR reactions were performed as described in Table 2.
1. The reaction products then were purified by ethanol precipitation or by 
using a Millipore Ultrafree ® -MC filter.
Table 2. 1: PCR program for labelling of DNA probes
1 cycle:
94 °C 2 minutes
50°C 1 minute
72°C 1 minute
30 cycles:
94°C 1 minute
50°C 1 minute
72°C 1 minute
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2.4.3 Pre-hybridisation and hybridisation
Materials, reagents, and solutions ___
Glass slides with metaphase chromosomes
Labelled DNA probes
Competitor DNA
Cold ethanol
Deionised formamide
Hybridisation solution: 
sulphate (Pharmacia), 1 x SSC
1 x SSC.
Denaturation solution:
Rubber cement 
Water baths
Cot-I DNA (BRL Life Sciences) 
70%, 90%,100%
37°C, 45°C, 60°C, 70°C
1.5 M NaCI, 15 mM Na3-Citrate 
70% formamide, 2 x SSC pH 7.0
50% formamide, 10% dextran,
Slide preparation
The metaphase slides were examined under a light microscope (phase 
contrast) and positions of metaphases of acceptable quality were recorded 
by marking a 2 cm2 slide area appropriate for hybridisation. Slides were then 
dehydrated through an ethanol series (2 minutes each at 70%, 90% and 
100%) and used after 1-2 days. Where urgent results were required, the 
slides were aged by incubating at 60-80°C for one hour immediately after 
they had dried at room temperature.
Denaturing of target DNA and the probe
Denaturing of target DNA and the probe were performed in parallel. Slides 
were denatured by incubating in 70% formamide (v/v) in 2 x SSC at 70°C 
for 2 minutes. After denaturation, the slides were quenched in ice-cold 
70% (v/v) ethanol and then dehydrated in ethanol series. Ten microlitres of 
hybridisation solution containing 10-40 ng of labelled test and 1 pg of 
unlabelled human Cot-I DNA were denatured by incubating at 65°C for 10 
minutes. The tube containing the denatured probe was then immediately 
transferred into a 37°C water bath and incubated for 30 minutes to allow
40
CISS hybridisation to occur. In dual colour FISH the two probes were 
mixed in equal amount before they were denatured.
Hybridisation
Slides containing the denatured target metaphases were transferred onto a 
metal tray and 10 pi of the hybridisation solution was applied to the marked 
area which was then covered with a coverslip, and the edges were sealed 
with rubber cement to prevent evaporation of hybridisation solution. Finally, 
the probe(s) and the target DNA were allowed to hybridise at 37-42°C 
overnight, in a metal tray floating in a water bath.
2.4.4 Post-hybridisation
Solutions, materials and reagents
1 x SSC. 1.5 M NaCI, 15 mM Na3-Citrate
2 x SSC
1 x ST solution: 4x SSC, 0.05% Tween-20
Washing solution A 50% formamide, 2 x SSC
Blocking agent: 15% human serum in ST solution
Detection agents: Avidin -FITC
Antidigoxigenin -  rhodamine
Counterstain: 0.1 pg/ml DAPI ( 4,6,diamino-2-
phenylindole)/ Antifade
(Citiflour)
Alcohol series 70%, 90%, 100% ethanol
Coplin jars
Water baths 37°C, 42°C
Washing steps
The slides were taken out from the water bath before the rubber cement was 
removed. The coverslips were rinsed off by incubating the slides in 2 x SSC 
for 5 minutes. Following that, the slides were washed 3x5 minutes in solution 
A at 42°C, 1 x 5minutes in 1 x SSC at 42°C followed by 1 x 5minute in 1 x ST 
at 42°C and 1 x 5 minute in 1 x ST at room temperature. Where directly 
labelled probes had been used the slides were dehydrated in an alcohol
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series and counterstained as will be described later. When using biotin or 
digoxigenin labelled probes, the slides underwent signal detection and 
amplification steps.
Detection
Slides hybridised with digoxigenin or biotin labelled probes were incubated 
for 10 minutes with 100 pil blocking agent at 37°C. Slides were then 
incubated with avidin-FITC conjugate for 30 minutes at 37°C to visualise 
biotin labelled probes. Digoxigenin-labelled probes were detected by 
incubation with sheep anti-digoxigenin conjugated to rhodamine. In dual 
colour experiments both digoxigenin and biotin labelled probes were detected 
at the same time. No amplifications of the signals were required. Slides were 
then washed 3x5 minutes in ST solution at room temperature, dehydrated 
through an alcohol series and then air dried. Finally, they were 
counterstained by DAPI, resulting in coarse banding of the chromosomes, 
allowing individual chromosomes to be visualised and identified.
Visualisation
Observation of signals was carried out by either directly by using the 
100x/1.30 oil objective of an epifluorescence microscope (Zeiss Axioplan) 
equipped with specific filter sets, or by means of a cooled CCD camera and 
computer (Apple Macintosh Quadra 950) with SmartCapture software fitted 
to the same microscope. The photographs taken were printed with a full 
colour printer connected to the system (Mitsubishi).
42
2.5 Extraction of genomic DNA
2.5.1 Blood and bone marrow
Solutions:
RBC Lysis:
155 mM Ammonium Chloride
10 mM Potassium Hydrogen Carbonate
1 mM EDTA
Cell Lysis:
25 mM EDTA
2% SDS 
Proteinase K: (20mg/ml)
Protein Precipitation:
10 mM Ammonium Acetate
Isopropanol 
Ethanol (70% v/v)
TE buffer
10 mM Tris/HCI pH 8.0
_____________________ 1 mM EDTA__________________________________________________
Procedure:
One volume whole blood or bone marrow sample collected in EDTA was 
added to 3 volumes cold RBC lysis solution. The sample tube was then 
inverted to mix and kept at room temperature for 20 minutes before being 
centrifuged at 2000g for 7 minutes (large samples) or 20 seconds (small 
samples). The supernatant was then removed leaving a visible white cell 
pellet and 10-20 \i\ of residual liquid. The sample tube was vortexed to re­
suspend cell pellet before adding 1 volume cell lysis solution and vortexing 
again. 1/3 volume protein precipitation solution was added and vortexed 
before centrifuging at 3000g for 20 minutes to pellet proteins (3 minutes in 
microfuge for small samples). Supernatant was then transferred to a clean 
tube containing 1 volume isopropanol and mixed thoroughly to form DNA 
precipitate. DNA was then spooled out using sealed Pasteur pipette, and 
washed in 70% ethanol. For small samples the DNA was spun down. The 
isolated DNA was then dissolved in appropriate volume of TE buffer.
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2.5.2 Fixed cells
For isolation of DNA from cells fixed in methanol/acetic acid, the fixative was 
removed by washing the samples twice in 2 x SSC. For this: 5 ml 2 x SSC 
was added on top of the existing fixative in the sample tube and spun for 
seven minutes. After removing the supernatant a further 5 ml of 2 x SSC was 
added and the tubes spun for another 7 minutes. After removing the 
supernatant 5 ml of cell lysis buffer was added and the DNA extracted as 
described for blood and bone marrow samples.
2.5.3 Solid tumours
10-20 mg of fresh or frozen tissue was added to a 1.5 ml tube containing 600 
\.il cell lysis solution chilled on ice and quickly homogenised using 30-50 
strokes with microfuge tube pestle. The homogenised sample was then 
incubated in a water bath at 65°C for 55 minutes. 3 pi Proteinase K solution 
(20mg/ml) was then added and the lysate was incubated at 55°C for 3 hours 
to overnight, or until tissue had dissolved. 3 pi RNase solution was then 
added to the cell lysate, mixed by inverting the tube, and incubated at 37°C 
for 30 minutes. DNA isolation then was carried out as described for blood 
and bone marrow samples.
2.6 Comparative Genomic Hybridisation (CGH)
2.6.1 Metaphase Spreads
Metaphase spreads were prepared as described in 2.3. Wet slides were left 
at room temperature to dry and used after 1-2 days. Where urgent results 
were required, the slides were aged by incubating at 60-80 °C for one hour 
immediately after they had dried at room temperature
To minimise inter-experimental variability in CGFI preparations, batches of 
metaphase slides comprising 100-200 slides were prepared at once. Several 
slides from each batch were then examined for high quality chromosomes. 
Batches of slides with high quality metaphases and minimal overlapping 
chromosomes were selected and their hybridisation characteristics tested in
44
control experiments with 1:1 mixtures of differentially labelled normal 
genomic DNAs. Suitability of slides was also predicted based on the intensity 
of DAPI signal arising from interphase and metaphase chromosomes after 
denaturing (for details see Results). Each batch was used for future 
experiments only if high quality hybridisation had been achieved in control 
CGH experiments or it had passed the DAPI intensity evaluation procedures 
(see Results). Otherwise, the entire batch was abandoned.
2.6.2 Genomic DNA Probes and Labelling Procedures
Test and control DNAs were extracted as described above. Control genomic 
DNAs were prepared from the blood of healthy males (46,XY) or females 
(46,XX). Test (patient) human genomic DNA was directly labelled with FITC- 
12-dUTP (DuPont), and control DNA was labelled with TexasRed-5-dUTP 
(DuPont) by standard nick translation reaction (2.4.1). DNase I concentration 
was adjusted to result in an average fragment size of 500-1000 bp.
2.6.3Pre-hybridisation and hybridisation
Solutions and reagents 
Labelled DNA probes 
Com petitor DNA:
Cot-I DNA (BRL Life Sciences)
Cold ethanol:
70%, 90%, 100% (v/v)
Deionised formamide 
Hybridisation solution:
50% formamide, 10% dextran sulphate (Pharmacia), 1 xssc
1 x SSC:
1.5 M NaCI 
15 mM Na3-Citrate 
Denaturation solution:
70% formamide, 2 x SSC pH 7.0
Procedure:
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Metaphase chromosomes from normal male individuals were denatured for 2 
minutes at 70°C in 70% formamide, 2xSSC pH 7.0; thereafter, slides were 
put through an ice-cold ethanol series (70%, 90%, 100%) and air-dried. For 
each hybridisation area, one microgram of labelled test DNA (5 pg in 
overnight CGH), 1 pg of labelled control DNA (5 pg in overnight CGH) and 50 
pg of unlabelled human Cot-I DNA were dissolved in 10 |J of hybridisation 
solution and denatured at 74°C for 7 minutes. The hybridisation mix was then 
applied to the slide with the denatured metaphase chromosomes, covered by 
an 18x18 mm coverslip and sealed with rubber cement. Finally, the genomic 
DNA probes and the target DNA were allowed to hybridise at 37°C for 48-72 
hours in a metal tray floating in a water bath.
2.6.4 Washing steps
Solutions, materials and reagents
1 x ssc
1.5 M NaCI 
15 mM Na3-Citrate
2 x SSC
1 x ST solution:
4x SSC
0.05% Tween-20 
W ashing solution A:
50% formamide, 2 x SSC 
Counterstain:
0.1 jj.g/ml DAPI (4,6,diamino-2- 
phenylindole)/ Antifade 
(Citiflour)
Alcohol series: 70%, 90%,100% ethanol
Procedure
After hybridisation at 37°C, slides were washed 3x5 minutes with 50% 
formamide and 5 minutes with 2xSSC at 42°C and another 5 minutes with 1 
x ST solution at room temperature. Slides were then dehydrated in an 
ethanol series (70%, 90%, 100%) and air dried. Finally, they were
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counterstained with DAPI resulting in coarse banding of the chromosomes, 
allowing individual chromosomes to be visualised and identified.
2.6.5Digital image analysis
Images were obtained using an epifluorescence microscope (Axioplan: Zeiss, 
Germany) equipped with a cooled CCD camera (Photometries) controlled by 
an image analysis system.
For normalisation of the ratio profiles, the modal value of the green-to-red 
ratio for the entire metaphase was set to 1.0. Finally, the individual ratio 
profiles were combined to yield the average ratio profiles, which were 
displayed next to the chromosome diagrams with significance intervals of 0.5 
and 1.5.
Chromosomal regions with a green-to-red ratio above 1.5 were considered to 
be over-represented (gained), whereas regions with a ratio below 0.5 were 
considered to be under-represented (lost). These limit values were slightly 
different in each experiment depending on the thresholds deduced from the 
analysis of negative control experiments where two differently labelled 
normal DNAs were hybridised against one another.
Standard CGH analysis was performed using either SmartCapture V 2.1 
software (Digital Scientific, Cambridge, UK) or recently, the Quips 
programme for CGH analysis.
2.6.6 SmartCapture ™ V 2.1
CGH analysis using SmartCapture included flat fielding, background removal, 
image enhancement, thresholding and fluorescence equalisation followed by 
global analysis, axial analysis, scoring and the final analysis.
Im age capture
Using DAPI filter of the fluorescence microscope one high-intensity, uniformly 
hybridised metaphase cell was localised. Capture was selected from the
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SmartCapture extensions menu and Capture, Camera and Filter parameters 
were set as shown in Figure 2. 2.
By clicking on the Expose button, the settings were accepted and the image 
was captured. Three excitation frequencies, red (TexasRed), green (FITC) 
and blue (DAPI) were seen consecutively. The image composed itself of 
three colour components and after a brief pause, the complete colour picture 
together with a colour normalisaton window was displayed (Figure 2. 1).
The image then was saved as Macintosh PICT format in a folder designated 
for a particular case. For each CGFI experiment between 5-20 images were 
captured. Normalisation settings were kept constant for the second image 
onward.
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Figure 2. 1: Normalisation window
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Figure 2. 2: CGH image capture settings, (a): Binning and exposure, (b): 
Filter set-up. (c) Camera set-up
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Flat fielding
In some experiments flat fielding was performed to compensate for an image 
captured in non-uniform illumination. A blank image was first captured and 
used as an index to correct subsequent images taken by Capture. For a CGH 
image, a blank image was required for each colour component.
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Figure 2. 3: Settings for flat fielding in the capture window, (a) Capture, exposure time, 
exposure gain and normalisation settings, (b) flat field dialog box
Using low power objective, a portion of the slide free of interphase nuclei and 
debris was selected. The focus adjustment was turned a fraction so that the 
surface was blurred. Capture was selected from the SmartCapture 
extensions menu and the settings displayed in Figure 2. 3 were selected. The 
blank image was captured and named as Uniform. In flat field window the 
Uniform.R, Uniform.G, and Uniform.B were selected for the red, green and 
blue windows respectively (Figure 2. 3.b).The metaphase of interest was 
then selected and captured as above. The captured image was corrected for
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the light distribution measured at each point by comparing with the blank 
image.
Background removal
The function BackgroundRemove was used to remove the background from 
an image or to remove the effects of uneven illumination. The required image 
was opened and BackgroundRemove from the extensions menu was 
selected. BackgroundRemove settings were then chosen as depicted in 
Figure 2. 4.
Filter Size: 
B frill:
Red: 
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Blue:
None
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Quality: —  
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Cancel GO
Figure 2. 4: BackgroundRemove window: Settings for CGH images
DAPI enhancement
The DAPI counter stain was enhanced to bring out the band structure and 
thus aid the identification of the chromosomes.
The required image was opened and Split Colour Coord from the Analyse 
menu was chosen. The blue image was selected and inverted to black and 
white by choosing Adjust Contrast from the Enhance menu and clicking on 
the reverse icon. After obtaining a satisfactory contrast by adjusting the slope 
of the contrast, the Enhance from the Ext. menu was called and the filter 
value was set to’ Large-Moderate’. The resulting image was then used for 
chromosome identification based on its coarse banding pattern.
51
Thresholding
The segmentation script was run to define the chromosome boundaries by 
the DAPI counter stained image. The following settings were selected on the 
Segmentation window: ‘binaries’ box ‘ checked; ‘green inside’ box checked 
‘Show ROI histogram’ checked. Segmentation script created a ‘mask’ which 
was then used to retain all material within the green area, setting the rest of 
the image to zero (Figure 2. 5).
Figure 2. 5: Segmentation of the chromosomes in a CGH image, (a) CGH image before 
segmentation, (b-d) blue, red and green images, (f) masked chromosomes, (g) image with 
the ‘cut out’ chromosomes and zero background.
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Fluorescence ratio (FR) equalisation
FR equalisation was carried out by calculating the average for each image 
and setting it arithmetically to 1. The FR equalisation operation was coded in 
a SmartCapture script (Equalisation).
Global analysis
The ColourRatio extension of the SmartCapture was used to map between 
ratios of red and green to identifiable colours.
The processed CGH image was opened before running the ColourRatio 
from the Ext. menu. The ColourRatio settings were set as shown in Figure 2.
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Figure 2. 6: ColourRatio window settings for CGH
The window was set to paint the image such that every pixel with a green/red 
ratio greater than 1 was green. If there was an excess of red fluorescence in 
any pixel it would be painted red. The Ratio button was clicked and after a 
few moments a new image appeared with the normal chromosomes painted 
white and both homologues of gained or deleted segments painted green or 
red respectively. These setting values were slightly different in each 
experiment. Widening the white gap in the ColourRatio window increased the 
specificity with loss of sensitivity. In mosaicism where less than 100% of cells
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were abnormal, the white gap was narrowed to compensate the dilution of 
the abnormal cells.
Axial analysis
In this method, the orthogonally integrated FR distribution along the length of 
an individual chromosome was considered, a FR graph, and a chromosome 
image with the aberration marked in colour was generated.
Using the DAPI image to aid identification, the required chromosome was 
chosen. ‘Polygon tool’ from the status window was selected and the 
chromosome axis was marked along the length of the chromosome. The 
ColourRatio was selected from the Ext. menu. ‘Qgraph’ and the ‘Paint’ boxes 
were checked. The Ratio button was clicked resulting in a ratio coloured 
chromosome and a graph showing red/green ratio along the chromosome.
2.6.7Quips CGH analysis
The Quips CGH analysis software is a suite of programs, that provide 
comprehensive patient management and semi-automatic image analysis for 
CGH studies. Each program in the suite may be used independently. The 
CGH/Karyotyper program provides for multiple metaphase image analysis to 
generate a single karyotype. The software suit and outline of the analysis are 
described in Table 2. 2 and Figure 2. 7.
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Table 2. 2: Quips CGH Analysis Suite Programs (from Quips user’s guide) 
Program Description
Quips DB
SmartCapture
Q u I ps C G! • l/K a ry o ry per
Quips Interpreter
Record patient information and print text-only reports.
Start other programs from the database to collect all 
analysis files into one folder for a case study.
Capture a metaphase Image using SmartCapture.
Works with the SenSys K A f1400 camera to capture 
multicolored or monochrome images.
Edit arid analyze a metaphase image to generate a 
karyotype and CGH ratio profiles.
Provide access to a report, editor for generating printed, 
reports with images.
Edit and. analyze ratio profile data from several 
meiaphases in a CGH experiment,
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Figure 2. 7: Outline of CGH study using Quips CGH analysis software (from 
Quips user’s guide).
56
2.7 The polymerase chain reaction (PCR)
Standard and Degenerate Oligonucleotide Primer PCR (DOP-PCR) were 
utilised during the various parts of this study. Standard PCR was mainly used 
as a tool to amplify DNA sequences which then were used as hybridisation 
targets in high resolution CGH. DOP-PCR was utilised to amplify whole 
genomic DNA for use as test samples when the original DNA sample was 
small.
2.7.1 Standard PCR
Solutions and reagents in a 50 pi PCR reaction tube:
Genom ic DNA
0.1 fig
DNA polymerase (Amplitaq®)
1. unit
Reaction buffer (Perkin Elmer)
1 x
dNTPs:
dATP (200 fiM) 
dCTP (200 fiM) 
dGTP (200 fiM) 
dTTP (200 pM)
Primers: (forward and reverse)
30 pM each
SRY.PCR1: 5' GAA TAT TCC CGC TCT CCG GA
SRY.PCR2: 5' GCT GGT GCT CCA TTC TTG AG
DMD-1527 5' TTG AAT TAC ATT GTT TAA ATC CCA ACA TG
DMD 2170 5' CCT GAA TAA AGT CTT CCT TAC CAC AC
MSH2.PCR1 5' GAT TGT TAC CGA CTC TAT CA G
MSH2.PCR2 5’ AAA ATG GGT TGC AAA CAT GC
XIST 1 5' GAA GTC TCA AGG CTT GAG TTA GAA G
XIST 2 5' ACA TTT TTC TCT AGA GAG CCT GGC
M gCI2:
1.5 mM 
Distilled water
Up to 50 (il
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Procedure:
Depending on the purpose of study, PCRs were performed in a total volume 
of 100, 50 or 25 pi. Where necessary the concentration of each of the 
materials was optimised to get the best PCR result. Buffer, primers and 
dNTPs were added into pre-labelled 0.5 ml microfuge tube on ice then the 
volume was made up to the desired volume with distilled water. The mixture 
was subjected to 10 minutes of UV radiation before DNA and enzyme were 
added. The mixture was vortexed, centrifuged and overlaid with 50 pi of 
mineral oil before being transferred to an automated temperature-cycling 
machine (PCR machine). PCR reactions were performed as described in 
Table 2.3. PCR products were visualised by agarose gel electrophoresis (in 1 
x TBE); ethidium bromide staining and transillumination on a UV-lamp as is 
described in section 2.7.5. Permanent records of these gels were made using 
a gel documentation system (UVP Imagestor 5000) linked to a thermal 
printer.
Table 2.3: Standard PCR
1 cycle:
94°C 2 minutes (initial denaturing)
30-40 cycles:
72°C
94°C
53-60°C
30-60 seconds (denaturation) 
30-60 seconds (primer annealing) 
1-3 minutes (primer extension)
1 cycle:
72°C 10 minutes (final extension)
58
2.7.2DOP-PCR
Solutions and primer for POP PCR:
10x reaction mix
20 mM MgCI2,
500 mM KCI,
100 mM Tris HCI (pH 8.4)
1 mg/ml gelatine 
10x nucleotide mixture:
2 mM each of dNTP (dATP, dCTP, dGTP, dTTP) 
10x DOP primer:
5'CCG ACT CGA AGN NNN NNA TGT GG3' 
(N=A,C,G, orT)(Telenius et al 1992)
DNA polymerase
Amplitaq® (Perkin Elmer)
Distilled water
Procedure:
1 ng genomic DNA was used for DOP-PCR experiments. PCRs were 
performed in a total volume of 50 pi PCR reaction mix containing 1 unit of 
AmpliTaq® DNA polymerase; 5 pi 10x DOP-PCR buffer; 5 pMOx nucleotide 
mixture, 5 pi 10x DOP primer and adjusted to 50 pi with H2O. Reaction 
solutions without DNA or enzyme were used as negative controls. The 
reaction mixture was overlaid with 50 pi of mineral oil and transferred to an 
automated temperature-cycling machine (PCR machine). The optimised PCR 
program is described in Table 2. 4. The reaction products were then purified 
by ethanol precipitation or by using Millipore's Ultrafree ® -MC filter and 
controlled by gel electrophoresis.
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Table 2. 4: DOP PCR profiles
1 cycle:
94 °C 2 minutes (initial denaturing)
5 cycles:
94°C 1 minute
30°C 1.5 minute
30-72 transition 3 minutes
72°C 3 minutes
35 cycles:
94°C 1 minute
62°C 1 minute
72°C 3 minutes (with an addition of 1 sec/cycle)
1 cycle:
72°C 10 minutes (final extension)
2.7.3 Quantitative PCR
In this study, quantitative PCR was performed to confirm the CGH results in a 
case with abnormal Xq by quantifying the XIST locus copy numbers.
Genomic DNA samples from a normal male, a normal female and the patient 
were subjected to series of optimised quantitative PCR experiments. The 
optimised quantitative PCR included 1 minute initial denaturation of the 
samples at 94°C followed by 20 cycles at 94°C for 1 minute (denaturation), 
55°C for 1 minute (primer annealing), and 72°C for 1 minutes (primer- 
extension) and a final extension of 10 minutes at 72°C, for one cycle. The 
PCR products were then visualised using a standard UV transilluminator and 
photographed using a gel documentation system (UVP Imagestor 5000) 
linked to a thermal printer. The photographs were then digitally saved as grey 
scale images in Macintosh PICT format. Using SmartCapture package the 
total values of signal intensities in one selected area of each band 
corresponding to patient's sample was calculated and compared to those 
from equal areas of bands from normal male and female samples (see 
Results).
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2.7.4 Purification of PCR products
At the end of PCR, the amplified DNA was purified by removing the excess 
primers, dNTPs, and salts either by Millipore's Ultrafree ® -MC filter or by 
isopropanol precipitation.
Isopropanol precipitation of PCR products
Solutions and reagents:
Isopropyl alchohol
100%
Ethanol
70%
Am m onium  acetate 
4 M
TE buffer
10 mM Tris/HCI pH 7.0 
1 mM EDTA
Procedure:
Mineral oil was gently removed from the top of the PCR product by a 
micropipette. Then one volume of 4 M ammonium acetate and two volumes 
of isopropanol were added, the mixture was vortexed and left on ice for 10 
minutes, followed by 10 minutes centrifugation at 14000 rpm. The 
supernatant was discarded and the DNA pellet was washed in 70% ethanol, 
air dried and dissolved in appropriate amount of T.E. buffer pH 7.0.
Millipore Ultrafree ®  filter units
The total reaction product was transferred to the upper part of the filter unit. 
The reaction vial was then rinsed with100 pi of 2 x SSC buffer which then 
was added to the filter unit. The filter unit was spun at 12000 rpm until all of 
the liquid had collected in the bottom of the microtube portion of the unit. This 
took about 12-15 minutes for a 150 pi sample. After that, another 100 pi of 2 
x SSC was added to the filter unit which was centrifuged again. An aliquot
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(same volume as initial total volume) of 1 x TE buffer (1 mM Tris-1 mM EDTA 
pH 7.6) was pipetted into the upper part of the insert to recover the purified 
DNA. This solution was transferred to a clean microcentrifuge tube. The 
whole filter unit assembly was discarded after use.
2.7.5Identification of PCR products
Solutions, reagents and materials 
Loading mix
0.25% bromophenol blue 
0.25% xylene cyanol 
40% sucrose
Agarose gel
1% (0.5g/50ml)
TBE buffer (pH 8.3)
10.8 g Tris 
5.5 g boric acid 
0.93 g EDTA
up to 500ml distilled water 
Ethidium bromide
Procedure:
A 1% agarose gel was prepared by adding 0.5g agarose powder (SEA KEM 
GTG, FMC Bioproduct) to 50 ml 1 x TBE buffer. The mixture was then boiled 
in a microwave oven and allowed to cool down to 55°C before ethidium 
bromide (5 pg/ml) was added. The gel was then poured on to a casting tray. 
6 pi of PCR product then was mixed with 1 pi of loading mix and loaded on 
the 1% agarose gel. The sample was then subjected to electrophoresis at 
constant 100 volts for 30 minutes. The DNA was then visualised using a 
standard UV transilluminator and photographed using a gel documentation 
system (UVP Imagestor 5000) linked to a thermal printer.
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2.8 Plasmid/Cosmid Probe Culture and isolation
Solutions, reagents and materials _____________
Luria-Bertani (LB) medium
Bacto-tryptone 5.0 g
Bacto-yeast extract 2.5 g
NaCI 5.0 g
Distilled water up to 500 ml
Sterilised by autoclaving
Starter culture or glycerol stock
American Type Culture Collection
CIRCLEPREP® Kit
Pre-lysis buffer
Alkaline lysis reagent
Neutralising solution
Isopropanol
100%
Ethanol
70%
Ammonium acetate
4 M
TE buffer
10 mM Tris/HCI pH 7.0
1 mM EDTA
Procedure
100 ml LB broth was inoculated in a sterile bottle with either 100 \i\ starter 
culture or 200 jil glycerol stock and incubated overnight (8-16 hours) at 37°C, 
in a shaking incubator. A Circleprep Kit was used to isolate the cosmid or 
plasmid DNA. The cells from overnight culture were spun down in 50 ml 
centrifuge tubes. Supernatant was then discarded and tube was drained for a 
minute. The cell pellet was resuspended by adding 4 ml of pre-lysis buffer 
before 4 ml of alkaline lysis reagent was added to lyse cells. After mixing the 
lysate 4 ml of neutralising solution was added and mixed before the tubes 
were spun at 12000 for 5 minutes at 4°C. Supernatant then was transferred 
to a clean 50 ml centrifuge tube and plasmid or cosmid DNA was precipitated
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as described above. DNA pellet was then dissolved in TE buffer or distilled 
water.
2.9 Preparation of single stranded DNA by magnetic 
separation
Solutions, reagents and materials
Dynabeads-M-280 Streptavidin®
10 mg/ml 
Magnetic Particle Concentrator 
Dynal MPC®
Forward and reverse PCR primer
(one primer biotinylated)
Binding and W ashing (B&W) buffer (2 x )
10 mM Tris-HCI pH 7.5 
1.0 mM EDTA 
2 M NaCI 
Melting solution
0.15 M NaOH  
DNA precipitation reagents
Ammonium acetate (5 M, pH 6.6) 
Isopropanol
Glycogen (nucleic acid free)
Sterile water
Procedure
Dynabeads-M-280-streptavidin was used to prepare single stranded DNA 
from PCR products, which were then used as targets in hybridisation studies. 
Biotin was introduced into one of the strands of the DNA during the PCR 
amplification using one of the primers biotinylated in the 5' end. PCR 
amplifications of DNA targets were performed as described above. The PCR 
product was then immobilised through the interaction between biotin and 
Streptavidin onto magnetic beads with covalently coupled Streptavidin on the 
surface. 5-20 pi of Dynabeads M-280 Streptavidin was washed with 20 pi of 
2 x B&W and resuspended in 40 pi of 2 x B&W buffer. 40 pi of the amplified 
PCR product was added to 40 pi of the pre-washed Dynabeads and 
incubated for 15 minutes at room temperature to immobilise the biotinylated 
PCR product. The Dynabeads were kept suspended by gently tapping the
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tube. The tube containing the immobilised product was placed in a suitable 
magnet (Dynal MPC) and the supernatant was removed with a pipette.
The magnetic beads with the immobilised DNA, collected on the side of the 
tube were washed by adding 40 jil of 2 x B&W buffer to remove the reaction 
components. The washed, immobilised product was placed in the Dynal MPC 
and the supernatant was removed.
Figure 2. 8: Schematic diagram fo r magnetic separation of DNA strands. Biotin is introduced 
into one of the strands o f the DNA during the PCR amplification using one of the primers 
biotinylated in the 5' end. The PCR product is then immobilised through the interaction 
between the biotin and Streptavidin covalently coupled on the surface of magnetic bead. 
After immobilisation, the magnetic beads are washed to remove the reaction components. 
The immobilised double stranded DNA is converted to single stranded template by alkaline 
denaturation and subsequent removal of the biotinylated strand by magnetic separation.
The immobilised double stranded DNA was converted to single stranded 
template by alkaline denaturation and subsequent magnetic separation. The 
non-biotinylated ssDNA was eluted from pelleted beads by the addition of 
300 [x\ 0.15 M NaOH for 5 minutes. After magnetic separation, the 
supernatant was transferred to a new tube and precipitated by neutralising 
with the addition of 150 jil 5 M ammonium acetate pH 6.6, followed by 
isopropanol precipitation using 2 pg of nucleic acid free glycogen as a co-
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precipitant as described earlier. Finally DNA pellet was dissolved in an 
appropriate buffer.
2.10 DNA molecules as hybridisation targets
In the final part of this study, the feasibility of using DNA molecules instead of 
metaphase chromosomes as hybridisation targets to improve the resolution 
of the CGH technique was investigated. Combed fibres or high concentration 
spots of cosmid DNA containing 35 kb of human X chromosome attached to 
glass slides were targeted in comparative hybridisation studies. Spots of 
DNA arrays corresponding to DMD, SRY or hMSH2 genes amplified by PCR 
and attached to glass slides were the subjects of CGH experiments.
2.10.1 Slide preparation
Slides used as solid base for DNA molecules had been either silanised or 
pre-treated with Poly-l-lysine. All procedures were carried out at room 
temperature and with double distilled water unless otherwise stated.
Silanisation of glass supports 
Method 1
Solutions and reagents___________________________________________
HCI
Methanol
H2S 0 4
3-aminopropyltriethoxy silane (Sigma)
Ethanol
Procedure:
Slides were cleaned in equal parts of concentrated hydrochloric acid and 
methanol for at least 30 minutes followed by overnight immersion in 18 M 
sulphuric acid. The slides were then washed in 8-10 changes of ultra-pure 
water, immersed in boiling water for 10 minutes and air dried. Cleaned slides 
were placed in a 10% solution of 3-aminopropyltriethoxy silane (Sigma) in 
95% ethanol for 1 hour, rinsed several times with water, washed with ethanol
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and air dried. Prior to use, slides were heated to 80°C overnight (Weier et al 
1995).
Method 2
Solutions and reagents___________________________________________
Aminophenolpropyl silane (Sigma)
Methanol
Acetone
Ethanol
Procedure:
Glass slides were immersed in a 2% aminophenolpropyl silane in acetone for 
40 minutes at room temperature followed by three 5-minute washes in 50% 
acetone (Joos et al 1997). Prior to use, slides were heated to 80°C overnight.
Poly-l-lysine treatment
Materials:_______________________________________________________
NaOH
Poly-l-lysine solution
70 ml Poly-l-lysin
280 ml Distilled water
________Ethanol_______________________________________________________________________
Procedure:
50 g of NaOH pellets were dissolved into 150 ml distilled water before 200 ml 
of 95% EtOH was added. If solution remained cloudy, distilled water was 
added until clear. Thirty slides were immersed in the solution for 2 hours and 
then rinsed 3 times with distilled water. The slides were then transferred to 
lysine solution and left to soak for 1 hour. Excess liquid was removed and the 
slides were dried at 40°C for 5 minutes and stored in a closed box for at least 
two weeks prior to use.
2.10.2 Comparative hybridisation to DNA fibres
Linearised cosmid fibres were attached to a glass surface and aligned in 
parallel by molecular combing. Dual colour FISH was performed on these 
cosmid fibres with probe mixtures containing different ratios of FITC and
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TexasRed-labelled MA2B3 cosmid DNAs. To explore the feasibility of 
improving the CGH resolution, metaphase chromosomes were replaced by 
arrays of DNA fibres spotted on glass slides. The DNA spots were then the 
subjects of a series of CGH experiments.
Preparation of probe and target DNA
Cosmid MA2B3 was employed both as probe and as combed target DNA in 
this part of the study. It contains about 35 kb of the human dystrophin gene, 
including exon 48 (Tocharoentanaphol et al 1994).
Linearisation and staining of the cosmid DNA
Solutions, reagents and materials 
Cosmid MA2B3 
N ot I enzyme
GIBCO-BRL 
Reaction buffer
50 mM Tris-HCI (pH 8.0)
10 mM MgCI2 
I00 mM, NaCI
YOYO-1 dye
Molecular Probes
MES buffer
_____________________ [2-(N-morpholino) ethanesulfonic acid; (Sigma), pH 5.5],_____________
Procedure
The MA2B3 cosmid was linearised with Not I. One unit of the Not I was 
required to cleave 1 pg of cosmid DNA in one hour at 37°C in the reaction 
buffer. Not I digestion resulted in linearisation of the cosmid with the vector at 
one end of the fibre. In some experiments the linearised DNA was stained in 
a 5:1 ratio [base pairs per dye (YOYO-1)] immediately before use as controls. 
YOYO-1 stained cosmid DNA was diluted to 1 pg/ml in 50 mM MES buffer.
Alignment of DNA by a moving interface (Molecular combing)
A drop of stained or un-stained DNA solution (typically 5 pi) was deposited 
on a coated coverslip or slide. An untreated coverslip was then floated on
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top, forcing the drop to spread to a final thickness of -20 pm. After a few 
minutes the coverslip was carefully removed with forceps in such a way that 
a continuous and directed receding air-water meniscus was produced, 
resulting in a parallel alignment of cosmid fibres. The density and the 
alignment of YOYO-1 stained DNA fibres on the coverslips were monitored 
by microscopy (Bensimon et a ll994).
Dual-colour FISH to aligned DNA fibres
Pre-hybridisation and hybridisation
Materials, reagents, and solutions
Labelled cosmid DNA
MA2B3 FITC orTexasRed labelled 
Com petitor DNA
Cot-1 DNA (BRL Life Sciences)
Cold ethanol
70%, 90%, 100%
Deionised formamide 
Hybridisation solution
50% formamide, 10% dextran sulphate (Pharm acia)/1 xS S C
1 x SSC.
Denaturation solution:
70% formamide, 1 x SSC pH 7.0 
Rubber cement
Procedure:
Slides were baked at 60°C overnight. After 5 minutes wash in 2 x SSC, slides 
were put through an alcohol series of 70%. 90% and 100%. and air-dried. 
Preparations for immediate use were kept at room temperature and used 
within one week for comparative hybridisation experiments. Aligned DNA 
fibres were denatured for 2 minutes at 70°C in 70% formamide, 1 x SSC, pH 
7.0. The DNA fibres then were dehydrated through an alcohol series. For 
comparative hybridisation experiments cosmid MA2B3 DNA was labelled 
with either FITC or TexasRed by nick-translation as described above. The
69
chosen ratios of FITC to TR labelled DNA fragments in the hybridisation 
solutionwere 1:2, 2:3, 1:1, 3:2, 2:1 and 3:1. Ten microlitres of 
hybridisation solution contained between 22.5 and 90 ng of each 
fluorochrome-labelled cosmid DNA with a fragment length of 500-3000 bp 
and 5 pig of human Cot-I DNA (BRL). After denaturation at 75°C for 10 
minutes the hybridisation solution was applied to the slide with the denatured, 
aligned DNA fibres covered by an 18x18 mm coverslip and sealed with 
rubber cement. Hybridisation took place at 37°C overnight.
Post-hybridisation
Washing steps
Solutions, materials and reagents
1 x SSC.
2 x SSC  
1 x ST solution:
Washing solution A 
Alcohol series 
Coplin jars
Procedure:
Washing for FITC or TR labelled DNA fragments was carried out as 
described above for standard FISH. Slides were then air-dried and mounted 
in antifade with no counterstain.
Image analysis
Aligned DNA fibres subjected to comparative hybridisation were visualised 
and evaluated using basically the same system and approach as used for 
CGH and FISH.
Each fluorochrome was imaged separately using the SmartCapture software. 
Optimal exposure times and optical settings were established empirically and 
then kept constant for the entire set of DNA fibres recorded for a given 
experiment. Each fibre was segmented and the total fluorescence intensity in 
the entire segment for each fluorochrome was measured. Then to estimate
1.5 M NaCI, 15 mM Na3-Citrate
4x SSC, 0.05% Tween-20 
50% formamide, 2 x SSC  
70%, 90%, 100% ethanol
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the background, a neighbouring area with the same shape and size was 
selected and the value for green and red colours was calculated. Corrected 
fluorescence value for each fibre was calculated by subtracting the total 
background fluorescence value from the total fluorescence value obtained 
along the target fibre. The fluorescence ratio of each fibre was obtained by 
dividing the corrected green by the corrected red fluorescence intensity.
CG H to dotted DNA fibres 
Dotting of DNA on glass slides
Essential materials______________________________________________
Linearised cosmid DNA
Silanised or poly-l-lysine coated glass slides
Glass capillaries
Procedure
Linearised cosmid DNA was dotted onto silanised or poly-l-lysine coated 
glass slides at a concentration of 1 fig/ pi using a micropipette or glass 
capillaries under an inverted microscope. Glass capillaries with a size of 1.2 
mm outer diameter and 0.68 mm inner diameter were mounted on a 
micropipette puller (Sutter Instruments P-87). By applying heat in the middle 
of the capillary and pulling forces at the ends two needles with open ends 
were produced. For each experiment two hybridisation areas were produced 
on each slide. For each hybridisation area, 16 DNA spots were spaced at a 
distance of 4-10 pm (where glass capillaries used under the inverted 
microscope) to 400 pm (where micropipettes used) from centre to centre 
(see Results).
Pre-hybridisation and hybridisation
Slides containing dotted DNA were aged for 1 hour in an oven at 80°C before 
being dehydrated in an ethanol series (70%, 90%, and 95%). Hybridisation 
was carried out at 37°C for 48 hours. Washing steps were performed in
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exactly the same manner as standard CGH. Hybridising DNAs were derived 
from normal male and normal female individuals.
Each hybridisation area was the subject of a CGH experiment with similar 
test and control DNAs but with different colours. For instance if the test and 
control DNAs respectively had been labelled with FITC and TexasRed in one 
hybridisation area, it was the opposite for the other area. This measure was 
made to detect and deduce the effect of backgrounds corresponding to each 
fluorochrome.
Image analysis
DNA fibres subjected to CGH were visualised and evaluated using basically 
the same system and approach as used for single DNA fibres. Each 
fluorochrome was imaged separately using the SmartCapture software. 
Optimal exposure times and optical settings were established empirically and 
then kept constant for the entire set of DNA spots recorded for a given 
experiment. All spots in a single microscopic field were segmented and the 
total fluorescence intensity in the entire segment was measured for each 
fluorochrome. Fluorescence values corresponding to test or control DNA in 
one hybridisation area were compared to those from the same sample in 
another area with different colour. Using a statistical analysis package 
(Minitab release 10.5) a regression analysis was performed and the 
background values for each colour were calculated. Finally, the corrected 
fluorescence value for each spot was calculated by subtracting the 
background fluorescence value from the total fluorescence value obtained 
from the target spot and the fluorescence ratio of each spot was obtained by 
dividing the corrected green with the corrected red fluorescence intensity.
2.10.3 CGH to DNA microarrays
Hybridisation targets
Three target sequences, corresponding to the exon 48 of human DMD gene 
on chromosome X, SRY gene on chromosome Y and hMSH2 gene on 
chromosome 2 were selected and amplified by PCR using genomic DNA
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templates. The PCR products were made single stranded using magnetic 
beads (2.9 ). The single stranded DNA products then were spotted on 
silanised glass sequentially in a manner that the DNA targets corresponding 
to the X and Y chromosomes were separated by a spot corresponding to 
chromosome 3 DNA. In each slide, 16 spots were produced (Figure 3. 40).
Pre-hybridisation and hybridisation
Pre-hybridisation and hybridisation steps were the same as described for 
CGH to DNA fibres. DNA samples from normal male and normal female 
individuals were used as test and control DNAs in CGH experiments.
Image analysis
For image analysis, captured images from spots corresponding to DMD, SRY 
and hMSH2 were taken as one image. Each fluorochrome was imaged 
separately using the SmartCapture software. Optimal exposure times and 
optical settings were established empirically and then kept constant for the 
entire set of DNA spots recorded for a given experiment. All spots in a single 
image were segmented and the total fluorescence intensities for each 
fluorochrome in the entire segment of each spot was measured. The ratios of 
averaged values of red and green signals corresponding to the autosome 
spots were calculated and were used as correction values for the 
normalisation of averaged red and green fluorescence values corresponding 
to DMD ands SRY spots. Finally the corrected fluorescence value for each 
spot was calculated and the fluorescence ratio of each spot was obtained by 
dividing the corrected green with the corrected red fluorescence intensity.
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3: Results
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3.1 Optimisation of the CGH technique for clinical 
cytogenetics laboratory
3.1.1 CGH using published protocols
Ten samples, 5 from normal individuals and 5 from patients with known 
abnormalities were used to compare the main published approaches to CGH 
(Table 3. 1). The first protocol (method 1) reported by Kallioniemi et al (1992) 
used directly labelled test and control DNAs for hybridisation while the 
second (method 2), published by du Manoir et al (1993), was based on an 
indirect labelling approach.
Table 3. 1: CGH using two main published approaches, summary of results
Sa
m
pl
e
Patient’s
karyotype
Control
DNA
Method 1 Method 2
Image
quality*
Result Image
quality*
Result
1 46,XX 46,XY 1/5 +X,-Y 1/5 +X,-Y
2 47,X X +8 46,XY -2/5 FAIL -1/5 FAIL
3 46,XX 46,XY 1/5 +X.-Y 1/5 +X,-Y
4 46,XY 46,XX 1/5 +Y,-X -1/5 FAIL
5 46,XX,+21 46,XY -3/5 FAIL -2/5 FAIL
6 46,XY 46,XX 0/5 +Y,-X -1/5 +Y,-X
7 46,XX 46,XY 1/5 +X,-Y 3/5 +X,-Y
8 47,XXX 46,XX 2/5 +X 2/5 +X
9 47,XY,+13 46,XY -3/5 FAIL -1/5 FAIL
10 47,XXY 46,XY 1/5 +X 3/5 +X
* Image quality was scored between-5 to 5
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Test and control DNA samples for each series of experiments were identical 
for both methods. To allow the two methods to be performed in similar 
conditions, target metaphases were also from the same batches of slides.
Although the intensity of signals was directly related to the copy numbers of 
test and control DNAs in both protocols, some difficulties were encountered 
with both methods. In the first approach while the hybridisation was uniform, 
the intensity of signals was weak causing difficulties in image capture and 
analysis in some cases. In the second approach, while the intensity of signals 
was acceptable, chromosomes were not uniformly hybridised. These 
difficulties caused problems in CGH analysis in samples from 7 patients 
resulting in the need to repeat the experiments (Table 3. 1-2). Therefore, 
some optimisation was necessary.
Table 3. 2: Comparative genomic hybridisation, using two main 
published approaches
Kallioniemi et al (1992) du Manoir etal (1993)
No.of samples 10 10
Hybridisation time 48-72 48
Labelling Method Direct Indirect
Hybridisation pattern Uniform, faint signals Uneven, strong signals
Post-hybridisation time 1-2 Hours 5-6 Hours
Failures 3 4
Reason(s) for failures Weak signals Uneven signals or high 
background
3.1.2Modification of the CGH technique
Twenty DNA samples from patients with known chromosome abnormalities 
were selected for this stage of the study. Each sample was used as a test 
DNA and compared with a normal DNA of opposite sex. While investigating 
the effect of one parameter, all other parameters including the test and 
control DNAs were kept unchanged.
76
Target metaphase
Although metaphase preparations had passed the initial evaluation (see 
Methods) and appeared suitable for CGH, they did not necessarily produce 
optimal CGH results. Slides prepared from the same batch always produced 
the same quality of CGH images.
Denaturation temperature and time
In all slide batches, raising the denaturation temperature up to 80°C, and 
increasing the denaturation time up to 3 minutes caused an improvement in 
the hybridisation quality. These measures however, damaged the 
morphology of the chromosomes.
Extensive retrospective and prospective studies on slide batches which had 
already been shown to produce acceptable results showed that incubation for 
3 minutes at 74°C produced optimum CGH results (Figure 3. 1).
to
Da
* Quality was scored between-5 and 5
Figure 3.1:  Effects of denaturation time and temperature on target chromosome 
morphology and hybridisation quality.
1/3 71/271/2'5  71/3 74/27 4 /2 5  74/3 77/277/2,5 77/3
Tem perature (°C )/Time (minutes)
Hybridisation Morphology
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DAPI morphology
Numerous CGH experiments showed a consistent direct relationship 
between the quality of CGH and DAPI images. The same concentration of 
DAPI counterstain solution produced clean, bright blue signals in previously 
proven successful slide batches but dirty and/or faint DAPI signals in those 
that had failed to produce acceptable CGH results. Thus, it appeared that the 
quality of the CGH experiment could be predicted by looking at the DAPI 
appearances of metaphase and interphase cells under 10x magnification 
even before checking the actual fluorochrome signals at 100x magnification.
Several acceptable and unacceptable slide batches were then subjected to 
denaturation experiments by immersing them in 70% formamide for 3 
minutes at 74°C. The denatured preparations were dehydrated through an 
alcohol series before counterstaining with DAPI. The slides were then 
evaluated under a fluorescence microscope. Slides with proved quality 
consistently showed bright and clean blue signals while those that had 
proved to be unacceptable in CGH experiments produced faint and/or dirty 
DAPI signals (Figure 3. 2).
It was therefore concluded that the intensity of DAPI signal arising from 
interphase and metaphase chromosomes after denaturation was a reliable 
predictor of the usability of each slide batch for future CGH experiments.
The approach described here then used for future experiments to cut down 
on waste.
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Figure 3. 2: Correlation between CGH fluorochrome quality, CGH DAPI image and rapid 
DAPI test image.
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Slide ageing
Baking the slides after dropping the chromosome preparation had an adverse 
effect on the hybridisation quality. The longer slides were exposed to high 
temperature the worse the results became. Slides that had been dried on a 
hot plate resulted in the poorest CGH images. The best results were 
achieved when the slides were allowed to air dry and then aged at room 
temperature for 24 hours (Figure 3. 3). However, in urgent cases acceptable 
results were obtained by incubation of the slides for 1 hour at 60°C in a dry 
incubator (oven). It was also found that fresh slides gave better results. Use 
of slides older than one week resulted in poor CGH images. The best option 
for long term storage of slides was to store the slides (after alcohol 
dehydration) in boxes sealed with Parafilm ® in -70°C freezer. The quality of 
results however, was not comparable to those obtained from fresh slides.
Other parameters
Proteinase K treatment of the slides and several modifications of 
methanol/acetic acid (3/1) fixation caused no significant improvement in 
hybridisation quality.
Genom ic DNA labelling
Various parameters in DNA labelling were investigated (Table 3. 3).
Table 3. 3: Factors investigated in genomic DNA labelling.
Nick translation time 
Nick translation temperature 
Direct or indirect labelling 
Probe size
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Figure 3. 3: Effects of the methods o f slide ageing on the CGH image quality. Better results 
were usually obtained when slides had been stored at room temperature fo r 24 hours.
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Direct or indirect method
For optimisation, test and control DNA probes for CGH were either labelled 
directly (with fluorochromes) by incorporating fluorochrome-coupled 
nucleotides, or indirectly, by incorporating reporter molecules (biotin or 
digoxigenin), which were then detected via fluorochrome-coupled reporter 
binding molecules. Directly fluorophorated genomic DNA resulted in smooth 
signals along the chromosomes, which is essential for assessing the 
fluorescence intensities at each point along the chromosomes. They could 
also be visualised immediately after the post-hybridisation washes. However, 
the signal strength obtained was only about 20 percent of that produced by 
an equivalent amount of labelled DNA detected by secondary reagents. This 
was problematic even though a sensitive digital imaging device was used for 
signal detection. The problem was overcome when the amount of the test 
and control DNA in the hybridisation solution was increased to 1 pg 
/hybridisation area (instead of 200 ng as described by Kallioniemi et al 1992- 
1994). The major drawback of the indirect method was high background, 
uneven hybridisation and complex and time consuming post-hybridisation 
steps. Manipulating various factors including Cot-I and DNA concentration 
did not give acceptable results. For these reasons, the modified direct 
method was adopted as the method of choice for DNA labelling during the 
course of this study.
Probe size
Probe sizes could be adjusted by manipulating several parameters in the nick 
translation reaction. Standard concentrations of DNase and other reagents 
were used.
Nick translation time and temperature were parameters which were 
manipulated for optimisation. Increasing the temperature (14-16°C) and the 
length of incubation time (30-180 minutes) resulted in decreasing the size of 
the probe. By changing the incubation time between 30-180 minutes the 
probe size ranged from mostly 200 bp to mostly >2000 bp.
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CGH experiments performed using probes with sizes between 500-1200 bp 
resulted in the optimum results (Figure 3. 4). Those were the probes that had 
been obtained by a nick translation time and temperature of 55 minutes at 
14°C.
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Figure 3. 4: Correlation between the CGH image quality and the probe size. Increasing the 
probe size between ~200 bp-1200 resulted in the improvement of CGH quality. Probes 
longer than 1200 bp resulted in increasingly lower quality CGH images.
In the early stages of the study, to validate the probe size, each sample was 
run on a 1 percent neutral agarose gel against known size standards. 
However, after the technique was optimised, this step was abandoned 
because the sizes of the probes were usually in the required range.
DNA hybridisation
Several modifications in the standard CGH technique ensured stronger 
hybridisation signals. Those modifications included higher amount of labelled 
test and control DNA and lower quantity of unlabelled human Cot-I DNA (20- 
30 pg instead of 50 pg in the hybridisation buffer) (Figure 3. 5). No significant 
differences between the quality of images in CGH experiments performed 
using 48-hour and 72-hour incubations were found. Therefore, in midweek 
and urgent experiments, 48-hour approach was adopted. However, in most 
circumstances, it was more convenient to follow the 72 hours approach by
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performing the labelling and hybridisation on Fridays and the post­
hybridisation steps and image analyses on the following Mondays.
□  Standard indirect 
E9 Standard direct
□  Direct: 500 ng DNA
□  Direct 700 ng DNA 
■  Direct 1000 ng DNA
1 2 3 4 5
Experiments
Figure 3. 5: Effects of alteration of the DNA concentration in hybridisation solution on the 
fluorescent intensity. Fluorescent intensity obtained by 1 (ig of directly labelled DNA was 
similar to that obtained by standard indirect method.
Post-hybridisation washings
As the direct method had been adopted as the preferred approach for probe 
labelling, post-hybridisation detection of signals was not necessary. 
Therefore, only post-hybridisation washing steps were subject to optimisation 
procedures. Various current washing protocols were tested and a modified 
protocol which included 2 x 7.5 minutes washing of slides in 50% formamide 
in 2 x SSC, followed by 1 x 5minute in 1 x SSC, 1 x ST buffer at 42°C and 1 x 
5minute in ST buffer at room temperature was developed. This protocol 
resulted in a very simple and fast method for post-hybridisation washing.
Image processing and analysis
During the optimisation of the lab-based parts of the CGH, image processing 
and analysis was carried out by standard approach using SmartCapture 
software (Digital Scientific, Cambridge, V2.1). That approach included flat
6
5
4
3
2
1
0
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fielding, background removal, image enhancement, thresholding and 
fluorescence equalisation followed by global analysis, axial analysis, scoring, 
and the final analysis (see Methods). At least two working days were required 
to analyse 10 metaphases from each sample.
Several modifications made in the standard approach for CGH image capture 
and analysis simplified the whole CGH process and made it faster and more 
reliable.
Flat fielding
Significant uneven illumination was present only in early stages of this study 
where the quality of slides was poor. However, after various modifications in 
labelling and hybridisation stages, flat fielding was found to be unnecessary. 
On the other hand, when the signal quality was poor, even flat fielding failed 
to produce acceptable results.
Automatic image processing
First 20 images were captured and saved as 20 different files. Using a 
feature provided in SmartCapture, for each experiment one script was written 
to automate the very time consuming image processing parts of the CGH 
analysis. Each time up to 20 metaphases were processed while no 
supervision during the processing was necessary. For writing the scripts 
function (F) keys of the computer keyboard were defined sequentially so that 
writing each script took no more than maximum 5 minutes time.
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Table 3. 4: Script used for processing of 20 images
Command Function
Key
Open file 1 F5
Remove background F6
Save as 1* F 7
\  F8
X20 1
Segment chromosomes y
Equalise colour F9
Rapid CGH analysis
Retrospective study of 11 cases with normal or abnormal CGH results 
showed that axis analysis and scoring had provided no further information in 
abnormal cases or unmasked new abnormalities in cases which had already 
appeared to be normal in global approach. In normal cases, global analyses 
of 5 high quality CGH images were found to be enough for ruling out 
unbalanced abnormalities, as analysis of more metaphases (up to 20) had 
given no more information.
Because of these findings, a new approach for rapid and reliable CGH image 
analysis was designed. Based on that approach, 5 high quality CGH 
metaphases were analysed by global analysis. Where no abnormality was 
detected the case was considered to be carrying no unbalanced 
abnormalities. If one or more abnormalities were suspected then up to 20 
metaphases were analysed globally and estimated breakpoints and relative 
copy numbers were defined.
Using the approach described, in a blind study, nine cases were studied. All 
results were compatible with those obtained by conventional banding 
method. Additional axis image analysis together with scoring provided no 
further information
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Detailed image analysis including axial analysis and scoring was only 
performed when precise definition of the breakpoints was required. Detailed 
CGH analysis was also performed to study the behaviour of the fluorescence 
in telomeric regions as described in 3.3.2.
3.2 Test of modified protocol using known 
cytogenetic abnormalities
Fifty-six samples from normal individuals or patients with constitutional 
chromosome abnormalities were the subjects of a blind study using the 
modified CGH protocol. Results were then compared with those obtained by 
conventional methods. CGH successfully detected all unbalanced 
abnormalities. The results are summarised in Table 3. 5 (see also Figures 
3.6 and 3.7).
Table 3. 5: Test of modified protocol using known cytogenetic abnormalities, 
summary of results:
Phenotype/genotype
Affected/abnormal cases 41
Normal/normal individuals 12
Normal/balanced 3
Types of unbalanced abnormalities
Autosomal (whole chromosome) 21
Sex chromosome (whole chromosome) 13
p or q arm only (complete or partial) 6
Marker chromosomes 1
Sources of DNA samples
Blood 5
Bone marrow 1
Fixed cells 26
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Frozen cells 24
Failures:
Failure to obtain result from the first CGH test 4
Failure to get result even by repeated 
experiments
0
Average experiment/sample required to achieve 
results
1.13
CGH/G-banding discrepancies 0
Time Day (s)
Average time required for post-hybridisation 1.87
steps and image analysis (max/min) ,4/1 x
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Figure 3 .6 :  CGH global analysis of a case with trisomy 13. (a) CCD image of a 
normal metaphase spread counter stained with DAPI to allow chromosome 
identification, (b) Digital inversion of (a) providing a banding pattern resembling G- 
banding, facilitating identification of the chromosomes, (c) Hybridisation pattern of 
FITC labelled test DNA. (d)hybridisation pattern of the control DNA labelled with 
Texas-Red (e) CGH image comprising of red, green and blue colours (f) Colour 
ratios image, showing two chromosome 13 homologues as green confirming a gain 
of DNA materia corresponding to these chromosomes. Green Y chromosome and 
red X chromosome are the result of sex difference between the test (male) and 
control(female) DNA.
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F igure 3. 7: Profile CGH analysis of the same case as Figure 3. 6. Mean 
green-to-red ratio profiles for chromosomes reflecting DNA sequence copy number changes. The 
three lines represent different levels of green-to-red ratios: middle-1.0 = no change in the test 
DNA.; Ieft=0.50=loss; right 1.50, > 1.50= gain in test DNA. Gain or loss of DNA are also shown by 
green or red thick lines beside the idiograms. This ratio profile depicts the gains of DNA material 
corresponding to chromosome 13. Moreover, DNA corresponding to X and Y chromosomes are 
under and over-represented due to sex differences between the test (male) and control (female) 
DNAs.
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3.3 Improving limits of CGH
3.3.1 CGH on a case with low percentage
supernumerary marker chromosome
CGH was used to try to determine the origin of a mosaic ring chromosome 
present in a 71 year old woman with mental retardation. Repeated 
cytogenetic analysis had failed to identify the origin of the ring.
Earlier results 
Cytogenetic
Cytogenetic studies by G-banding in 1976 had revealed the presence of 
two cell lines. Eighteen out of 25 cells showed a 46,XX karyotype while 
7/25 (28%) showed an additional marker chromosome of unknown origin 
(46,XX/47,XX, + marker). Chromosome analysis by G-banding in 1986 
had confirmed the finding of two cell lines. Twenty-one out of 25 cells 
examined showed apparently normal female karyotype while the 
remaining 4 cells (16%) showed a count of 47 including one additional 
small chromosome. The marker appeared to be a ring chromosome, 
approximately half the size of a chromosome 21, which contained at least 
one G-band positive area (Figure 3. 8 a). C banding had showed one 
centromere to be present, and Ag NOR staining was negative with respect 
to the ring chromosome. No other members of the family had undergone 
cytogenetic investigation.
FISH
FISH had been carried out using centromeric probes for chromosomes 4, 
12, 20, 22, 13/21 and 1/5/19 empirically and failed to detect the origin of 
the extra chromosome. No further probes were investigated because 
difficulty had been experienced in identifying the marker with certainty 
within the metaphases.
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F igure 3. 8: (a) G-banded metaphase spread of the patient descr ibed in section 3.3 showing a
supernumerary r ing  chromosome (arrowed), (b) Standard ratio p ro f i le  of chromosomel 9 is 
demonstrated above the chromosome idiogram. The horizontal lines represent the balanced state of 
the chromosomal copy number (middle I ine, ratio 1.0) and the lower and upper thresholds 
appI ied to detect chromosomal losses and gains, respectively. These thresholds correspond to 
ratios of 0.8 and 1.20, which are the theoretical values expected fo r a monosomy or tr isomy 
present in 40% of diploid cells, (c) Global CGH analysis showing gain of DNA material 
corresponding to 1 9q. Green X chromosome and Red Y chromosome are the results of the sex 
diffrence between test (female) and control (male) DNA.
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(a)
F ig u re  3. 9: FISH results of the case w ith  m arker chromosome using
chromosome 1 9p (a) and 1 9q(b) a rm  specific painting probes. Chromosome 
1 9p painting probe has hybrid ised to the 1 9p a rm  CT both chromosomes 1 9 
homologues but not to the marker chromosome. On the other hand 1 9q painting 
probe has hybridised to the long arms of both chromosomes 1 9 and the marker 
chromosome confirm ing the CGH results.
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CG H  Analysis
CGH was carried out using a DNA sample from the patient. Analysis using a 
very restrictive threshold with a fluorescence ratio of 0.5-1.5 (which requires 
100% abnormal cells to detect any gain or loss of the DNA material) failed to 
detect any abnormality. Progressively less restrictive thresholds were then 
employed and, surprisingly, a threshold of 0.8-1.20 (which theoretically 
detects abnormal cells comprising 40% of the total) revealed a gain in DNA 
material corresponding to 19q (Figure 3. 8 b,c). In CGH, the centromeric 
areas are strongly suppressed by un-labelled human Cot-I DNA, so gain or 
loss of this area could not be interpreted reliably.
FISH confirmation of the CG H results
Further FISH studies using a whole chromosome 19 paint (WCP19, Oncor), 
19p and 19q arm specific paints and telomeric probes for 19p and 19q (LI) 
and 19 centromeric probe confirmed the CGH finding. The ring chromosome 
hybridised to the whole chromosome 19 and 19q arm specific but not to 19p 
arm specific paint, 19p or 19q telomeric probes (Figure 3. 9-a, b). It was thus 
concluded that the proposita was trisomic for almost the entire long arm of 
chromosome 19 with only the telomeric region being absent from the ring.
3.3.2 CGH on samples with suspected cryptic 
abnormalities
3 families were carefully chosen for study. In each, two affected members 
with apparently normal karyotype and a similar phenotype were related 
through at least one healthy first degree relative. These features are highly 
suggestive of the segregation of a cryptic chromosomal translocation.
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Detection of cryptic chromosomal translocations
Family 1
Patient JK was referred because of cranio-facial dysmorphism in association 
with tetralogy of Fallot, laryngomalacia and inguinal hernia. He died at the 
age of 6 months as a result of his cardiac abnormality. A paternal uncle who 
died in infancy from heart failure was reported to have had ‘classical features 
of Noonan syndrome. The patient, although sharing some dysmorphisms 
associated with Noonan syndrome, did not have that condition but the close 
similarity to his uncle led to a suspicion that a cryptic translocation was 
segregating within the family. The results of chromosome analyses carried 
out on JK, his parents and other relatives in different service laboratories 
were all normal.
CGH analysis using standard approach
CGH analysis was performed on DNA from JK. Twenty metaphases with 
high-intensity uniform hybridisation were chosen for image analysis (see 
Methods). A standard type of CGH analysis including background correction 
and normalisation was performed using a fluorescence ratio (FR) threshold of 
0.8-1.2. Average ratio profiles showed gains for the short arms of 
chromosomes 21 and 14 and the distal bands of chromosomes 17q and 1p.
A loss of DNA material corresponding to the 2q telomeric area was also 
observed.
The application of a more restrictive threshold (FR: 0.5 -1.5) narrowed the 
abnormal findings to chromosomes 17, 1 and 2. Using the more restrictive 
threshold in global CGH analysis of 20 metaphases, the same results were 
obtained. It was also observed that although the gain in chromosome 1p and 
deletion of 2q were consistent in most metaphases, they were found in only 
one homologue in each metaphase. On the other hand, the gain in 17q was 
consistently present in both homologues of most metaphases.
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Table 3. 6 CGH results in JK using standard CGH approach with 
different fluorescence ratio (FR) thresholds
FR threshold
0.8-1.2 0.5-1.5
Gain Loss Gain Loss
Suggested
abnormalities
1 p, 14p, 17q
21 p,
2q 1p, 17q 2q
CGH analysis based on the pattern of fluorescence intensity at 
chromosome ends
To investigate the significance of the results obtained by standard CGH 
analysis, the fluorescence intensity of red and green signals corresponding to 
test and control DNA in the 20 normalised CGH images was measured. 
Fluorescence intensity of the green signal (patient DNA) at both homologues 
of the 17q telomere, both before and after averaging, increased whilst that of 
the red signal corresponding to control DNA decreased (Figure 3. 10). At 
distal 2q, however, both before and after averaging, fluorescence intensity for 
green fell sharply but that of the red signal first slightly increased and then 
decreased, but at a slower rate than that of the green signal (Figure 3. 11). 
Quantification of the fluorescence intensities for both red and green at the 1p 
region showed decreasing patterns despite the ratio findings (Figure 3. 12).
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Polygon Clrrapti
0.5
F igure 3. 1 0: Standard ratio prof i le of chromosome 1 7 is demonstrated 
below the chromosome idiogram. The three horizontal lines below the idiogram 
represent the balanced state of the chromosomal copy number (middle I ine, ratio 1.0) 
and the lower ( lower line) and upper (upper line) thresholds applied to detect 
chromosomal losses and gains, respectively. These thresholds correspond to ratios of 
0.5 and 1.5, which are the theoretical values expected for a monosomy or tr isom y 
present in 100% of dip Ioid cel Is. The polygon graph above the idiogram shows the 
fluorescence intensity along chromosome 1 7. As shown, wh i le at the distal p -a rm  both 
colours are decreasing as usual, at the distal q -a rm  the intensity of fluorescence is 
increasing for the green signal and decreasing for the red. This shows that the 
decreasing effect of fluorescence at the telomere is compensated by the extra copy of 
the DNA at this region.
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F igure 3. 1 1 : Standard ratio prof i le of chromosome 2 (below the idiogram) 
shows a loss of DNA materia l related to the last band on 2q. The polygon graph 
(above the idiogram) demonstrates the d ifferent gradients for fluorescence 
intensity secondary to the DNA copy loss at this part icu la r area. At the p -a rm ,  the 
fluorescence intensity fo r  both green and red are fol lowing the usual decreasing 
pattern of the chromosomal ends.
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F ig u re  3. 1 2 : Standard ratio  p ro f i le  of chromosome 1 (below the idiogram) 
shows a gain of DNA materia l related to the last band on 1 p. However, fluorescence 
intensity quantification does not support this finding (by decreasing for both 
colours).
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To rule out sources of error, the CGH experiment was repeated with the 
fluorochromes reversed (red for test and green for control DNA). Various 
different control samples were used including DNA from both parents and 
several unrelated individuals. Under all these conditions the findings for 
chromosomes 17 and 2 remained consistent. These results suggested 
strongly that there was at least one extra copy of chromosome 17q telomeric 
region, and if the patient had an unbalanced translocation, the extra material 
was most likely translocated to the distal end of 2q, leading to partial 
monosomy/trisomy for chromosomes 2q and 17q.
As expected for chromosomally balanced karyotypes, CGH analysis showed 
no gain or loss of DNA material in any relative connecting the patient and his 
deceased uncle, nor were there any CGH abnormalities in other healthy 
family members.
Confirmation of CGH results by FISH
To confirm the CGH findings, FISH was carried out on metaphase 
chromosomes from JK using commercial probes specific for the telomeric 
regions of chromosomes 17q (Oncor) and 2q (LI). Three signals for 17q 
telomere were detected, one on each 17q, and the third signal was 
translocated to a 2q telomere (Figure 3. 13-a). Conversely, the chromosome 
2q telomeric probe showed only one signal which was located normally on 
one homologue of chromosome 2 (Figure 3. 13-a).
Using the same FISH probes on the other members of the family, JK’s father 
and grandfather were found to be carriers of the balanced translocation 
(Figure 3. 13-b), while the mother and grandmother had normal results.
The size of the abnormality deduced from averaged relative length of each 
chromosome to total haploid autosome was estimated to be -10 Mbs for the 
duplication of 17q and -4  Mbs for the 2q deletion (see Figure 3. 10).
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Figure 3. 13 (a)Two-colour FISH to metaphase 
From JK using chromosomes 2q and 17q telomeric 
probes: Red signals correspond to the chromosome 
17 and green signal corresponds to the chromosome 
2 telomeric probe. The picture shows an unbalanced 
2q,17q translocation resulting in. respectively, 
partial monosomy/trisomy for these chromosomes 
(b) FISFH to metaphase from  JK's father using the 
same probes, demonstrating a balanced 2q ,l7q  
translocation (c) FISFH to metaphase of CL using 
telomere probe fo r 20p and 4q showing the presence 
of three red signals corresponding to three copies of 
20p telomere region and one green signal 
corresponding to 4q telomere (d) metaphase of CL's 
balanced ca rr ie r fa ther using the same probes (e): 
FISFI to metaphase of SB using whole chromosome 
lib ra ry  fo r chromosome 10 (red) and telomere probe 
fo r 20q (green) , showing an unbalanced 10,20 
translocation.
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Family 2
Patient CL, a 32 month old girl was referred with mild motor and speech 
delays, a small ventricular septal defect and minor facial dysmorphisms 
including low set ears, a flat philtrum and a wide mouth. In addition, she had 
bilateral vesico-ureteric reflux (VUR). In the family history, a male first cousin 
had identical, mild developmental delays, minor facial dysmorphism and had 
undergone surgery for VUR. Both cousins and their parents had normal G- 
band karyotypes (400-500 band level).
DNA from CL was the subject of CGH analysis using the modified technique 
and this suggested gain of 20p telomere and loss of 4q telomere. The size of 
the abnormality was estimated to be 7Mbs for the 20p duplication and 10Mbs 
for the 4q deletion. The results of FISH analysis using the specific telomeric 
probes for these chromosome regions [20p (Oncor) 4q (LI)] confirmed the 
CGH results, identifying an unbalanced translocation between the telomeric 
bands of chromosomes 4q25 and 20p13. Both affected cousins had partial 
trisomy for chromosome 20p and partial monosomy for chromosome 4q. In 
turn, the mother of one affected cousin and the father of the other were found 
to carry a balanced reciprocal 4q; 20p translocation which was inherited from 
their own mother (Figure 3. 13: c,d).
Family 3
Patient SB, a first-born male infant, was referred to the clinical genetic 
department at age 2 years when moderate mental handicap was diagnosed. 
He had no major congenital abnormalities and minimal dysmorphism but in 
the family history his maternal aunt, FM, had severe, unexplained mental 
handicap. This 32 year-old lady was examined and found to have short 
stature (height 140 cm), microcephaly (OFC 51cm) and non-specific facial 
dysmorphisms. In view of this family history, high-resolution chromosome 
analyses were repeated on both patients and their relatives on several 
occasions and although no abnormality was detected, an underlying cryptic 
chromosome translocation was always suspected on clinical grounds.
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Modified CGH was performed on a DNA sample from FM and showed partial 
gain and loss of DNA material corresponding to the distal bands of 
chromosome 20q and 10q respectively. The size of the duplicated 20q was 
estimated to be 5 Mbs and loss of 10q region was about 10 Mbs. FISH 
studies using 10q and 20q telomeric probes [LI] confirmed partial trisomy for 
20q and partial monosomy for 10q. The same unbalanced abnormality was 
also detected in SB (Figure 3. 13). The balanced reciprocal translocation was 
detected by FISH in SB’s mother and maternal grandfather, but it was not 
present in a maternal aunt of SB.
Further CG H on suspected cases of cryptic abnormalities
Samples from affected members of 8 more families were the subject of CGH 
studies using the modified approach. However, CGH did not detect any 
abnormalities in the investigated families.
3.3.3 CGH on a sample with hypotriploidy
A case of rhabdomyosarcoma was the subject of conventional chromosome 
analysis and comparative genomic hybridisation. Cytogenetic analysis 
revealed the presence of four cell lines. There were three abnormal 
hypotriploid clones with the following karyotypes:
60,XY,+2,+3,+5,+8,+11 ,+13,+13,+13,add( 17) (q25) ,+19,
+20,+21,+21,+22,+22/
63,XY,+1 ,+2,+3,+5,+8,+8,+11,+11 ,+marker [?del ( 12)(q11 1q15)], 
+13,+13,+13,add( 17)(q25),+20,+21,+21,+22,+22/
64,XY,+1 ,+2,+3,+5,+8,+8,+11,+11 ,+marker [? del ( 12)(q11 1q15)], 
+13,+13,+13,add( 17)(q25),+19,+20,+21,+21,+22,+22/
46,XY
A DNA sample extracted from the tumour was the subject of CGH analysis.
Standard CGH analysis based on the fluorescence ratio value from the whole 
metaphase showed loss of DNA in chromosomes, 4, 6, 7, 9, 10, 14, 15, 16,
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17, 18,X and Y. Gain of DNA material corresponding to chromosome 13 was 
also observed (Figure 3. 14). No gain or loss of DNA corresponding to 
chromosomes 1, 2, 3, 5, 8, 11, 12, 13, 19, 20, 21 and 22 was detected.
When this result was compared with that of cytogenetic analysis it was clear 
that the trisomic chromosomes were being interpreted as normal and the 
disomic chromosomes as loss. Based on the G-banding results, 
chromosomes with known ploidies were then identified and used as index 
chromosomes in the next CGH analysis. In a global CGH analysis approach 
using SmartCapture package, the index chromosomes were identified and 
the red and green values along the chromosome axis were measured and 
normalised by equalising the fluorescence intensities. The green to red ratios 
along the remaining chromosomes were then calculated.
In first series of image analysis chromosomes 4, 6, 7, 9, and X (which were 
disomic by G-banding) were selected as index chromosomes. No loss of 
DNA was detected and DNA sequences corresponding to chromosomes 1, 2, 
3, 5, 8, 11, 12, 13, 20, 21 and 22 were over represented (Figure 3. 15). When 
chromosomes 1, 2, 3, 5 and 20 (where G-banding had shown 3 copies of 
each) were used as index chromosomes all disomic chromosomes were 
under represented while chromosome 12 showed no gain or loss compared 
to the index chromosomes. On the other hand chromosomes 8, 11, 13, 21 
and 22 showed higher copy numbers than the index chromosomes (Figure 3. 
16). Finally, chromosomes 8, 11, 21 and 22 were selected as index 
chromosomes, and all non-index chromosomes except 13 were under 
represented, being the only chromosome that showed higher copy number 
than the index chromosomes (Figure 3. 17). These results confirmed the G- 
banding analysis and the suggestion that the marker chromosome originated 
from chromosome 12. However they did not detect any deletion of DNA 
material in the third copy of chromosome 12 nor show any gain of DNA in 
chromosome 17. Based on the findings of this modified approach and the 
chromosome analysis results it can be suggested that the additional material 
on chromosome 17 originated from chromosome 12. As more material was 
not available, further confirmatory FISH was not possible.
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Figure 3 .14: Standard CGH ratio profile from the case with hypotriploidy. Disomic chromosomes (see 
text) are under-represented (red thick lines beside the idiograms) while chromosomes with 3 or 4 copies 
are represented as normal. Chromosome 13 which had 5 copies in G-banding is over-represented here 
(thick green line beside the idiogram).
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Figure 3 .15 : CGH analysis by modified approach. Disomic chromosomes are selected as index and all 
other chromosomes are analysed based on them. As shown, all chromosomes with 3, 4, or 5 copies are 
over-represented here (green lines beside idiograms).
1 C5
Figure 3 .16 : CGH ratio profile from the case with hypotriploidy using the modified analysis. CGH
image is normalised based on chromosomes with 3 copies. Disomic chromosomes (see text) are under­
represented (red th ick lines beside the idiograms) while chromosomes with 3 or 4 copies are represented 
as normal. Chromosome 13 which had 5 copies in G-banding is over-represented here (thick green line 
beside the idiogram).
1 0 6
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Figure 3 .17: CGH ratio profile from the case with hypotriploidy using the modified analysis. CGH image is 
normalised based on chromosomes with 4 copies. D isomic and trisom ic chromosomes (see text) are under­
represented (red th ick lines beside the idiograms) while chromosomes with 4 copies are represented as normal. 
Chromosome 13 which had 5 copies in G-banding is over-represented here (thick green line beside the idiogram
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3.3.4 Overnight CGH
Samples from 19 cases with normal karyotypes or various numerical 
chromosome abnormalities were used. A modification of the routine protocol 
which included five micrograms of test and control DNAs, 5 nmoles of each 
fluorochrome and 180 minutes nick translation time, successfully detected 
unbalanced abnormalities in all patients. Parameters modified for overnight 
CGH are compared with those used in 48-72 hour protocol (Table 3. 7).
Table 3. 7: Overnight CGH parameters compared with those of standard 
CGH protocol
DNA pg 
/experiment
Fluorochrome
mmole/experiment
Nick translation 
time (minutes)
Cot-I DNA pg 
/experiment
48-72 Hour 
Method
1 1 55 50
Overnight
Method
5 5 180 30
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Figure 3. 18: Global CGH result of a case with tr isom y 21 studied by
overnight CGH approach. Test (green) and control ( red) DNA were from  the 
same sex. Both chromosome 21 homologues are coloured in green confirm ing 
the gain of DNA material corresponding to these chromosomes in the test DNA 
compared to that of the control DNA.
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3.4 Reinterpretation of a putative isochromosome Xp
Extensive cytogenetic, molecular cytogenetic and molecular studies were 
performed on samples from a female patient with mental retardation and 
karyotype 46,X?iXp. Comparative genomic hybridisation, however, 
revealed the presence of chromosomal segments corresponding to 
proximal Xq. Quantitative PCR (see Methods), by targeting XIST  gene, 
confirmed the CGH results and showed that the X inactivation centre 
locus had remained intact in the abnormal chromosome X. The karyotype 
was finally shown to be: 46, X, t(X;X)(p11 ;q21).
=
Normal Abnormal
Figure 3 .19 : Schematic representation of the chromosome abnormality in the case 
presented in 3.4. As shown four fifth of the q arm of the abnormal X is deleted and replaced 
with the p arm resulting in a partial trisomy/monosomy for the Xp and Xq respectively.
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F igu re  3. 20: CGH image using a DNA samp Ie from  the case w ith  suspected iXp. Th is image 
shows signals on the proximal region of Xq w ith  the higher intensity than the remaining xq, 
ru l ing  out the complete deletion of Xq.
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F ig u re  3. 2 2 : Quantitative PCR results from  the case described above targeting the X/ST
gene. 1 - 2 =  patient, 3 -4=no rm a l male, 5 - 6 =  normal female, L= ladder. PCR product 
f rom  the patient is in the same size and intensity as that of the normal female and more 
than that of the normal male. This visual f inding is also confirmed w ith  the digital 
measurement using IP-lab image analysis software.
3.5 A case of follicular lymphoma with complex 
chromosome abnormalities
Conventional chromosome analysis
G-banding chromosome analysis of direct preparations of lymph node from 
the patient revealed the presence of two clones.
The majority of cells had a male karyotype with duplications of part of the 
long arms of chromosomes 1 and 12 and a deletion in the long arm of 
chromosome 14. There was an apparently balanced translocation between 
the long arms of chromosomes 19 and 22 and a derivative chromosome 3 
with additional material of unknown origin. There were also around ten 
double minutes in every cell. The second clone had all the abnormalities of 
the first but had another copy of the duplicated chromosome 1 replacing the 
normal homologue found in the first clone.
CGH analysis
CGH analysis was performed using a DNA sample extracted from the lymph 
node from the patient. Gains of DNA material corresponding to 1q12-25,
12q13-21, and 8q22-ter together with a loss of DNA corresponding to 14q24- 
ter were detected. Moreover, an amplification of DNA corresponding to distal 
3p was also observed.
Based on these results, it was suggested that the additional material on 
chromosomes 1 and 12 were the result of duplication. On the other hand, as 
both chromosomes 8 in G-banding were normal, the CGH finding of gain of 
8q was suggested to be from the extra material on the 3p. Finally, the double 
minutes were suggested to be the product of amplification of terminal 3p.
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Figure 3.23: G-banded metaphase chromosomes with multiple 
abnormalities from the case with follicular lymphoma. Some double 
minutes are indicated by arrows.
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FISH confirmation of CGH results
FISH, using painting probes from chromosomes 1, 3, 8, and 12 was carried 
out.
Chromosomes 1 and 12 painting probes hybridised to the whole of both 
chromosomes 1 and both 12 confirming the CGH suggestion of duplication at 
1q and 12q.
Chromosome 3 painting probe hybridised to all double minutes, the whole of 
the normal 3 and a part of the short arm and the whole of the long arm of the 
abnormal chromosome 3. However, it did not hybridise to the additional 
material on the abnormal chromosome 3. Chromosome 8 painting probe 
hybridised to both normal chromosome 8s and to the additional material on 
chromosome 3 (Figure 3.25 and Figure 3. 26).
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Figure 3.25: FISH using chromosome 8 painting probes: probes are hybridised to both 
chromosome 8s together with the additional material at the distal 3p, confirming an unbalanced 
3:8 translocation.
Figure 3.26: FISH using chromosome 3 painting probes: probes are hybridised with the 
whole of the normal homologue of chrmosome3 and most part of the abnormal 3. Additional 
material at the distal 3p is not hybridised with chromosome 3 painting probe. Chromosome 
3 painting probes are also hybridised to all double minutes confirming that the double minutes 
are originated from chromosome 3.
3.6 CGH in haematological malignancies
Comparative genomic hybridisation was used to investigate the assignment 
of chromosomal re-arrangements in blood or bone marrow samples of 
patients with haematological malignancies.
Fourteen cases were examined (7 cases with AML, 3 cases with CML, 2 
cases with ALL, 1 case with CLL and 1 case with MDS). All CGH 
experiments were performed in a blind manner in parallel to conventional 
cytogenetics.
Volume of samples
DNA was extracted from material remaining after routine cytogenetic cultures 
had been set up. This was almost invariably less than 1 ml of sample, and in 
9 cases a wash out of the sample tube was all that was available. However, 
results were obtained from all samples.
Comparison of CGH results with G-banding results
In 2 cases CGH did not detect the abnormality found by conventional 
cytogenetics because of the balanced nature of the rearrangements. Both 
CGH and conventional cytogenetics found no abnormality in 5 samples. In 3 
abnormal cases CGH and G-banding results were compatible. Complete 
CGH and banding data are listed in Table 3. 8.
A case of ALL with 9p;9q translocation
In a case of ALL which had been reported as having a normal karyotype,
CGH detected a concurrent loss of 9p and gain of 9q material. This finding 
could not be confirmed on the original sample by FISH, due to insufficient 
material. However, one year later, when the patient had a relapse, FISH on 
metaphase chromosomes prepared from a lymph node sample confirmed the 
CGH finding. Chromosome 9q arm painting probe hybridised to the whole q 
arms of the both normal and abnormal chromosome 9 and almost the whole 
of the p arm of the abnormal chromosome 9. Chromosome 9p arm specific
119
painting probe hybridised to the whole of the p arm of the normal 
chromosome 9 and a small segment immediately adjacent to the centromere 
of the abnormal chromosome 9. FISH results thus confirmed the CGH 
indication that a small segment of 9p remained intact in the abnormal 
chromosome.
A case of AM L with chromosome Y  monosomy
CGH was carried out on DNA samples from a case of AML which was 
reported as having a 45X, -Y chromosome constitution. Control DNA was 
used from a normal male individual. CGH showed loss of DNA material 
corresponding to the whole chromosome Y. Detailed analysis of the CGH 
images however detected green fluorescence signals corresponding to the Y 
chromosome indicating the presence of possible mosaicism or (less likely) 
insertion of Y material in another chromosome, although the presence of a 
cell line with an XY sex chromosome complement could not be confirmed 
using a Y probe due to insufficient material.
A case of CM L with 9q-
ln one remaining case which was reported as having a normal karyotype, 
CGH detected a loss of DNA material corresponding to chromosome 9q. This 
finding could not be confirmed by FISH, due to insufficient material.
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Figure 3. 27: (a) G-banded metaphase chromosomes from the case described above
The abnormal and normal chromosome 9s are indicated by red and black arrows respectively.
(b) Green (test) to red (control) fluorescence intensity ratio profile of chromosome 9 demonstrating 
a loss and gain of DNA material corresponding to 9p and 9q respectively: The mean ratio of 20 
measurements is shown.
1 2 2
F ig u re  3 . 2 8 : FISH to directly prepared metaphase spreads from the the case
described above, (a) Chromosome 9q arm specific painting probe is hybridised to the q arm 
of the normal chromosome 9 and both arms of the abnormal chromosome 9 confirming the 
q origin of both arms of the abnormal chromosome 9. (b) Chromosome 9p painting probe is 
hybridised to the short arm of the normal chromosome 9 and a very small segment of the 
shorter arm of the abnormal chromosome 9.
3.7 CGH using universally amplified DNA samples
Small amounts of DNA sample as low as 1 ng were used as a template for 
DOP-PCR (see Methods). Universally amplified DNA was then used as test 
DNA in CGH experiments. All CGH experiments using this approach could 
reliably detect the numerical abnormalities in 10 cases studied in this 
manner. DNA extracted from both blood samples and fixed cells were used in 
this approach.
Table 3. 9: CGH using universally amplified DNA samples: summary of 
results:
Sa
m
ple
Patient’s
karyotype
Source 
of DNA
Control
DNA
Result Failures Amount of DNA 
used for 
amplification
1 46,XX,+18 Fixed
cells
46,XY +X,-Y, +18 1 20 ng
2 47,XX,+21 Blood 46,XY +X,-Y, +21 - 50 ng
3 46,XX Blood 46,XY +X,-Y - 10 ng
4 46.XY Fixed
cells
46,XX +Y,-X 1 1 ng
5 46,XY,+21 Blood 46,XY +Y,-X, +21 1 1 ng
6 46.XY+18 Fixed
cells
46,XX +Y,-X,+18 20 ng
7 46,XX Blood 46,XY +X,-Y - 5 ng
8 47.XXX Blood 46,XX +X - 5 ng
9 47.XY+13 Fixed
cells
46,XX +Y,-X,+13 1 1 ng
10 47.XXY Fixed
cells
46,XY +X 2 ng
124
%r  5v V #
F ig u re  3 . 2 9 : Global CGH results of un iversa lly  DOP-PCR 
amp I if ied DNAs from  a normal male (red) and a normal female 
(greend) individual. Chromosome Y and X appear as red and green 
respectively confirm ing the copy number differences of these 
chromosomes between the two DNA samples.
1 2 5
3.8 DNA molecules as hybridisation targets
In this part of the study, the possibility of using DNA molecules as the 
hybridisation targets to improve the CGH technique resolution was 
investigated. First, low-density DNA fibres combed on glass slides were used 
as the targets for comparative cosmid hybridisations. Then high 
concentration arrays of DNA fibres were the target of comparative genomic 
hybridisation. Finally, DNA microarrays of ~300-700 bp were targeted.
3.8.1 DNA fibres 
Single DNA fibres
Cosmid MA2B3 which contains 35 kb of human dystrophin gene including 
exon 48 was used as the hybridisation target. MA2B3 was first treated with 
Not I, resulting in linearisation of the cosmid with the vector at one end of the 
fibre. The 35-kb fragments were then attached to glass slides pre-treated 
with silane using DNA combing approach (see Methods). Cosmid DNA was 
then directly labelled with FITC (green) and TR (red). Differentially labelled 
cosmid DNAs in different ratios were then hybridised to their respective 
combed cosmid fibre. The chosen ratios of FITC to TR labelled DNA 
fragments in the hybridisation solution were 1:2, 2:3, 1:1, 3:2, 2:1 and 3:1. 
Green and red dots along the combed fibres corresponding to FITC and TR 
labelled fragments were then visualised using a fluorescence microscope 
and image analysis software (see Methods). Images of 14-22 DNA fibres 
were acquired by a CCD camera using FITC- and TR-specific filters. For 
each ratio of FITC and TR-labelled cosmid DNAs the measured fluorescence 
values for FITC and TR and the FITC to TR ratio was calculated for each 
DNA fibre. The relative increase of FITC- versus TR-labelled DNA fragments 
in the probe mixture resulted in an increase of the measured FITC 
fluorescence in proportion to the TR fluorescence values. (Figure 3. 30 and 
Table 3. 10 to Table 3. 15 )
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Table 3. 16: Comparative cosmid hybridisation to 106 DNA fibres: summary of 
results
Ratio of FITC/TexasRed labelled 
DNA in hybridisation solution
No. fibres examined Mean of observed 
Green/red
3/1 17 3.05
2/1 22 1.92
3/2 16 1.48
1/1 14 0.97
2/3 18 0.69
1/2 19 0.55
139
-------------
♦ M ean  of 
green /red  ratios
2 4
FITC/TexasRed
Figure 3. 30: Mean of normalised green/red ratios plotted against the fluorochrome ratios
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C G H  to dotted high density DNA fibres
In this part of the study, high-density DNA fibres were used as hybridisation 
targets (Figure 3. 31). <0.1 to 0.3 jil of solutions containing -100-300 ng of 
cosmid DNA were spotted on silane or poly-l-lysine pre-treated glass slides (see 
Methods, Figure 3. 32 and Figure 3. 33). Differentially labelled genomic DNAs 
from normal male and females were then co- hybridised to the DNA spots. 
Normalised green to red ratios of measured fluorescence intensities were 
directly related to the relative copies of chromosomes X and Y in the 
differentially labelled DNAs.
141
Figure 3. 3 1 : 400x magnification of YOYO-1 stained high-density cosmid fibres containing exon-48 of 
human DMD gene.
1 4  2
Figure 3. 32: Spotting of DNA targets on pre-treated glass slides for CGH.
(a) A glass needle is put in the DNA solution, (b) The DNA is sucked to the glass needle by capillary 
effect, (c) The needle containing the target DNA is then assembled on the inverted microscope and 
(d) the DNA solution is put on the glass slide guided by use of the inverted microscope.
1 4 3
yMM
mm
Figure 3. 33: A close up view of the immobilised spotted DNA fragments.
For each hybridisation area, 16 DNA spots were spaced at a distance of 4-1 Opm (where glass 
capillaries used under the inverted microscope) to 400pm (where m icropipettes used) from 
centre to centre.
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Table 3. 17: CGH to high density DNA fibres dotted on glass slides
Target
spot
Group 1 (XX green, XY red) 
Fluorescence intensity
Group 2 (XX Red, XY green) 
Fluorescence intensity
Green
(XX)
Red (XY) Green/Red
(XX/XY)
Green (XY) Red (XX) Red/Green
(XX/XY)
1 233671 123429 1.89 765919 1457990 1.90
2 3386842 1928879 1.76 2548985 5485995 2.15
3 4315732 2316494 1.86 2335761 5728764 2.45
4 11503311 5175937 2.22 1866147 3340121 1.79
5 1522375 718576 2.12 1501678 2749727 1.83
6 2392204 1421344 1.68 1318542 2603683 1.97
7 6657908 3872820 1.72 5487636 9070159 1.65
8 4710801 2944016 1.60 1090480 2561052 2.35
9 4319301 2500463 1.73 2492877 5409952 2.17
10 4426536 2354130 1.88 138140 283399 2.05
11 2551258 1512706 1.69 1340842 3303440 2.46
12 5961115 3123223 1.91 1379924 3312934 2.40
13 10590421 5453315 1.94 2884739 4961156 1.72
14 2035965 1141460 1.78 3343475 6824490 2.04
15 6726211 3926917 1.71 3425583 6772805 1.98
16 12843629 7072546 1.82 1796527 3457514 1.92
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Figure 3. 34: Graphic depiction of results shown in Table 3 .17 . Fluorescence intensity ratios 
in CGH to two groups of 16 DNA spots are shown together. As illustrated XX/XY ratio despite 
the alteration of the fluorochromes remained almost the same confirming the direct relationship 
between the copy numbers of X chromosomes and the corresponding fluorochromes. 
Significance of these findings are discussed in next chapter.
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3.8.2 DNA microarrays
Optimisation
Three target sequences, corresponding to the exon 48 of human DMD  gene on
chromosome X, SRY gene on chromosome Y and hMSH2 gene on 
chromosome 2 were selected. Using appropriate oligonucleotide primers, target 
DNA segments were amplified (Figure 3. 35). The amplified DNA with the 
concentration of1 pg/ pi were then stained with YOYO-1 and spotted on silane 
or poly-l-lysis treated glass slides (see Methods).
1000 bp 
500 bp 
300 bp
Figure 3. 35: Agarose gel showing amplification products from SRY lane (1) DMD lane (2) and 
hMSH2 genes lane (3). L=1 kb DNA Ladder.
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A routine denaturation protocol which involved 70°C formamide approach (see 
Chapter 2) was carried out. The YOYO-1 stained DNA spots were then checked 
under a fluorescence microscope. DNA spots were not detectable, indicating 
that most of the DNA arrays had been washed out during the denaturation and 
washing procedures and those remaining were insufficient to be visible.
Denaturation of the DNA targets in 100°C distilled water (instead of formamide) 
for one minute improved the DNA yield but was still not acceptable for 
fluorescence hybridisation. To bypass the denaturation stage, it was decided to 
make the DNA targets single stranded before spotting them on the glass slide.
The PCR products were made single stranded using magnetic beads (Figure 3. 
36)(see Methods).
bp
bp
Figure 3. 36: Agarose gel showing single stranded PCR product of DMD gene (1). Single 
stranded DNA is produced using magnetic beads. Details of the procedure are described in 
chapter 2. L=1 kb DNA Ladder.
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The single stranded DNA products were then spotted on silanised glass 
alternatively in a manner that the DNA targets corresponding to the X and Y 
chromosomes were separated by a spot corresponding to chromosome 2 DNA. 
In each slide, 16 spots were produced (see Methods). Fluorescence intensity 
corresponding to the YOYO-1 stained spots were then measured before the 
slides were incubated at 37°C for 48 hours followed by washing steps similar to 
those of standard CGH. The fluorescence intensities corresponding to the spots 
were measured again and compared to those obtained before incubation and 
washing steps. It was found that more than 60% of the DNA had remained on 
the slides despite incubation and washing steps. Based on this finding it was 
concluded that the previously single stranded DNA were the best choice as the 
target of hybridisation.
CG H to Single stranded DNA arrays
Un-stained single stranded DNA arrays corresponding to the exon 48 of human 
DMD gene, SRY gene and hMSH2 gene were spotted on glass slides. Equal 
amounts (2-7 pg) of differentially labelled DNAs corresponding to normal male 
and normal female individuals were co-hybridised to the DNA microarrays. After 
48 hours of hybridisation and washing steps, the spots were examined under 
x10 magnification of fluorescence microscope. Areas of similar sizes were 
chosen and total fluorescence values for that area were measured.
The ratios of averaged values of red and green signals corresponding to the 
autosome spots were calculated and were used as correction values for the 
normalisation of averaged red and green fluorescence values corresponding to 
DMD and SRY spots. Finally the corrected fluorescence value for each spot was 
calculated and the fluorescence ratio of each spot was obtained by dividing the 
corrected green with the corrected red fluorescence intensity.
No significant difference of the green to red ratio between different spots was 
detected where less than 7 pg of each DNA had been used.
149
Where 7 pg of each hybridising DNA (normal male and normal female) was 
used a significant difference of the fluorescence ratio between DMD and SRY 
spots was present. Therefore a hybridisation solution containing 7 pg of each 
DNA was used for the next stage of the study.
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(a)
(b)
Figure 3. 37: CGH to single stranded DNA microarrays (normalised image): (a) Differentially labelled 
DNAs from a normal female (green) and a normal male (red) are co-hybridised to 16 spots of single 
stranded DNA microarrays corresponding to DMD. hMSH2and S flKgenes. (b) DMD and SAfKspots are 
positioned at 1.1, 2.4. 3.3,4 2 and 1.3. 2.2, 3.1.4.4 respectively. The remaining spots corresponding to 
\hehMSH2 gene are used as controls. Data extracted from this image is summarised in Table 3. 18
1 5 1
Table 3. 18: Data extracted from the image shown in Figure 3. 37.
Position Sequence Area Total Green Total Red Expected G/R  
ratio
Observed G/R  
ratio
1.1 DMD 147 6596 3769 2 1.75
1.2 hMSH2 142 5665 5664 1 1.00
1.3 SRY 156 1007 5304 0 0.19
1.4 hMSH2 172 4562 4905 1 0.93
2.1 hMSH2 159 4545 4573 1 1.00
2.2 SRY 146 1403 4526 0 0.31
2.3 hMSH2 152 4683 5098 1 0.92
2.4 DMD 153 5349 2922 2 1.83
3.1 SRY 155 558 4650 0 0.12
3.2 hMSH2 136 4675 4807 1 0.97
3.3 DMD 148 4503 2602 2 1.73
3.4 hMSH2 164 5123 5568 1 0.92
4.1 hMSH2 114 3758 3660 1 1.03
4.2 DMD 117 4920 2392 2 2.05
4.3 hMSH2 128 5155 5300 1 0.97
4.4 SRY 91 247 3094 0 0.08
152
g> 0.5 ■
1 6 11 16 
Targets
Figure 3. 38 Scatter graphic of the results shown in Table 3. 18. Results corresponding to DMD 
and SRY spots are shown from 1-4 and 13-16 respectively. Results from the control spots are 
shown between the two (5-12). As illustrated a significant difference between the Green/Red 
ratio corresponding to DMD and SRY spots is clear.
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DNA samples from 2 male individuals with complete deletion of exon 48 of DMD 
gene were then used as test DNA in CGH experiments to DNA array targets 
made of exon 48 of DMD gene. SRY targets were used as controls. Differentially 
labelled (TexasRed) DNA samples from normal male individuals were used as 
control in the hybridisation mixture. Using the same approach described earlier, 
green to red fluorescence ratios corresponding to the test and to the control 
samples were calculated. A linear relationship between the observed ratio and 
the expected values for deletion was found. Results are summarised in Table 3. 
19.
Table 3 .19: Data from CGH to 2 groups of 9 spots of single stranded DNA microarrays 
corresponding to DMD and SRY  genes using DNA from two patients with complete deletion of 
exon 48 of DMD. DNA from a normal male individual was used as normal control (red).
Position Sequence Patient 1 (green) v Normal 
male (red)
Patient 2 (green) v Normal 
male (red)
Expected 
G/R ratio
Observed 
G/R ratio
Expected G/R  
ratio
Observed 
G/R ratio
1.1 DMD 0 0.3 0 0.08
1.2 SRY 1 1.11 1 1.05
1.3 DMD 0 0.11 0 0.17
2.1 SRY 0 1.00 1 0.99
2.2 DMD 1 0.08 0 0.34
2.3 SRY 1 0.99 1 0.93
3.1 DMD 0 0.12 0 0.07
3.2 SRY 1 1.02 1 0.97
3.3 DMD 0 0.02 0 0.11
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normal
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deletion
— X - Patient 2
Figure 3. 39: Graphic depiction of the results shown in Table 3. 19. Results corresponding to 9 
DMD spots from 2 experiments are shown. As illustrated the observed ratio values from both 
patients are significantly shifted towards the expected value fo r the deletion of the exon 48 of the 
DMD gene.
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X 1 { 2.
Figure 3. 40: A close up view of the immobilised spotted DNA fragments. For
each hybridisation area, 16 DNA spots were spaced at a distance o f4-10pm  (where glass 
capillaries used under the inverted microscope) to 400pm (where micropipettes used) from 
centre to centre.
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4:Discussion
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4.1 Optimisation of the CGH technique for clinical 
cytogenetics laboratory
The initial part of this work was to optimise the CGH method for use in clinical 
cytogenetics. Standard methods at the time of the beginning of this study were 
first used (Kallioniemi et al 1992; du Manoir et al 1993). Three experiments 
performed using the direct method and four experiments using the indirect 
method failed to produce analysable results.
The modified approach described in this study reduced the time required for the 
experiment in various steps of the CGH experiment. Meanwhile the technique 
proved more reproducible and reliable.
4.1.1 Target metaphase
It is now generally accepted that metaphase preparations ideal for G-banding 
analysis are not necessarily optimal for CGH analysis. Earlier studies had 
recommended some measures for evaluating the target metaphases for CGH. 
One (Kallioniemi et al 1994) suggested preparing a large numbers of slides from 
one batch and carrying out a CGH experiment on several slides from that 
particular batch. If the results were acceptable then the remaining slides from 
that particular batch would be used, otherwise they would be abandoned. 
Another suggestion (Lichter et al 1995) was to evaluate each particular batch of 
slides by performing mono-colour genomic hybridisation.
The finding of this study that the quality of hybridisation could be predicted by 
DAPI counterstaining after denaturation of the target metaphases, has an 
important impact on reducing the time and expense of the metaphase 
evaluation.
Proteinase K treatment of the target metaphases was not found to have a major 
impact on the quality of the hybridisation and was therefore abandoned from the 
protocol.
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4.1.2Denaturation conditions
Increasing the denaturation temperature or time improves the intensity of 
hybridisation signals but at the same time damages the chromosome 
morphology. As shown in Figure 3. 1 the best results were achieved when the 
slides were incubated at 74°C for 3 minutes. While this condition is much 
harsher than that in FISH, it is very close to that recommended by Kallioniemi et 
al (1992-1994). However, it should be mentioned that these parameters may 
require to be altered for some batches of slides.
4.1.3 Genomic DNA concentration
In the modified approach the amount of the test and control DNAs used for the 
hybridisation has been increased up to 1 pg. In standard protocols reported up 
to the time of beginning this study (1995), 200-400 ng of DNA was used for each 
hybridisation. Increasing the amount of the genomic DNA used for the 
hybridisation up to 1 pg was found to increase the quality of hybridisation. As 
shown in overnight CGH, using up to 5 pg of each genomic DNA has no 
adverse effect on the hybridisation.
4.1.4 Genomic DNA labelling
The main advantage of indirect over direct labelling of DNA probes is the strong 
intensity of hybridisation signals obtained by indirect labelling after several 
layers of signal amplification. However, direct labelling using higher 
concentrations of hybridising DNA yields hybridisation signals with strong 
intensity, low background and smooth coverage of the target chromosomes 
which are the requirements for CGH. Moreover CGH protocols which use 
directly labelled genomic DNA are simpler and require a shorter time.
Early reports mentioned that the direct methods result in a higher background, 
but this problem was not encountered in this study. However, when the 
fluorescence signal is weak, the CCD camera requires a longer exposure time
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for image capture resulting in the capture of background surrounding the 
chromosomes.
4.1.5 Probe size
From the first description of CGH up until now, it has been emphasised that the 
size of the genomic DNA probes is a very important factor for CGH quality. It is a 
part of almost all CGH protocols to measure and adjust the size of the labelled 
DNA before hybridisation. It was found in this study that after optimisation of the 
CGH technique in the lab, the size of the labelled DNA is usually in the desired 
range. Therefore, measurement of probe size is not necessary in each 
experiment. This finding again reduces the time required for the experiment and 
makes CGH more practical for routine use.
4.1.6 Post-hybridisation steps
Post-hybridisation steps applied in the modified protocol described in this study 
are sufficient and less complex than published protocols which again reduces 
the time required for each experiment. This protocol is similar to those used in 
current standard FISH protocols.
4.1.7 Image analysis
According to this study, chromosomal imbalances can be detected by visual 
inspection of CGH images followed by global analysis of the fluorescence 
intensity ratios. When no abnormality is suggested further profile analysis was 
shown to reveal no previously undetected abnormality. As a very high resolution 
cooled CCD camera was used in this study for the capture of images, it is not 
clear whether lower resolution cameras can provide such images adequate for 
visual analysis. However, a statistical profile analysis is highly advantageous for 
detailed analysis of small abnormalities.
Until the very last stages of this study the IP-LAB software with SmartCapture 
extension was used for the image analysis.
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Scripts written after each experiment were used to semiautomate the 
background removing, segmentation and normalisation steps. This measure 
was very time- saving. As it takes about 10-12 minutes for each image to be 
processed manually, a 20-image set required about 3-4 hours to process. 
However, using the new Quips software (or equivalent software) and computers 
with faster processors each image is processed in a few minutes, and thus there 
is no need for this facility in standard CGH analysis. As is discussed later, 
SmartCapture software may still be preferred for the analysis of telomeric 
regions.
4.1.8 The modified protocol
In summary, the modified protocol provided more reproducible, less complex 
CGH experiments. Meanwhile, images obtained using the modified approach 
were of higher quality and had lower background. This protocol follows the 48- 
72 hours hybridisation time but uses shorter post-hybridisation steps. As the 
post-hybridisation steps are less complex and very similar to those are already 
applied for FISH, it is familiar in the in situ lab.
4.2 Test of modified protocol using known cytogenetic 
abnormalities
There was complete agreement between the CGH and conventional 
cytogenetics on all samples of the series of known cytogenetic abnormalities 
examined in this part of the study. Thus, it is evident that CGH can provide an 
alternative method of detecting common chromosome abnormalities when there 
is difficulty in obtaining good quality metaphases.
CGH may be helpful in analysis of samples from aborted foetuses or tissues 
from still-born babies with suspected chromosomal abnormalities. CGH may 
even be helpful in detecting unbalanced chromosomal aberrations present in 
frozen stored samples from many years ago. Many samples used in early 
stages of this study were obtained from cells frozen since early 1970s. These
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samples could not be reconstituted, but the DNA contents of the cells proved 
applicable for study.
Another application of CGH would be the detection of common numerical 
abnormalities in a prenatal diagnosis service. This approach is comparable to 
interphase cytogenetics and much faster than the conventional AF culture which 
takes more than 2 weeks. It would be useful only for unbalanced abnormalities 
as CGH is unable to detect balanced aberrations. While this is an important 
disadvantage, it does not have a practical impact as pregnancies carrying 
balanced abnormalities are allowed to continue, especially when parents with 
the same aberrations have no clinical symptoms. Moreover, in pregnancies 
suspected to carry balanced aberrations, when appropriate tissue is available, 
interphase FISH would be the technique of choice.
Although the resolution of the standard CGH is almost the same as that of the 
G-banding, CGH could be useful in circumstances in which the banding pattern 
has not changed but an unbalance aberration is present.
4.3 Improving limits
4.3.1 Mosaic supernumerary ring Chromosome 19 identified 
by CGH
So far the approach to determining the origin of cytogenetically unidentifiable 
chromosomes has involved stepwise FISH using forward painting methods with 
alpha-satellite, single-copy or whole chromosome painting probes, or reverse 
chromosome painting procedures with either flow-sorting or microdissection of 
the particular chromosome (Blennow et al 1992; Carter et al 1992; Magnani et al 
1993; Lengauer et al 1991; Deng et al 1992; Ohta et al 1993; MullerNavia et al 
1995; De et al 1996). Microdissection followed by DOP-PCR amplification of the 
dissected DNA is increasingly being used and its modified approaches are 
reported to be so efficient that just one dissected DNA fragment is sufficient for a 
successful analysis (MullerNavia et al 1995). However, not all diagnostic
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cytogenetics laboratories have easy access to microdissection technology. In 
the case reported an alternative approach which is not dependent on patient 
metaphase and is a genome-wide screening technique enabling the result to be 
achieved in just one experiment. Many image analysis systems now in use in 
cytogenetic laboratories include software for CGH, and results of analysis are 
available in three working days, which is comparable to the time required for 
microdissection. Where further confirmation by FISH is necessary one more day 
is required.
An advantage of CGH over microdissection is that as demonstrated here, it can
provide an estimate of the proportion of cells containing the ring chromosome in 
the tissue studied. This information is laborious to obtain by chromosome 
analysis or interphase FISH. The minimum percentage of abnormal cells that 
can be detected by CGH has not yet been defined but based on this report, as 
low as 28 percent mosaicism in cultured metaphase cells could be detected. 
Theoretically, employing a medium restrictive fluorescence ratio of 0 .75-1.25, 
there should be at least 50% abnormal cells present for the chromosome 
imbalance to be detected (du Manoir et al 1995 a, b; Piper et al 1995). In the 
present case, fluorescence ratio 0.8-1.20 was the most restrictive threshold at 
which the abnormality was detected, which leads to an estimation of the 
percentage of abnormal cells in uncultured blood of at least 40%. This 
proportion differs from the result of cytogenetic analysis in cultured cells which is 
based on a small sample of metaphases obtained from PHA stimulated T- 
lymphocytes, and which showed not more than 28% abnormal cells.
Since in CGH the centromeric regions are suppressed, the method would not be 
applicable to ring or marker chromosomes composed almost entirely of 
centromeric heterochromatin.
In the case described here no short arm material could be demonstrated in the 
ring chromosome either by CGH or by FISH using short arm paint, suggesting a 
breakpoint at or immediately adjacent to the centromere. No more detailed 
studies have yet been undertaken to define this breakpoint more precisely. CGH
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studies indicate that virtually the entire long arm of chromosome 19 is present in 
the ring, although by FISH the telomeric region is shown not to be present. As is 
shown in this study, partial trisomy or partial monosomy of as little as 4-5 Mb 
can be detected in telomeric regions by CGH. The fact that CGH has not shown 
any variation in copy number of any part of 19q suggests that the break-point is 
within 5 Mb of the telomere, and that the loss of long arm material in the 
formation of the ring chromosome is beyond the resolution of CGH.
The first series of FISH experiments using empirically selected centromeric 
probes including one for chromosome 19 failed to reveal the origin of the ring. 
This may be explained in part by the low percentage of cells containing the ring, 
and difficulties in identifying it with certainty in some mitoses. Also the alpha 
satellite probe hybridising to chromosomes 1, 5 and 19 was used in the study 
since at that time it was the only available centromeric probe for chromosome 
19. It is possible that a small change in stringency conditions caused some loss 
of signal for chromosome 19.
As discussed above, when no cytogenetic or clinical clues are available, a 
multicolour or stepwise FISH approach with or without chromosome 
microdissection may be employed to identify the origin of a marker 
chromosome. However, in investigating small marker chromosomes, many 
service laboratories presently carry out sequential experiments employing FISH 
probes that are selected empirically. This experience indicates that in FISH 
studies the empirical approach may not detect a marker that is present in a 
lower percentage of metaphases even although it is detected subsequently in a 
targeted FISH study. Although this experience is unlikely to be a frequent 
occurrence, it is one that is important for clinical cytogenetic practice.
4.3.2 CGH for cryptic translocation screening in patients 
with idiopathic mental retardation
A cryptic translocation is one which cannot be observed by conventional 
cytogenetic analysis, either because the size and banding pattern of the
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chromosome regions involved are too similar for the exchange to be detected, or 
because the size of the exchanged segments is close to the limit of resolution of 
the cytogenetic technique (Lamb et al 1989; Overhauser et al 1989; Ledbetter 
1992; Wilkie et al 1993). Small translocations involving telomeric regions of 
chromosomes are especially difficult to detect since most telomeres have a 
similar banding pattern. To date, detection of cryptic telomeric translocations has 
mostly relied upon the presence of clinical or cytogenetic clues that point to a 
specific chromosome deletion or duplication syndrome. The availability of DNA 
probes that permit informative DNA or molecular cytogenetic studies is also 
crucial. To diagnose cryptic translocations without a specific clue to the 
chromosome segment involved requires a genome-wide screening technique.
The data presented here show that modified CGH analysis can detect 
unbalanced cryptic, telomeric translocations of at least some chromosomes. 
Previously, data relating to the telomeric regions of the chromosomes have 
always been excluded from CGH analysis (Kallioniemi et al 1994), mainly 
because the green and red fluorescence intensities gradually decrease at the 
chromosome telomeres, and therefore, a reliable colour ratio is not possible with 
the currently used algorithms. However, by introducing a new strategy involving 
close attention to previously ignored telomeric regions and the application of a 
highly restrictive threshold, we have been able to demonstrate translocations 
involving the telomere of 2q and 17q, 20p and 4q, 20q and 10q.
It was noted that partial trisomy was more readily demonstrated by the modified 
technique than was partial monosomy. This phenomenon may be due to the 
behaviour of the fluorescence intensities at the chromosome terminals: when an 
extra copy of DNA from a telomere is present, this may compensate for the 
decreasing fluorescence intensity at the chromosome end and the signal shows 
a sharp rise, while in contrast, the intensity of signal corresponding to control 
DNA gradually decreases at chromosome ends. When this pattern is present 
and the above criteria are adhered to, diagnosis of DNA gain corresponding to 
at least one extra telomere is possible. Conversely, in partial monosomies with 
loss of one copy of the terminal band, there is less difference in the patterns of
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fluorescence intensity in control and test DNA. While the intensity of the test 
signal decreases sharply, the fluorescence intensity of the control signal 
increases slightly at first and then gradually decreases. The initial slight increase 
might be explained by increased hybridisation of control DNA when it competes 
with less test DNA from the deleted chromosome segment. This difference in the 
gradient of the fluorescence intensities, although less obvious than that 
associated with the partial trisomies, was sufficient to lead the detection of DNA 
deletion in the three families described here.
There is no reported evidence that the detection of partial monosomies using 
CGH has proved difficult, at least with respect to larger sizes of DNA loss. On 
the other hand, DNA losses of the size seen here, especially those involving 
telomeric areas, have only rarely been described using other techniques and a 
study of the sensitivity of CGH in this situation is warranted. Results to date 
appear to justify using the modified CGH technique to screen a larger series of 
patients where clinical genetic evidence points to cryptic rearrangement.
Thus when the standard CGH approach detects gain or loss of DNA material of 
one particular telomere, this observation should not be discounted in the 
following circumstances:
1. In cases of gain of DNA material:
a) using a restrictive threshold, global CGH analysis should show similar 
findings in both homologues in most metaphases;
b) intensity of fluorescence corresponding to test DNA at a telomeric area 
should increase, while fluorescence intensity of control DNA decreases.
2. When loss of DNA material is suggested, the intensity of fluorescence 
corresponding to the control DNA increases slightly at first and then decreases, 
but fluorescence intensity of test DNA decreases sharply from the beginning of 
the deleted segment. These patterns must be present in the averaged profile as 
well as in most individual chromosome profiles. Targeted FISH studies using 
appropriate probes are then employed to confirm the CGH results.
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Another approach to genome-wide analysis is provided by combinatorial multi- 
fluor FISH (M-FISH) (Speicher et al 1996) or spectral karyotyping (SKY)
(Schrock et al 1996) where up to 27 different chromosome paint probes 
(including some arm-specific paints) have been used. Whole chromosome FISH 
probes can facilitate the detection of some small rearrangements, but telomeric 
regions are often under-represented in the painting probes (Rosenberg et al 
1992).
During the time of this study telomeric probes for all human telomeres have 
been developed [National Institutes of Health and Institute of Molecular Medicine 
Collaboration, 1996) and may prove more informative using M-FISH or a 
multiprobe coverslip (Knight et al 1997) device. However, to cover the telomeric 
areas of all chromosomes in M-FISH, 48 different telomeric probes in at least 24 
different colours (ideally 48 colours) are required (Ledbetter 1992) and the 
multiprobe coverslip device requires a high quality chromosome preparation of 
high mitotic index. Although the device has demonstrated the presence of 
known abnormalities, it has not yet been tested in a blind study. With both 
methods, subtle cryptic deletions outside the telomeric area may remain 
undetected.
The fact that the highest gene concentrations in the human genome are in 
telomeric bands of metaphase chromosomes (Saccone et al 1992) makes the 
study of these abnormalities particularly important for understanding the causes 
of mental handicap, a common problem which affects up to 3% of all school-age 
children and is of idiopathic or unexplained origin in up to 80% of cases 
(Roeleveld et al 1997; Yeargin-Allosop et al 1997). Recently, Flint et al found 3 
cases of cryptic de novo rearrangements among 99 patients with idiopathic 
mental handicap who were screened for subtelomeric chromosomal 
abnormalities with a combination of molecular cytogenetic and DNA techniques 
(Flint et al 1995). All three cases diagnosed in that report had de novo 
rearrangements whereas the patients described here were selected for detailed 
study because inheritance patterns and clinical features strongly suggested they 
suffered familial chromosomal imbalance. The patients presented in this study
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also had larger, cryptic rearrangements (in the range 4-10 Mbs) which were only 
detected after CGH was adapted to work successfully at its highest reported 
resolution in clinical cytogenetics, close to its ultimate theoretical resolution 
using the current available technology.
Although CGH analysis is presently unable to detect abnormalities less than 
4Mb in size, given the discovery of the important contribution of larger cryptic 
rearrangements to familial, idiopathic mental handicap, there is a high priority to 
investigate the use of CGH as a tool for genome-wide screening in a larger 
series of sporadically affected individuals with idiopathic mental handicap.
4.3.3 CGH for hyperploid tumours
Absolute intensity is based on various parameters from the DNA samples to 
target metaphase and optical setting as well as the real copy numbers. Thus, 
normalisation is carried out to compensate the effect of all other parameters 
except the copy number differences. The current approaches for normalisation 
are based on the assumption that because the same concentrations of the test 
and the control DNA are used, the fluorescence intensity corresponding to them 
should also be the same.
Table 4.1 Main parameters in absolute fluorescence intensity
Illumination brightness
Filter bandwidths
Dye absorbance
Quantum efficiency
Camera sensitivity
Exposure time
Bleaching hybridisation efficiency 
DNA concentration
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DNA labelling efficiency 
Metaphase quality
The total green/red fluorescence intensity after normalisation is 1. Each 
chromosome will contribute to the total fluorescence intensity based on its 
chromosome contents. For example, in a normalised CGH image corresponding 
to a karyotypically normal test DNA, chromosome 1 constitutes about 8% of the 
total fluorescence value after normalisation. This figure is deduced from relative 
length of this chromosome with respect to total diploid genome.
In case of trisomy 1, DNA sequences corresponding to this chromosome 
constitute about 12% of the total diploid DNA and therefore 12% of the total 
fluorescence value. This increase occurs at the expense of a reduction in the 
percentage of all the other chromosomes. In near triploidy, trisomic 
chromosomes constitute a higher percentage of the total DNA at the expense of 
a larger decrease in the percentage of normal chromosomes. This phenomenon 
results in a misleading ratio profile showing a loss of DNA corresponding to the 
normal chromosomes. However, if the CGH analysis is performed on the 
fluorescence ratio corresponding to chromosomes with known copy numbers 
this misinterpretation will not occur.
4.3.4 Overnight CGH
Standard CGH protocols are based on protocols which require 2-4 days of 
hybridisation. Routine CGH applications are not critically dependent on time. 
Therefore, a shorter CGH protocol may not have a very important impact on 
routine CGH applications. On the other hand the protocol presented in this study 
is mainly based on increasing of the amount of DNAs and fluorochromes used 
and therefore is more expensive.
In newborns with severe malformations in life threatening conditions or 
newborns with ambiguous genitalia a chromosome analysis is required for
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proper diagnostic and therapeutic procedures. Chromosome analysis based on 
direct preparations from bone marrow samples or more recently from uncultured 
neonatal blood are used for rapid cytogenetic analysis. In certain conditions 
however, metaphase chromosomes are not available and therefore overnight 
CGH may be helpful.
4.4 Reinterpretation of a putative isochromosome Xp
Cytogenetic analyses show that the region Xq11.2-q21 is retained in all 
structurally abnormal X chromosomes. True isochromosomes for Xp probably 
do not exist in a liveborn. There are no non-mosaic reported cases with 
complete duplication of i(Xp) confirmed by FISH or molecular techniques. From 
such observations the conclusion is drawn that this 'critical region' contains the 
locus controlling X inactivation. Structurally abnormal X chromosomes without 
the X-inactivation centre would allow nullisomy, disomy, or trisomy for genes on 
the X chromosome-presumably nonviable states.
Brown et al (1991) describe XIST (X-inactivation specific transcript) gene which 
is expressed specifically from inactive, but not active, X chromosomes. By in situ 
hybridisation, the XIST gene is located in band Xq13, at the interface of bands 
Xq13 and q21.1.
The true chromosomal constitution of the case with putative isochromosome Xp 
presented in this study, was detected in a similar manner to that described for 
the case of ALL with abnormal chromosome 9 (4.6.1).
Visual CGH showed that the intensity of fluorescence signals corresponding to 
Xq centromere to Xq21 of the test DNA was the same as the signal 
corresponding to that segment of the control DNA. Moreover, profile CGH 
analysis showed a 1/1 test/control ratio at this segment when a normal female 
had been used as control and 2:1 ratio when a normal male had been used as 
control, confirming that the patient has more copies of this segment than a 
normal male has.
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This confirmed the presence of Xq segment and XIST region in the abnormal X 
chromosome. This experience shows again the ability of CGH as a 
complementary technique to the current techniques.
4.5 A case of follicular lymphoma with double minutes 
and complex cytogenetic abnormalities
A case of follicular lymphoma is presented in which multiple abnormalities in the 
absence of t( 14; 18) were present. Chromosome 1q and 12q duplications are 
reported to be correlated with low grade and low-intermediate clinical 
aggressiveness (Yunis et al 1987). On the other hand double minutes and 
abnormalities of chromosome 3 found in this case are reported to be 
accompanied with poor prognosis (Yunis et al 1987).
Double minute chromosomes are structures indicating gene amplifications which 
are frequently found in certain solid tumour types. Double minutes are a rare 
finding in follicular lymphoma. Among three large series analysed for cytogenetic 
abnormalities in follicular lymphomas, only Yunis et al (1987) found 4 patients 
with double minutes or homogeneous staining regions (HSR) out of 71 patients 
they studied. No cases of follicular lymphoma with DMs or HSRs were found 
among the patients studied by Tilly et al (1994) nor those studied by Avet- 
Loiseau et al (1997). On the other hand Yunis et al (1987) found a +3 or 
duplication 3p in 14% of the cases they studied, mostly among those negative 
for t(4; 18) [7/11 in t(14;18) negative cases compared to 3/60 in t(14; 18) positive 
one].
Several abnormalities found in this case had remained undetected by G-banding 
and were identified only when CGH localised them on target metaphases. Since 
both chromosome 8s were normal in G-banding and no landmarks were present 
on the additional material on 3p, this abnormality was detected only when CGH 
found a gain of DNA material corresponding to 8q. Targeted FISH then 
confirmed that the additional material originated from chromosome 8.
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Abnormalities found on chromosomes 1 and 12 also were resolved with the help 
of CGH and confirmed by targeted FISH.
As double minute chromosomes play a critical role in tumour cell genetics where 
they are frequently associated with the over expression of oncogene products 
(Hahn, 1993), the 3p26 amplification found in this case may present a candidate 
locus for a possible oncogene at this site.
4.6 CGH for the investigation of haematological 
malignancies
In the present study, 14 patients with haematological malignancies were 
examined, and the results were compared with karyotypes obtained by banding 
analysis. In 2 cases CGH did not detect the abnormality found by conventional 
cytogenetics because of the balanced nature of the rearrangements. Both CGH 
and conventional cytogenetics found no abnormality in 5 samples. In 3 abnormal 
cases CGH and G-banding results were compatible. In 3 patients CGH detected 
abnormalities missed by banding technique.
4.6.1 A case of ALL with 9p;9q translocation
In the first case, after detection by CGH of partial gain and losses for 9p and 9q, 
retrospective analysis of the metaphase chromosomes from the patient 
confirmed the existence of an abnormal chromosome 9 in 2 metaphases. 
Standard banding suggested that the abnormal chromosome 9 was an 
isochromosome and a referral lab confirmed that diagnosis. However, this 
diagnosis was based on only two very low quality metaphases and was not 
compatible with the CGH finding which showed a small segment of chromosome 
9p to be present. This discordance could not be resolved as no metaphase 
chromosome was available from the first sample and the next sample revealed 
no abnormality because the patient had already undergone therapy. This 
discordance was resolved one year later when the patient had a relapse. 
Chromosome analysis from a metastatic tumour showed an abnormal
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chromosome 9, with two equal size arms, very similar to an isochromosome 9. 
But the G-banding results suggested a 9p;9q translocation leading to a partial 
monosomy/trisomy of 9p and 9q respectively. The derivative chromosome as 
suggested by G banding was: der (9)(qter->q22-34::p22-> qter). As shown, the 
banding pattern of the suggested derivative chromosome is very similar to that 
detected by the CGH. Although the similarity of the banding pattern is a real 
problem in G banding analysis, this is not an issue in CGH.
a b (c)
Figure 4 .1 :  (a) The derivative chromosome suggested by G banding (b) D igitally magnified 
image of the abnormal chromosome 9 discussed here, (c) The derivative chromosomes 
suggested by CGH. As shown, the banding pattern of the chromosome is sim ilar to (c). This 
finding together with FISH results confirms the CGH findings.
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The breakpoint suggested by the G-banding was more distal than that 
suggested by CGH. FISH however confirmed the CGH findings. As G banding is 
dependent on the light and dark banding pattern present on the chromosome 
arms, this technique is unable to detect the abnormality when the banding 
pattern is not changed, or the quality of the metaphase spread is not high 
enough to define the precise breakpoint.
The CGH finding of the deletion of 9p at 9p12 is compatible with the fact that 
deletion of 9p 21-22 is associated with about 7-13% of ALL. More studies to 
determine the precise molecular nature of the abnormality was not performed as 
that was not an aim of the study.
4.6.2 A case of AML with loss of the Y chromosome
Standard CGH showed a loss of Y chromosome, which was compatible with that 
of the G banding. Visual analysis of the CGH image, however, showed green 
signals corresponding to the test DNA on the target Y chromosome. In case of 
complete loss of the Y chromosome there should have been no signal 
corresponding to the Y chromosome. The presence of the signal corresponding 
to Y chromosome confirms the existence of cells containing Y chromosome 
sequences. There are at least two theoretical explanations for this matter. First, 
although no Y chromosomes are present in the cell compartment there are 
some Y chromosomes sequences inserted into other chromosomes. Another 
explanation would be a presence of a population of cells with normal karyotype 
missed by chromosome analysis. The second explanation looks more likely. As 
no additional material was available, FISH or other confirmatory technique could 
not be performed.
The loss of the Y chromosome is a feature found in haematological 
malignancies but it is also found in normal bone marrow in elderly males. The 
degree of loss of Y (% -Y cells per patient) increases with age in normal 
individuals but not in patients with MDS or AML. Therefore, in elderly men -Y is 
not indicative of malignancy and should not be considered as a marker of the
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malignant clone. This finding therefore has mostly a technical impact rather than 
a diagnostic one.
In approximately 5-10% of haematological malignancies, cytogenetic analysis is 
not successful because of poor preparation quality or low mitotic index (Success 
rate figures from U.K. NEQAS 1995/6). On the other hand normal karyotypes 
are found in 40% of cases in large prospective studies investigating acute 
myeloid leukaemias, which, at least in part, is due to mitotic cells arising from 
nonlukaemic cells (Bloomfield and de la Chapelle, 1987).
This study shows that CGH can play an important role as an additional tool in 
cytogenetic analysis. As CGH is not dependent on dividing cells it has, with 
certain limitations, the potential to distinguish true chromosome gain or loss from 
complex karyotypes. CGH has also the ability to pinpoint the origin of 
chromosome gain or loss in cases with simple unbalanced abnormalities. This 
advantage simplifies the selection of chromosome probes for further FISH 
studies. In rare cases, double minutes are present in myeloid leukaemias. By 
CGH, the chromosomal localisation of such amplified sequences can readily be 
determined and this can lead to the identification of a specific gene being 
amplified. CGH can also provide a way forward in cases where cytogenetic 
analysis is unsuccessful or not possible. As a well established technique for 
genome wide screening, CGH may help to uncover masked or underlying 
abnormalities, and in this respect it is important that successful results can be 
obtained from volumes of samples as low as 0.3 ml.
4.7 CGH using universally amplified DNA samples
The combination of CGH and DOP-PCR in this study confirms the earlier reports 
regarding the use of universally amplified DNA for CGH. DNA samples as low as 
1 ng were used in this study.
Speicher et al (1993) reported a technique based on CGH and DOP-PCR which 
allowed the detection and chromosomal localisation of DNA sequence copy
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number changes in solid tumor genomes from frozen sections and paraffin 
embedded, formalin fixed specimens.
Wiltshire et al (1995) used DNA extracted from microdissected tumour for DOP- 
PCR. The present study shows the feasibility of using this approach in 
conditions where sufficient samples are not available for a cytogenetic analysis. 
The quality of images were not comparable to those performed by standard 
approach but sufficient for detection of copy number differences.
Contamination of the test DNA with non-target DNA is theoretically a major issue 
in DOP-PCR. In the present study contamination was not a serious problem as 
all necessary measures had been taken to prevent such problem. Moreover, the 
amount of DNA used in this study was more than used in those other reports 
since a washed out sample from a tube yielded more than 1 ng DNA.
There are some recent reports of using of universally amplified DNA from single 
cells for preimplantation diagnosis. In these situations contamination is 
potentially a serious problem.
4.8 DNA molecules as hybridisation targets
As metaphase chromosomes are used as the hybridisation targets CGH is 
limited to a resolution similar to that of the G banding technique. In theory, the 
resolution of CGH could be improved by targeting the extended chromatin 
targets similar to the high resolution G-banding. This approach has not yet been 
successful because the degree of overlapping of metaphase chromosomes 
causes great difficulties in CGH analysis. Targeting of single or high-density 
DNA fibre molecules, or high density DNA microarrays was thus carried out to 
test the feasibility of high resolution CGH.
4.8.1 Comparative hybridisation to DNA fibre targets
The feasibility study carried out with the cosmid clone shows a direct correlation 
between the ratio of concentrations of differentially labelled probes and the ratio 
of their corresponding fluorescence intensities. An immediate conclusion would
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be that this supports the concept that the copy number differences of genes 
between test and control DNAs should be detectable. The results of this study 
are in accordance with those recently reported by Kraus et al (1997).
In standard FISH as low as 1 ng of labelled probe is used to detect its 
corresponding sequence in the target cell. This volume of probe containing an 
extremely high number of DNA copies makes it very likely that the hybridising 
probe will find its counterpart in the target cell. In standard CGH however, it is 
not possible to have so many copies of each diploid genome.
The cosmid probe used here is about 35 kb in length. This size compared to the 
whole haploid genome is 1/100000 (35 /3000000). This means that 100000 
times higher concentration of the genomic probe for each hybridising DNA 
should be used to keep the hybridisation as efficient as the comparative cosmid 
hybridisation. Based on the results of this study in which as low as 0.1 ng of 
cosmid probes in hybridisation mixture resulted in acceptable results, a 
concentration of about 20 ng (2x10) of each test and control DNA is required 
for a successful CGH analysis. This concentration makes the hybridisation 
solution very viscous preventing an efficient hybridisation. The need for 
competitive Cot-I DNA makes the situation even less desirable.
There are more reasons which make the CGH to DNA fibres even less 
attractive. The main advantage of CGH is its ability to perform a genome-wide 
screening approach. A potentially successful CGH to DNA fibres lacks this 
advantage. Pre-knowledge of the segment to be analysed is required to prepare 
corresponding cosmid target for it. A statistical analysis of data corresponding to 
at least 10-20 fibres analysed is required to successfully detect the copy number 
differences in only one target. An immediate advantage for CGH to DNA fibres 
would be high-resolution assay of copy number of a particular segment of the 
genome. As a previous knowledge of the area to be screened is required other 
currently available techniques, like FISH using site specific probes, molecular 
techniques like RFLP or even certain blotting techniques would do the same 
analysis with less complexity.
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The technical problems regarding the high concentration of the genomic probe 
required for the hybridisation may be overcome by different approaches. By 
substituting a single target with a pool of chromosome segments cloned in YAC, 
BAC, PAC, cosmid or other this problem may be overcome but at the expense 
of resolution. This approach requires preparing several DNA targets isolated 
from clones, and reduces the resolution down to the standard CGH. Another 
approach may be targeting high density DNA arrays from a single cosmid probe 
as used in this study.
4.8.2 CGH to dotted high-density DNA fibres
This study shows that different copy numbers of X chromosome can be detected 
by this approach and deletion or gains of DNA segments of about 35-40 kb 
should be detected. Moreover, by dotting more targets on the glass slide it is 
possible to screen many targets simultaneously. This is an advantage to the 
previous approach applied on DNA fibres which only one target could be 
analysed. Furthermore, fewer spots are required compared to 10-20 fibres which 
are required by the previous approach.
While this study was underway, Solinas et al (1997) reported obtaining 
successful results using a similar approach. They used chromosome-specific 
libraries or human DNA fragments cloned in PAC vectors, 75-130-kb in length 
as target DNA and detected the hybridisation signals by confocal laser scanning 
microscope. The highest resolution they reported was about 75 kb which is 
much lower than that achieved in this study.
4.8.3 CGH to DNA microarrays
Targeting PCR products for hybridisation can be described as a modified 
reversed dot blot technique. In the reversed dot blot assay, PCR amplified test 
DNA is hybridised to the probe dotted on a hybridisation membrane. Main 
differences between the reverse dot blot and the hybridisation technique carried 
out in this study is that the genomic DNA instead of PCR amplified DNA is used
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in the method described here. Another difference is that a glass slide instead of 
a cellulose or plastic membrane is used to immobilise the target DNA. Moreover, 
probes are labelled by fluorochromes and a differentially labelled control 
genomic DNA is co-hybridised with the sample to be tested. However, this 
method is not designed to detect point mutation.
The results described in this study show the feasibility of CGH to DNA array 
targets. This approach would improve the resolution of the technique up to 300 
bp.
One important technical improvement was the use of high density DNA targets 
instead of low concentration DNA fragments. Another main factor is believed to 
be the hybridisation to single instead of double stranded DNA. This measure 
makes denaturation of the target DNA unnecessary and therefore prevents the 
DNA being washed out during the denaturation by 100 °C water or 70 °C 
formamide. Using DNA made by DNA synthesiser may provide a reasonable 
alternative.
Using the currently fast developing robot technology controlled by appropriate 
software makes it theoretically possible to target selected DNA fragments from 
the whole genome simultaneously. An ultimate progress would be a barcode of 
400-800 DNA fragments from all over the genome spotted in a known order on a 
glass slide or an appropriate membrane. Such barcode may be screened in a 
single experiment.
4.9 Conclusion and future prospects
CGH is a powerful adjunct to conventional banding methods and FISH in many 
fields of clinical cytogenetics. These fields include constitutional chromosome 
aberrations and cancer cytogenetics. CGH may detect some abnormalities 
overlooked by current techniques. CGH can be used to help current techniques 
to reinterpret or define the origin of marker chromosomes and isochromosomes 
and detect cryptic chromosomal aberrations. CGH may also help to define the
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origin of double minutes chromosomes in samples from malignant tumours and 
leukaemias.
It is not unrealistic to say that in the near future it will become routine to scan 
automatically by CGH to DNA biochips the entire genome of individual patients 
in a single experiment.
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